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Introduction 
Cancer is a major health problem worldwide. Prevalence of gastrointestinal malignancies 
vary in geographical area and depends upon the genetic, socioeconomic and dietary 
factors(1). Monitoring time trends and incidence is essential for cancer research and health 
care planning. Cancer registries provide the best means of evaluating the cancer burden on 
the general population(2).  
Therefore studying the pattern of gastrointestinal malignancies helps identify people at high 
risk and recommend appropriate preventive and surveillance strategies(1).  
The incidence of cancers is low in India and this is one third to one half of the USA. The 
rates are expected to rise as the life expectancy increases along with urbanization and, within 
the next few decades, may reach those recorded in Indians living abroad. The incidence of 
malignancy of the esophagus and stomach is declining spontaneously in India. It may be 
possible to accelerate this decline by reducing the use of tobacco and improving the diet. But 
at the same time the incidence of cancers of the colon, pancreas, liver and gall bladder is 
rising, largely due to urbanization that leads to major changes in the diet and personal habits. 
A preventive approach is needed by public health education. Individuals should be 
encouraged to retain their traditional protective diets, eat more fruits and vegetables, do more 
physical activity, and abstain from tobacco. Gastroenterologists can help in secondary 
prevention by screening high-risk individuals, e.g., patients with chronic liver disease for 
liver cancer and relatives of patients with familial bowel cancer(3). 
The present study is intended to know the spectrum of gastrointestinal and hepato-pancreato-
biliary tract malignancies at a tertiary centre in south India. 
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 Aims and objective 
 
Aim: To study the spectrum of gastrointestinal and hepato-pancreato-biliary tract 
malignancies at a tertiary centre in south India. 
Objective:  To analyse the clinico-pathological profile of gastrointestinal and   hepato-pancreato-  
biliary tract malignancies. 
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Review of literature 
Cancer is a major health problem worldwide. Prevalence of gastrointestinal malignancies 
vary in geographical area and depends upon the genetic, socioeconomic and dietary 
factors(1). Monitoring time trends and incidence is essential for cancer research and health 
care planning. The analysis of cancer registry databases reveals incidence trends and provides 
information on changes in the characteristic features of the cancers. Cancer registries provide 
the best means of evaluating the cancer burden on the general population(2). Therefore 
studying the pattern of gastrointestinal malignancies helps identify people at high risk and 
recommend appropriate preventive and surveillance strategies(1).  
The incidence of cancers is low in India and this one third to one half of the USA. The 
cancers occur more frequently in the middle aged. The rate is expected to rise in India as life 
expectancy increases. Inspite of advances in diagnostic techniques, surgery, radiation and 
chemotherapy, gastrointestinal malignancy remains undefeated. In absence of screening most 
gastrointestinal malignancies are diagnosed in late stage with regional and distant metastasis. 
The real hope for control and early diagnosis is by screening or primary prevention. 
Gastrointestinal malignancies being deeply seated require investigational modalities like 
endoscopy, ultrasound or CT/MRI abdomen for diagnosis. In western countries tobacco is 
implicated in the causation of nearly 30% of the cancer death. The incidence of malignancy 
of the esophagus and stomach appears to be declining spontaneously in India(3,4). This 
decline may be aided by reducing tobacco use further and dietary improvement. 
Simultaneously, malignancies of the colon, pancreas, liver and gall bladder is rising, probably 
due to urbanization which leads to changes in lifestyle(3,4). 
The present study is intended to know the spectrum of gastrointestinal and hepato-pancreato-
biliary-tract malignancies at a tertiary centre in south India. 
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In a retrospective study by Rawal KK et al published in 1995 on 1751 patients over  period of 
ten years (1984-93), showed that relative distributions of gastrointestinal malignancies 
according to site was esophagus 36.0%, stomach 19.9%, liver secondaries 13.9%, colon 
9.8%, periampullary 5.6%, gall bladder 4.5%, duodenum 3.0%, malignant ascites 2.6%, HCC 
2.3% and pancreas 1.1%. Out of 83380 patients registered in the gastroenterology department 
of GB Pant Hospital, New Delhi over 10 years, a total of 1751 (2.1%) patients with 
gastrointestinal malignancies were identified. The mean age for esophageal malignancy was 
53.5 +/- 11.4 year, stomach malignancy 51.8 +/- 12.9, colon malignancy 49.1 +/- 16.7, 
duodenum malignancy 45.3 +/- 11.4, malignant ascites 51.8 +/- 13.1, pancreatic malignancy 
46.9 +/- 15.3 and HCC 52.5 +/- 12 years. Male were more affected as compare to female 
except for cancer of the gall bladder. The overall mean age of all GI malignancies was 49.7 
+/- 13.4 years(5). 
 In another retrospective pathology centric study by Kalyani R et al from Kolar, Karnataka, 
India, revealed that gastro-intestinal neoplasms constituted 22.96% of all the cancers 
diagnosed. Adenocarcinoma was the most common histology type. There was increased 
incidence of GI cancers over time. The male to female ratio was 1:0.6. The maximum 
incidence occurred in the 7th decade of life. Stomach was the commonest site (48.4%) 
followed by esophagus (27.7%), rectum (6.5%), colon (5.0%) and hepatocellular carcinoma 
(HCC) (4.76%)(1). 
According to Indian cancer registries, the digestive system is the commonest site of cancer in 
males. In women, breast cancer was most frequent followed by genital organs and digestive 
system. Cancer of the colon was the 3
rd
 most frequent cancer in the world in both sexes, after 
cancer of the lung and stomach in males and after breast and cervix in females. The age 
adjusted incidence rate for cancers of esophagus, colon, rectum and liver in men are almost of 
similar magnitude between five registries i.e. 8 per 100,000 population for esophagus and 3 
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per 100,000 for the cancers of colon, rectum and liver. In Indian registries, in the ranking of 
cancer incidence in men, cancer of esophagus ranks third in Mumbai, Chennai and Bangalore 
Registries, fourth in Bhopal registry and eighth in Delhi registry. Cancer of the stomach ranks 
first for Bangalore Registry, second for Chennai Registry and ninth for Mumbai Registry. It 
has been observed that there was a statistically significant decrease in the incidence of 
esophagus cancer for Mumbai and Delhi registries. There was an increase in the incidence for 
Chennai registry. There has been statistically significant decrease in the incidence of stomach 
cancer over a period of time in most of the registries, highest decrease was observed for Delhi 
registry. The trend in the incidence of colon, rectum and liver has been shown to be 
increasing in all the registries. Statistical significant increase was noticed in Chennai, 
Bangalore and Delhi registries for cancer of colon. For rectum, there has been increase in the 
incidence for Chennai and Bangalore registries. For liver cancer, increase in Mumbai, 
Chennai and Bangalore registries has been noted over the time period examined. While 
esophagus and stomach malignancies are decreasing, malignancies of colon, rectum and liver 
are increasing in the Indian population(6). 
A retrospective study from India by Malhotra SL et al revealed that gastric malignancies were 
more common in the south of our country. Most of the malignancies presented in the fifth and 
sixth decade. On the other hand, primary malignancies of liver and gall bladder are more 
common in north India. A total of 470 proved gastrointestinal malignancies were studied. The 
relative distributions of gastrointestinal malignancies according to site was esophagus 11.0%, 
stomach 18.0%, liver cancer 5.53%, colon 14.70 %,  gall bladder 2.55%,  and pancreas 1.7%. 
This pattern may be related to common etiological factors, most of which are dietary(7). 
A retrospective study by Patel MM et al from Medical College Surat analysed 244 cases and 
demonstrated an increased incidence of gastrointestinal malignancy from 2006-10.  Most of 
the GI malignancies were in age group 41-50 years (64 cases, 26.22%), followed by age 
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group of 51-60 year (58 cases, 23.77%).  Nine cases (3.68%) were present below 20 year of 
age. The rate of malignancies increased after the age of 30 year. The male: female ratio was 
1.39:1.  Most of these patients came from a lower socioeconomic status. The most common 
GI malignancy was esophageal carcinoma (38.93%) followed by colorectal carcinoma 
(32.79%) and carcinoma of stomach (16.80%). Of forty one cases of stomach malignancy, 
twenty two cases were adenocarcinoma, nine cases of signet ring adenocarcinoma and four 
cases of lymphoma. Most of the cases of squamous cell carcinoma presented from the 
esophagus whereas adenocarcinoma was from the colon. Microscopically, adenocarcinoma 
was the commonest malignancy (45.90%), followed by Squamous cell carcinoma 
(33.60%)(8). 
Esophagus malignancy: 
Esophageal Cancer is the second most common cancer in India responsible for about 0.3 
million deaths a year. This is the second most common cancer among males and the fourth 
most common cancer among females(9). Esophageal malignancies increase with age and 
peak in the seventh and eighth decade of life.  Squamous-cell carcinoma and adenocarcinoma 
are the two main histological subtypes. The endoscopic appearance is similar in both 
adenocarcinoma and squamous cell carcinoma. Seventy-five percent of cases of 
adenocarcinoma are found in the lower esophagus. Squamous-cell carcinoma is more 
common in the proximal and middle esophagus. Adenocarcinoma is three to four times 
common in men while being more equally distributed for squamous-cell carcinoma(10). 
The Asian esophageal cancer belt has a high incidence of esophageal cancer(11). Both 
squamous cell and adenocarcinoma commonly affect the esophagus. Worldwide, squamous 
cell carcinoma (SCC) has been the most common (~90%). However, while cancer incidence 
trends show an overall decrease in SCC, adenocarcinoma has been increasing in the West 
(12). 
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The etiology of squamous cell esophageal cancer has been linked to excess alcohol 
consumption and/or cigarette smoking, smoked opiates, and fungal toxins in pickled 
vegetables, the ingestion of lye, radiation-induced strictures, chronic achalasia, Plummer-
Vinson syndrome and, tylosis palmaris et plantaris. Male are more affected than female. The 
etiology of adenocarcinoma is related to diets high in cholesterol, smoking, obesity, Barrett’s 
esophagus(13,14). 
According to a study by Lal N et al and Gado A et al, the biopsy yield increased from 95.8% 
when two biopsy specimens were taken to 100% when five to six were taken(15,16). 
A retrospective study by Cherian JV et al from south India on 994 patients with esophageal 
carcinoma revealed that squamous cell carcinoma was the most common malignancy, 912 
(92%). Eighty two patients (8%) had adenocarcinoma. Sixty five of these eighty two patients 
(79%) had gastroesophageal junction malignancy and seventeen (21%) had tumor in the 
lower third of the esophagus. Sixty-five of the 82 patients with Adenocarcinoma had an 
esogastric junction (EGJ) malignancy and in seventeen the lesion was in the lower third of 
the esophagus. None involved the middle or upper third of the esophagus. In squamous cell 
carcinoma, the male to female ratio was 2.16:1. Most common location of squamous cell 
carcinoma (SCC) was lower esophagus (N-413, 41.6%). In middle and lower esophagus, 
there were 379 (38.1%) and 120 (12.1%) cases of squamous cell carcinoma. In 
adenocarcinoma, male to female ratio was 3.6:1. The mean age was 54.7 ± 11.4 and 49.3 ± 
13.5 in squamous cell carcinoma and adenocarcinoma respectively. The author concluded 
that squamous cell carcinoma is the most common type of esophageal malignancy cancer in 
the India. Adenocarcinoma is not common and affects more frequently men younger than 
forty years old(17). 
A prospective study by Sepehrvand N et al from Iran showed the mean age of 61.8 ± 12.0 
years. The male to female ratio was 0.84. Seven cases (4.2%) were located in cervical 
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esophagus, five in upper thoracic (3%), sixty four in middle thoracic (38.6%), sixty eighty in 
lower thoracic (41%), and cardia in twenty two cases (13.2%).  SCC (81.1%) was the most 
common type of esophageal cancer. In male, carcinoma of esophagus usually involves the 
lower parts, while in female it involves the upper parts of esophagus. SCC was the most 
common type of esophageal cancer in all age groups. The symptoms of esophageal cancer 
were dysphagia in 155 subjects (93.4%), loss of appetite in 5 (3%), and weight loss in 6 
(3.6%). Three patients (1.8%) had a past medical history of achalasia(18). 
 A retrospective study by Tony J et al was done in the Department of Gastroenterology at 
Calicut Medical College from January 1985 to December 2004. Among 29,926 gastroscopies 
done over 20 years, 909 cases of esophageal cancers were identified. Mean age was 63.12 
±11.2 years (range 28–87). The male to female ratio was 2.77:1.  Malignancy were seen in 41 
(4.7%) in the upper, in middle in 341 (39.7%) and in lower third in 476 (55.4%) cases. All 
malignancies involving the upper and the middle thirds of esophagus were SCC. 476 cases of 
biopsy proven malignancy of lower oesophagus were included for analysis.  Two hundred 
forty nine (52.3%) were adenocarcinomas and 227 (47.7%) were squamous cell. There was 
an increase in the frequency at the gastro-oesophageal junction but it was not of statistical 
significance (p value < 0.15). Fifty five percent of malignancies affected the lower third of 
the oesophagus and gastroesophageal junction. Forty percent of malignancies were located in 
the middle third and five percent were located in the upper third. Adenocarcinoma were 
located in lower end than  squamous cell carcinomas(19). 
Retrospective studies by Giri P et al from western Maharashtra, India on 5879 patients with 
diagnosis of cancer were reviewed.  Of them, 207 (3.52%) patients had esophageal cancer.  
121 (58.46%) were males and 86 (41.54%) were females (ratio 1.4:1). Eighty six (41.54%) 
patients were in more than 60 years of age, followed by sixty three (30.43%) patients in age 
group of 50‑60 years and nineteen (9.17%) patients in the age group of <40 years(20). 
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Gastric malignancy: 
Gastric carcinoma is the third most common type of carcinoma in South India. In northern 
India, some states have high incidence of stomach malignancy. In India, carcinoma of 
stomach was estimated to be the fifth commonest site in males and the seventh in females 
overall.  Rates in India are lower than in other countries around the world(21–23). Possible 
etiological factors for gastric cancer are consumption of smoked, poorly preserved and salted 
foods, low consumption of vegetables and fruits, infection (Helicobacter pylori), previous 
gastric resection and pernicious anemia(24). 
Ninety per cent of stomach cancers are adenocarcinomas and other rare gastric malignancies 
include lymphomas, gastrointestinal stromal tumours(GIST), and neuroendocrine 
tumours(NET)(25). Endoscopy with biopsies is the standard of care for the diagnosis of 
gastro-oesophageal cancer(16,26). 
A retrospective study by Barad AK et al on 158 patients of primary gastric cancer diagnosed 
in the Department of Surgery at Regional Cancer Centre, Manipur, India from July 2009 to 
June 2013 showed male to female ratio of 2.16:1, age ranging from 28 to 91 years.  Forty two 
percent patients were old than 60 years. Twelve (7.6%) patients had a positive family history 
of gastric cancer. 67.6% of males and 44% of females were smokers. History of combined 
consumption of alcohol and smoking was present in 33.5% of patients. Pain in upper 
abdomen was the most common presenting symptom in 97 (61.4%) of patients followed by 
weight loss in 94 patients (59.5%), nausea in 63 patients (39.9%), early satiety and poor 
appetite in 55 patients (34.8%), vomiting in 33 patients (20.9%), dysphagia in 29 (18.4%) and 
melena in 25 patients (15.8%). The most common site was antrum (N-80, 50.6%) followed 
by cardia (N-27, 17.1%). Thirty seven percent of patients had distant metastasis at the time of 
presentation. Most common site for distant metastasis was found in liver in 17.1% patients 
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followed by left supraclavicular lymph node (7.6%). About seventy patients (44.3%) had 
poorly differentiated, fifty five (35.8%) moderately differentiated and thirty one patient 
(19.6% ) well differentiated adenocarcinoma(27). 
A retrospective study by Pulimood A et al from CMC, Vellore (India) on 361 cases of 
gastrointestinal lymphomas over a period of 10 years (2001–2010) showed that primary GI 
lymphoma was present in 267 males (79.64%) and 68 females (20.24%). The mean age was 
45 years. Diffuse large B-cell lymphoma was the commonest type in 222 patients (66.71%). 
Thirty four patients (10.12%) had low-grade marginal zone lymphoma and 35 patients 
(10.48%) had Burkitt’s lymphoma. The commonest site was stomach in 180 patients 
(53.57%), followed by small intestine in 79 patients (23.51%) and large intestine in 68 
patients (20.23%). Of large intestine lymphomas, 34 cases were located in ileocecal region, 
23 case in the colon, and 12 cases in the rectum(28).  
Another retrospective study by Kurian S et al from CMC, Vellore (India) on Ninety-two 
cases of GIST encountered over a 7-year period (1999–2005) showed that GISTs were almost 
equally prevalent in the stomach and the small intestine (40%). The colorectum had only 
8.6% of the tumors and, much less frequently, GISTs were present in the esophagus (two 
patients) and in the anal canal (three patients). Ninety-five percent of the GISTs were positive 
for CD117 (KIT). GISTs were infrequent before the 3rd decade (6.5%).  49.5% of patients 
were in the 4th and 5th decades of life. The oldest patient was 82 years old. Male to female 
ratio was 3:1. 50% presented with GI bleed and 24% with a mass or fullness of the abdomen.  
One patient each presented with dyspepsia, anemia, and acute abdomen due to tumor 
perforation. One patient was asymptomatic and in 3 patients, GIST was an incidental finding 
during investigation for hypertension, synchronous gastric carcinoid and neurofibromatosis 
type I (NF1). 70.4% patients were of the high-risk malignant category(29). 
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A prospective study by Saha AK et al from West Bengal on 23851 patients underwent upper 
GI endoscopy over a period of five years (2006–2010) showed that four hundred and sixty 
two patients were detected to have gastric malignancy.  Male to female ratio was 2.7: 1. In 
this study, the median age was 55 years. Abdominal pain was the most common symptom in 
306 patients (66.23%) followed by indigestion in 212 patients (45.88%) and weight loss in 
200 patients (43.29%). Melena was present in 44 patients (9.52%). H. pylori was positive in 
80.09% of gastric carcinoma. The antrum was commonest site of involvement (51.9%). It 
was followed by body (18.6%) and fundus (16.5%). Incisura(12.9%) was  least common 
site(30). 
A retrospective study by Cherian JV et al from Chennai, India on 1719 patients with 
adenocarcinoma from 1989 to 2004 showed that the mean age was 55.50 ± 12.68 years. The 
study period was divided into four cohorts of 4 years each (1989-1992, 1993-1996, 1997-
2000 and 2001-2004). The most common sites of gastric cancer was antrum in 1157 patients 
(67.3%) followed by the body in 400 patients (23.3%), proximal stomach in 97 patients 
(5.6%) and OGJ in 65 patients (3.8%)(31). 
Small intestine malignancy: 
Small intestinal malignancies are rare group of GI tumours (3-6%) that extend from the 
duodenum to the ileum(32–34). 
Risk factors for small intestine tumors are Crohn’s disease, celiac disease, and inherited 
disease (Hereditary nonpolyposis colorectal cancer , Familial adenomatous polyposis,  Peutz-
Jeghers syndrome)(32,35). 
 A retrospective analysis by North JH et al on 144 patients of small intestinal cancer revealed 
that males were 92 (64%), ratio, 1.76:1 with median age of 55.7 years.  Sixty eight patients 
(47%) had adenocarcinoma, 41 patients (28%) had carcinoid, 18 patients (13%) had 
leiomyosarcoma, and 17 patients (12%)  had  lymphoma(33).  
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Another retrospective study by Egberts J-H et al from Europe on 43 patients with small 
bowel cancer showed that 37.2% had adenocarcinoma (n=16), neuroendocrine tumors (n=12; 
27.9%), gastrointestinal stroma tumor (GIST) (n=10; 23.3%), lymphoma (n=3; 7%) and 
desmoid tumor (n=2; 4.6%). Tumor localizations were within  duodenum (46.5%), jejunum 
(16.3%) and ileum (37.2%)(34).  
A retrospective analysis by Dabaja BS et al from Texas, USA on 217 patients with small 
intestine adenocarcinoma showed that the mean age was 55 years. The male to female ratio 
was 1.58:1. Eighty three patients (38%) were more than 60 years. Most common clinical 
presentation was abdominal pain (66%), obstruction in (40%), and bleeding (24%). Ninety 
patients (60%) had well or moderately differentiated malignancies, 56 patients (37%) had 
signet ring and poorly differentiated tumors, two patients had papillary carcinoma, one 
patient had villous carcinoma, and one patient had small cell carcinoma. Nine (4%) patients 
had Stage I disease, forty three (20%) patients had Stage II disease, eighty six (39%) patients 
had Stage III disease, and seventy five (35%) patients had Stage IV disease. The liver was the 
most common site of metastasis in forty four (59%) patients. Tumors were located in 
duodenum in 52% patients, in jejunum in 25% patients, in ileum in 13%  patients, and in 
unspecified sites in 10% patients(36).  
A retrospective study by Haoues N et al on 20 patients of small intestine malignancies in the 
department of general surgery of Habib Thameur Hospital in Tunis (Tunisia), from January 
1994 through June 2011 showed that the mean age was 62 years and male to female ratio was 
1:1.2. In twelve patients, tumor was located in ileum and in seven patients, tumor was located 
in jejunum. 45% of patients had clinical features of acute generalized peritonitis. Most of 
patients had abdominal pain (50%) and impaired general health (30%). 8 patients had 
Carcinoid tumor, Leiomyosarcoma in 7 patients, B-cell lymphoma in 2 patients, malignant 
stromal tumor in 2 patients and malignant myxoid schwannoma in one patient. Malignant 
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tumors of the small bowel most commonly arise in the ileum (60%) followed by the jejunum 
(35%)(37). 
A retrospective study by Cunningham JD et al from New York, USA on 73 patients of small 
intestinal malignancies showed that the male to female ratio was 1.5:1. The median age was 
57 years (range 26-90 years). The location of tumors in the study was 25% in the duodenum, 
37% in the jejunum, and 38% in the ileum. Adenocarcinomas were located most commonly 
in the duodenum and jejunum. Thirteen of eighteen duodenal tumors were adenocarcinoma. 
Tumors located in the jejunum were most likely adenocarcinomas or lymphomas. Half of the 
ileal tumors were carcinoids. Lymphomas and sarcomas were located most commonly in the 
jejunum or ileum. The most common symptom was abdomen pain (53%).  Other symptoms 
included weight loss (12.3%), anemia (8.21%), gastrointestinal bleeding (13.6%), or the 
carcinoid syndrome (9.58%)(38).  
A retrospective study by Koo DH et al on 91 patients with advanced small bowel 
adenocarcinoma showed that the median age was 58 years (range, 25- 82 years). Male to 
female ratio was 2.7:1. In seventy one patients, tumor was located in duodenum and twenty 
patients, jejuno-ileal. Forty four patients had well-differentiated/moderately differentiated 
adenocarcinoma. Thirty eight patients had undifferentiated adenocarcinoma. Thirty nine 
cases had liver metastasis and 42 cases had peritoneal metastasis at time of presentation(39). 
Colorectal malignancy: 
Colorectal carcinoma (CRC) is the second most common carcinoma in males and fourth most 
common carcinoma in females. The age-standardized rates of CRC in India have been 
estimated to be 4.2 and 3.2/100,000 for males and females, respectively(40–42). 
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Risk factors for CRC include are environmental risk factors such as obesity, cigarette 
smoking, hereditary factors, ureterosigmoidostomy, previous colorectal cancer and 
inflammatory bowel disease(43). 
A retrospective study by Hussain N et al from Raipur, India on 233 patients with colonic 
malignancies revealed that 39.05% of the patients were less than 40 years of age and 4.29% 
were less than 20 years of age. One hundred and thirty four patients (57.51%) were males and 
ninety nine (42.48%) were females (ratio-1.35:1). In patients who were less than 40 years of 
age, majority were males (63.73%), mostly located in the rectum (84.61%). One hundred 
patients (42.91%) had well differentiated adenocarcinoma; fifty four patients (23.77%) had 
moderately differentiated. Poorly differentiated adenocarcinoma was seen in 79 (33.90%) 
patients and most of had advanced stage (71.42%)(44). 
A retrospective study by Peedikayil MC et al from Kerala, India on 220 cases of CRC 
showed the median age at diagnosis was 58 years (range 23–85 years). Majority of the 
patients were in seventh decade (31.8%), followed by sixth decade (26.4%). Twenty eight 
(12.7%) patients of colorectal carcinoma (CRC) were below the age of 40 years. The male to 
female ratio was 2.09:1. One hundred and fifty five (70.5%) patients presented with bleeding 
per rectum, 86 (39.1%) had significant weight loss, 72 (33%) had constipation, and another 
55 (25%) had intermittent diarrhea. Hundred (45.4%) and 51(23.1%) patients had tumor in 
rectum and sigmoid colon. One hundred sixty three of the tumors (74%) were located in left 
side of colon(45).  
A retrospective study by Nath J et al from CMC Vellore, India on 287 patients with rectal 
cancer showed that 35.5% were 40 or younger at presentation. The median age was 45 (range 
16–86). 12(4.2%), 184(64.1%) and 91(31.7%) patients had well differentiated, moderately 
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and poorly differentiated adenocarcinoma respectively. CEA levels were more 4 ng/ml in 162 
(65.3%) patients and more than >10 ng/ml in 108 (43.5%) patients(46).  
A prospective study by Zargar SA et al from Kashmir, India on 212 cases of colorectal 
cancers showed that 113 (53.3%) cases were located in the colon and 99 (46.7%) cases in 
rectum. The male to female ratio was 1.2:1. Thirty four patients were detected in the age 
group 55–59 years and 30 patients in age group 50–54. The incidence rate of colorectal 
cancer was 3.65/100,000; it was 3.78 in males, and 3.50/100,000 in females(47). 
A prospective study by Halder SK et al from West Bengal on 192 patients with colorectal 
malignancy showed that 78 patients were of younger age group (<35 years) and 114 patients 
were older (>35 years). The mean age of was 44.1 years. The male to female ratio in younger 
and older group was 1.68:1 and 1.85:1 respectively. Rectal bleeding was the commonest 
symptom. Pain in abdomen (39.7%) and intestinal obstruction (21.8%) were the predominant 
presenting features in the patients of younger group whereas weight loss was commonest 
presenting feature in the patients of older age group. Most common histological type was 
adenocarcinoma (93.8%). Moderately differentiated adenocarcinoma was the commonest 
subtype affecting 45% of patients. Poorly differentiated adenocarcinoma was seen in 26.7%. 
Right sided colonic growth was more common in women  while rectum was the commonest 
site in man(48). 
A retrospective study by Santos AC et al from Brazil on 107 patients operated of colonic 
malignancy showed mean age 59.8 years and 52 (48%) had more than 60 years. Male were 
more affected than females (ratio-1:0.84. The most common symptoms were abdominal pain 
(97.2%), vomiting (76.6%), and anorexia (40.2%). Adenocarcinoma was the most frequent 
histologic tumor type (n=105). Fifty one percent malignancies were located in the 
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rectosigmoid, 20% in transverse colon, ascending colon (12.1%), and descending colon 
(11.2%). Six percent of the cases had synchronic lesion(40).  
A retrospective study by Mukherji A et al on 32(9.9%) young patients with colorectal cancer 
between ages of 10-25 years treated between January 2000 and December 2006 were studied. 
In this same period, the total number of colorectal carcinomas registered was 324. The 
median age of presentation was 21.5 years. The male to female distribution was almost equal, 
with a slightly higher female predominance. The mean duration of symptoms was 11.7 
months. Four-fifths of the cases presented in late stage. Nodal involvement was seen in 38% 
cases and metastatic disease in 12% cases. Rectum was the most commonly involved site 
(81%), followed by the sigmoid colon (19% cases) and then the descending colon. Anal canal 
was also involved in 12% cases. A majority of the patients presented with pain (81%), altered 
bowel habits (72%) and bleeding per rectum (78%). Most common type of malignancy was 
the mucinous or mucin secreting adenocarcinoma (31%). cases. Well differentiated 
adenocarcinoma was seen in 5 patients (16%). Poorly differentiated carcinomas were seen in 
3 cases (9%) and moderately differentiated adenocarcinoma was seen in only six (19%) 
cases(49). 
Gall bladder malignancy: 
Gall bladder carcinoma (GBC) is the most common tumour of the biliary system. GBC is ten 
times more common in North India as compared to Southern part of India. Risk factors for 
GBC are Anomolous union of the pancreaticobiliary ductal system, Adenomyomatosis, 
Cholelithiasis ( >1 cm), first-degree relatives, inflammatory bowel disease (IBD), primary 
sclerosing cholangitis and porcelain gallbladder(50). 
 A retrospective study by Sachidananda S et al from Chennai, India on 61 biopsy proven 
cases of gallbladder cancer showed that male to female ratio of 1.6:1. Abdominal pain was 
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present in 42% followed by jaundice in 27% of cases. Only twelve patients had associated 
gallstones (19.6%). Only six patients (9.8%) had operable disease while forty patients (50%) 
had distant metastasis. Fundus of the gallbladder (40%) was the most common site for GBC 
followed by the neck (3%)(51). 
A prospective study by Khan I et al from Kolkata, India on 63 cases of gall bladder cancer 
showed incidence of four cases per one lakh population per year. Forty nine percent were in 
fifth decade of life. The male to female ratio was 1:3.8.  Gall stones were present in 45 out of 
63 cases (71.42%). Abdominal pain was the commonest complaint (87.30%), followed by 
pallor, lump in right upper quadrant, nausea & vomiting and jaundice in 71.42%, 69.84%, 
66.66%, 31.74% patients respectively(52). 
A retrospective study by Batra Y et al from AIIMS, New Delhi on 634 patients with GBC 
over ten years revealed a mean age of 51 ± 11 years and male: female ratio of 0.36:1.00. 81% 
of patients had abdominal pain and 73% had jaundice. Cholangitis was present in 18.0%. 
Gallstones were noted in 54% of patients and the majority of patients had unresectable 
disease.  Two percent had stage I GBC, 3.4% stage II, 17.5% stage III, 47.0% stage IVa and 
29.8% stage IVb(53). 
A prospective study by Pandey M et al from BHU, India on 99 cases of gallbladder cancer 
showed that the most common symptom was abdominal pain (83%). Other symptoms include 
anorexia (41.4%) and significant weight loss (39.4%). Male:female ratio was 1:3 and mean 
age was 49.9 years. 70 cases were confirmed by fine-needle aspiration cytology (FNAC). 
Three percent patients had stage 0, 12.1% had stage I, 14.1% had stage II, 12.1% had stage 
III, and 58.6% patients had stage IV disease.  Most of the GBCs’ were diagnosed in late 
stages(54). 
 
30 
 
Hepatocellular carcinoma (HCC): 
Worldwide, HCC is the fifth most common cancer in men and the eighth most common in 
women ranking fourth in annual cancer mortality rates(55,56). 
Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, alcoholic cirrhosis, 
among other causes of chronic liver disease are strongly associated with HCC(57). In India 
there are 19,000 new cases of HCC and 17,000 deaths due to HCC annually. Given the 
prevalence of two major risk factors for HCC in India, chronic hepatitis C (HCV) (1–1.9% 
population) and active hepatitis B (HBV)(2.4%), the incidence of HCC in India can be 
expected to increase(58). 
On autopsy studies from India, the prevalence of HCC is low, and varies from 0.2 to 1.9%. 
On autopsy, presence of cirrhosis in patients with HCC ranges from 70-80%. In India the 
hepatitis-B surface antigen (HBsAg) positivity in patients with HCC varies from 36 to 74% 
(mean of 47%)(55). The male: female ratio for HCC in India is 4:1. The age of presentation 
varies from 40 to 70 years. In India, almost half patient with HCC has underlying HBV 
infection and one quarter have HCV infection(59,60). 
A prospective study by Sood A et al from north India on 128 patients with HCC revealed that 
mean age was 49.8±10.2 years. The overall male to female ratio was 4.8:1. Underlying 
cirrhosis was present in 99.2%. Alcohol was most common etiology (45.3%), followed by 
HCV (24.9%). HBV related HCC was present in 2.9% and NAFLD had 3.1%; 4.9% had 
cryptogenic chronic liver disease. Seventy four (57.8%) patients were known cases of 
cirrhosis, while 53 (41.4%) patients were diagnosed as having cirrhosis for the first time 
during their current presentation. Most patients (83.5%) had features of decompensated 
cirrhosis.  91% had ascites, jaundice was noted in 17.9% and hepatic encephalopathy in 21% 
of patients. 8.6% of patients with HCC presented for the first time with an upper GI bleed. 
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HCC leading to decompensation of cirrhosis was the first presentation of the liver disease in 
nearly one third of the cases. The mean size of HCC was 5.3±2.9 cm. HCC was multicentric 
in 57% of patients, and portal vein thrombosis was present in 34.4% patients. About 66% of 
the patients belonged to BCLC stage C or D. The median AFP value in patients with an HCC 
size <2 cm was 69 ng/mL, with an HCC size of 2–5 cm was 380 ng/mL, and with an HCC 
size >5 cm was 1,000 ng/mL. Serum alpha-fetoprotein was >200 ng/mL in 67.2% of the 
patients, while it was normal in 18.7% of the patients(61). 
A retrospective study by Paul SB et al from AIIMS, India on 324 case of HCC showed mean 
age of 52.4 years. The male to female ratio was 7.1:1. The right upper quadrant pain was the 
predominant symptom in 53% of the patients. Ascites was the main complaint in 13% and 
weight loss was present in 9%. 165 (51%), 110 (34%) and 49 (15%) patients were in CTP A, 
B and C respectively. In 265 (85%) patients, the dominant lesion was more than 3 cm in size. 
The etiology of HCC was: hepatitis B virus 165 (51%), hepatitis C virus 38 (12%), alcohol 20 
(6%), combined 31 (10%) and unknown 70 (21%). 316(97.5%) had underlying cirrhosis. 
There was a past history suggestive of acute hepatitis in 34 (11%) and chronic hepatitis in 26 
(8%) patients. for HCC. In this study, AFP was elevated in 71% of patients. Serum alpha–
fetoprotein (AFP) was > 400 ng in 36%(62). 
A retrospective study by Kumar R et al from GB Pant hospital, New Delhi on 191 patients 
with HCC showed mean age of 52 years, (range 9–85 years). The male to female ratio was 
5.1:1. Fifty one percent patients had ascites, jaundice in 34% and encephalopathy in 5%.  
New onset ascites was noted in 57% of cases.  Upper GI bleed was present in 22% patients. 
Most under lying etiology was HBV related HCC (N-107, 73%). Twenty two patients (15%) 
had HCV related HCC. Sixteen patients (11%) was cryptogenic cirrhosis. The HCC most 
commonly involved right lobe of liver (48%), followed by bilobar involvement (34%). The 
left lobe was involved in approximately one fifth of cases. Multicentric HCC involving either 
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one lobe or both lobes were seen in 36% of patients. Very large tumors (>5 cm) were seen in 
three-fourth of cases. Small HCC (<2cm lesion) was seen in only 0.8% of patients.  
Approximately 8.4% cases were detected incidentally. Fine needle aspiration was available in 
118 patients and liver biopsy in 12 patients. Sixteen patients (17%) had normal AFP value. 
The median serum AFP value was 320 ng/ml (range 2.5–900 000). Diagnostic level of serum 
AFP was seen in only 46%(63). 
A case–control study was performed by M Kumar et al from GB Pant hospital, New Delhi on 
213 patients with HCC where 254 control subjects not affected with hepatic diseases or 
neoplasm were recruited. They looked at chronic viral markers and alcohol as risk factors for 
HCC. Among patients with HCC, one hundred and fifty (70.42%) patients were positive for 
one or more of the HBV markers, 26 (12.21%) patients for HCV markers and 10 (4.69%) 
patients had markers for both. History of significant ethanol intake was found in 25 
(15.24%)(64). They concluded that any of the HBV markers were a risk factor for HCC even 
in the absence of cirrhosis, unlike HCV and alcohol were the presence of cirrhosis was 
essential for development of HCC(64).  
Pancreatic malignancy: 
Pancreatic cancer is the fourth leading cause of death due to cancer in men and women. The 
majority of pancreatic cancer arises in the exocrine pancreas. Incidence increases 
exponentially with age after 30 years old, and 80% of all cases are diagnosed between the 
ages of 60 and 80. Eighty percent are adenocarcinoma of the ductal epithelium. Other 
includes cystic neoplasms and NETs. Sixty percent of pancreatic malignancies are located in 
the head of the pancreas, and 20 to 25% located in the body and tail of the pancreas. The 
signs and symptoms are related to the location of pancreatic cancer. Patients with pancreatic 
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cancer most commonly present with abdominal pain and weight loss. Jaundice is a most 
common symptom of tumors in the head of the pancreas(65). 
Pancreatic cancer is associated with environmental factors like smoking, obesity and several 
genetic syndromes including hereditary pancreatitis syndrome, chronic pancreatitis  and 
Peutz–Jeghers syndrome(65,66). 
The sensitivity of helical CT in revealing pancreatic carcinoma is high, ranging between 89% 
and 97%. EUS-guided fine-needle aspiration biopsy (FNAC) is a safe and highly accurate 
method for tissue diagnosis of patients with suspected pancreatic carcinoma(67). 
An analysis of data from National Cancer Database in USA by Sener SF et al showed that 
peak age was 70-79 years. A total of 100,313 patients were analysed. 6% of all patients were 
less than 50 years of age, and 18% were over 80 years at the time of presentation. The 
anatomic site distribution was: head, 78%; body, 11%; and tail, 11%. 83% did not have a 
surgical procedure and 58% did not have cancer-directed treatment, reflecting the advanced 
nature of disease at presentation(68). 
A prospective study by Yeo CJ et al on 650 patients who underwent 
pancreaticoduodenectomies  showed pancreatic cancer (n = 282; 43%), ampullary cancer (n 
=70; 11%), distal common bile duct cancer (n = 65; 10%), duodenal cancer (n = 26; 4%), 
chronic pancreatitis (n = 71; 11%), neuroendocrine tumor (n = 31; 5%), periampullary 
adenoma(n=21;3%), cystadenocarcinoma (n = 14; 2%), cystadenoma (n = 25; 4%), and other 
(n = 45; 7%). The mean age was 63 ± 12.8 years, with 54% male. Six ,sixty three and thirty 
one patients had well, moderately and poorly differentiated adenocarcinoma(69).  
A prospective multicentric phase 2 trial by Mukherjee S et al from UK assessing the efficacy 
of gemcitabine based chemotherapy in locally advanced pancreatic cancer showed a mean 
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age of 63.1 years with 31 (86%) of patients having pancreatic malignancy in the head and 
five (14%) in body and tail. None of the patient had underlying chronic pancreatitis(70). 
A nationwide survey by Ito T et al from Japan on 3379 patients with gastrointestinal neuro-
endocrine tumors (GI-NET) showed an overall prevalence of 2.69 per 100,000 people. The 
locations of GI-NETs varied: foregut, 26.1%; midgut, 3.6%; and hindgut, 70.3%. 65.5% were 
non-functioning tumor (NF)-PNETs followed by insulinoma (20.9 %) and gastrinoma (8.2 
%)(71). 
Periampullary carcinoma: 
The area within 2 cm of the ampulla is called periampullary region. Ampullary carcinomas 
are rare, accounting for less than 1% of all gastrointestinal cancers and 4% to 8% of 
periampullary carcinomas. The etiology of periampullary carcinomas is unknown in the 
majority of cases. Most periampullary tumors are adenocarcinomas(72). 
A retrospective study by Chauhan A et al from Manipal, India on 24 patients with 
periampullary carcinomas revealed that the majority were in the 50-60 years age group 
(28.3%), followed closely by the 60-70–year age group (27.2%). Males and females were 
58.7% and 41.3% respectively. All of the patients (100%) had jaundice as a presenting 
complaint. Other complaints were pruritus (66.7%), abdominal pain (54.2%), weight loss 
(54.2%), and vomiting (29%)(73). 
A retrospective study by Klein F et al from Germany on 143 patients showed a median age of 
64 years (range 33–83 years). Eighty seven (61%) patients were male. History of smoking 
was present in 44 (31%) patients and regular alcohol consumption in 32 (22%) patients. 
Seventy five (52%) patients presented with jaundice, and 88 (62%) patients had nonspecific 
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epigastric pain. Twenty-nine (20%) patients described a weight loss of more than 10 kg in the 
three months preceding the presentation(74). 
A retrospective study by Yeo CJ et al form USA on 242 patients with periampullary 
adenocarcinoma showed that 149 (62%) were pancreatic primaries, 46 (19%) arose in the 
ampulla, 30 (12%) were distal bile duct cancers, and 17 (7%) were duodenal cancers. Fifty 
five percent were male. Twelve percent were well-differentiated adenocarcinoma. 88% of the 
tumors were moderately or poorly differentiated adenocarcinoma was most common 
histology(75). 
A retrospective study by Riall TS et al from USA on 890 patients who underwent 
pancreaticoduodenectomy for periampullary adenocarcinoma revealed that mean age was 65 
years. Fifty five percent were male. Sixty eight percent were moderate to well differentiated 
and thirty two percent were poorly differentiated .The carcinoma origin was pancreatic in 
46%, ampullary in 25%, distal bile duct in 17%, and duodenal in 12%(76). 
Cholangiocarcinoma: 
Cholangiocarcinoma is a rare malignancy that can occur anywhere along the intrahepatic or 
extrahepatic biliary tree. The most common site (60% to 80%) of cholangiocarcinomas are in 
the perihilar region(77). 
Predisposing causes of cholangiocarcinoma are Infestation with Opisthorchis viverrin in 
northeast Thailand, Infestation with Chlonorchis sinensis in China, Intrahepatic stones, 
Primary sclerosing cholangitis, Choledochal cysts, and Ulcerative colitis(78,79). 
The preoperative histological assessment using biopsies or brush cytology has limited 
sensitivity (30–60%) in spite of high specificity (>95%). The sensitivity, specificity and 
diagnostic accuracy of MRI/MRCP (87.5%, 85.3%, 82.7%, respectively) was marginally 
superior to CT (79.2%, 79.4%, 79.3%, respectively)(80,81). 
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A retrospective study by Nakeeb A et al from USA on 294 patients with cholangiocarcinoma 
showed that 18 (6%) had intrahepatic, 196 (67%) had perihilar, and 80 (27%) had distal 
tumors. Mean age was 62.2 ± 0.7 years. Fifty five percent patients were male. Age, gender, 
race, and associated diseases were similar among the three groups. The most common 
presenting features were jaundice (84%) followed by abdominal pain (35%), weight loss 
(33%), and fever (10%). Patients with intrahepatic tumors, by definition, were less likely (p < 
0.01) to be jaundiced and more likely (p < 0.05) to present with abdominal pain(77). 
A retrospective study by Yusoff AR et al analysis from Malaysia on 69 patients with cholan-
giocarcinoma showed that 38 (55%) were male. Mean patient age was 61 ± 14.2 years. 
Twelve patients (17%) had intrahepatic, 38 (55%) had perihilar and 19 (28%) had distal tu-
mors. The most common symptoms  were  jaundice (78%), anorexia (57%), weight loss 
(52%), abdominal pain (44%), abdominal mass (44%), itching (25%), vomiting (9%) and 
fever ( 7%)(82).  
A retrospective analysis by DeOliveira M et al on 564 patients with Cholangiocarcinoma 
showed that 44 (8%) had intrahepatic, 281 (50%) had perihilar, and 239 (42%) had distal 
tumors. The mean age was 65 years and 58% were males. The most common symptoms were 
jaundice(84% ),abdomen pain (30% ) and wt loss(35%)(83). 
A retrospective study by Rasoulian J et al from Iran on twenty two cholangiocarcinoma 
patients showed that the median age was 68.55 years. Male to female ratio was 1.44:1. 
Twenty-one were extrahepatic and only one Intrahepatic CCA. Initial symptoms were 
jaundice with abdominal pain in 13 (59.1%) patients, whereas 8 (36.4%) presented with 
painless jaundice and one had cholangitis. CT scan with ERCP or MRCP and elevated 
tumour markers (CA19-9, CEA) were the most used procedure for diagnosis of CCA in these  
patients(84). 
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                                                  Material and methods 
Study design 
This study was a prospective observational study performed in Christian Medical College 
(CMC), Vellore (which is a tertiary care centre in southern India). 
Study setting and population 
The study was conducted in the department of Gastrointestinal Sciences in CMC Hospital, 
Vellore from August 2013 to December 2014. 
All patients seen in the outpatient / inpatient and endoscopy areas of the departments of 
Gastroenterology and Hepatology with a diagnosis of GI or HPB malignancy during the 
study period were enrolled after an informed consent. The diagnosis was based on the 
histopathological report of endoscopic biopsies in case of gastrointestinal cancers 
(esophageal, stomach, periampullary, small intestinal and colo-rectal). A combination of 
radiological findings, laboratory markers and if available, histopathology were used to 
diagnose HPB malignancies. Data regarding clinical presentation, age distribution, site of 
involvement, life-style factors, socio-economic status and histological types where available 
were collected and analysed. These results were compared with other studies. 
Variables: Broad groups of variables were included:   
   Diagnostic  criteria 
- Esophagus Cancer: The diagnosis required endoscopy with biopsy(85).  Esophagus  tumor 
can be located in the cervical (15-20 cm), upper (20-25 cm), middle (25-30 cm), lower (30-
40cm), or GE junction (I- esophagus, II- cardiac, III-subcardiac)(86). 
- Stomach cancer: The diagnosis required endoscopy with biopsy(87). Gastric malignancy 
can be classified in to proximal (cardia) or distal (fundus, body and antrum)(88). 
39 
 
-Small intestine Cancer: The diagnosis requires endoscopy with biopsy(89). Small intestine 
can be located in duodenum (excluding periampullary region, as defined below), jejunum or 
ileum(88). 
- Colorectal cancer: The diagnosis required colonoscopy with biopsy.  In all patients with 
colonic malignancy, colonoscopy was done till cecum unless because of stricture or growth, 
the scope could not negotiate the lesion(90).  Colonic  carcinoma  can be located in different 
part of the colon as  defined by anatomical location(88). 
-Hepatocellular carcinoma: The diagnosis of HCC based on a combination of                     
radiological imaging techniques, S. alfa-feto protein (AFP) and/or biopsy. S. AFP > 200 U/ml 
was considered significant(91). Contrast-enhanced study of the liver (Dynamic CT-scan or 
MRI) showing intense arterial uptake followed by ‘‘washout’’ of contrast in the venous-
delayed phases was considered diagnostic of HCC. HCC staging was done according to 
Barcelona Clinic Liver Cancer staging system (BCLC)(88). 
For surgical resection, tumor should be confined to one lobe and nontumorous liver tissue 
should not be cirrhotic. Surgical option can also be considered if the tumor is limited to the 
left lobe or a portion of the right lobe, CTP class A cirrhosis, normal serum bilirubin level, 
and portal hypertension is not present. Radiofrequency ablation (RFA) is considered most 
effective for a lesion less than 3 cm in largest diameter(88). 
The Milan criterion was used to define patients with HCC as potential candidates for liver 
transplantation. The Milan criteria include: a single lesion upto 5 cm or 2 or 3 lesions, each 
upto 3 cm, with no large vessel vascular invasion or metastasis. 
 -Cryptogenic cirrhosis- Despite extensive investigations, a significant fraction of patients 
cannot be offered a definite etiological diagnosis and are labeled as cryptogenic cirrhosis(92). 
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-Non-Alcoholic Fatty Liver Disease (NAFLD)- NAFLD is designated when clinical, 
anthropometric and pathological evidence exists and significant alcohol intake has been 
excluded(92). 
-Carcinoma of the gallbladder: The diagnosis was based on radiological imaging                    
(USG /CECT abdomen) and / or histopathology where available(93). Surgery is a curative 
option for gallbladder carcinoma.  Stage Tis (carcinoma in situ) and T1a gallbladder (tumor 
invades lamina propria) cancer can be treated with simple cholecystectomy. A simple 
cholecystectomy can be done for stage 1b gallbladder carcinoma but higher recurrence rates 
have been observed after simple cholecystectomy. Therefore, radical cholecystectomy is 
preferred for stage 1b gallbladder carcinoma (tumor invades muscularis propria). Invasion of 
the muscularis propria, as in stage T2 (tumor invades perimuscular connective tissue without 
extension beyond serosa or into liver), requires radical cholecystectomy. Contraindications to 
surgery includes hepatic/peritoneal/distant metastases, malignant ascites, encasement of 
major vessels, or poor performance status(88). A gall bladder carcinoma was considered 
inoperable if there was liver/peritoneal/distant metastasis or major vessel involved. A gall 
bladder carcinoma was considered locally advanced if vessel encased or locally spread to 
lymph node seen on imaging. 
-Cholangiocarcinoma: The diagnosis was based on radiological imaging                  
(MRCP/ERCP) and / or  histopathology where available(94). Surgical resection is the 
treatment of choice if there is no atrophy of one liver lobe with encasement of the 
contralateral portal vein branch/contralateral secondary biliary radical involvement, 
involvement of major vessel, encasement, distant lymph node metastases/intrahepatic/ distant 
metastases, primary sclerosing cholangitis (PSC), or associated significant comorbid 
conditions(88). All patients underwent CECT abdomen and MRCP, and if required an EUS. 
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A CCA was considered inoperable if there was liver metastasis, secondary biliary radical or 
major vessel involvement. 
-Periampullary carcinoma: Periampullary carcinomas arise from within 2 cm of the 
ampulla of Vater. The diagnosis required side-view scopy with biopsy(95). On imaging 
(CECT abdomen and MRCP and if deemed necessary, an EUS) absence of mass lesion in the 
head of pancreas or distal common bile duct was necessary to classify these patients under 
the periampullary malignancy group. Hepatic metastasis, serosal implants, ascites, lymph 
node involvement outside the resectional field, and major vessel invasion all are 
contraindications to surgical resection(88). A periampullary carcinoma was considered 
inoperable if there was liver metastasis, periaortic lymph nodes or major vessels involved. A 
periampullary carcinoma was considered locally advanced and inoperable in this study if 
vessel encased or locally spread to lymph node seen on imaging. 
-Pancreatic cancer: The diagnosis was  based on imaging (CECT Abdomen/Endoscopic 
ultrasound-EUS) and / or EUS guided Fine-needle aspiration cytology or post-operative 
histopathology(96). Pancreatic malignancies can be located in head, body, neck, tail or 
uncinate process(65). Surgery is absolute contraindicated in extrapancreatic disease 
(malignant ascites or metastasis to the liver, peritoneum, or periaortic lymph nodes). Relative 
contraindications includes encasement or occlusion of the major vessels(88). A pancreatic 
malignancy was considered inoperable if there was liver metastasis, major vessel encased or 
periaortic lymph node involved.  A pancreatic carcinoma was considered locally advanced 
and inoperable in this study if there was vessel encasement or local spread to lymph node as 
seen on imaging. 
All radiological images were reported by one of three specialised abdominal radiologists and 
reviewed if necessary by one of the others.  
Socioeconomic status was defined by modified Kuppuswamy's socioeconomic scale(97). 
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For BMI, cut-off" for an  Indian  population were used(98). 
Alcohol intake of >40 gm per day in males and >20 gm per day in females for 10 years was 
considered  significant intake(88). 
Standard definition of urban and rural area was used as defined by government of India(99). 
Weight loss was considered significant if weight loss more than >5% in  one month or >10 % 
in 6 months(100).  
Site of involvement 
Relevant Tumor markers 
History of relevant risk factors for each malignancy 
Family history of malignancy 
Biopsy report and radiological findings 
Inclusion criteria:  
All patients diagnosed with GI or HPB malignancies (on the basis of histopathology or a 
combination of radiological findings, laboratory markers and if available histopathology) 
who presented to the Gastroenterology and Hepatology departments (Outpatient / Inpatient / 
Endoscopy areas) and who give informed consent were included in this study.       
 Exclusion criteria:  
Those who were unwilling to participate in study 
Ethics Committee review  
The Institutional Review Board and Ethics Committee of CMC, Vellore reviewed and 
approved the proposal and consent forms. 
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Sample size: 
 Survey of OP / IP and endoscopy reports for the month of June 2013 showed that out of 
3680 patients, 111 had GI or HPB Malignancies [Cancer(Ca) stomach-36 (32.43%), Ca 
Colon-21 (18.91%), Periampullary -17 (15.31%), Ca pancreas-11 ( 9.90%), Ca esophagus-
9(8.10%), HCC-6(5.40%), Ca gallbladder-5(4.50%), Ca small intestine-3(2.70%), Ca 
cholangiocarcinoma-3(2.70%)]. We estimated a sample size of 1200 cases.       
Statistical analysis: 
 Mean, median, standard deviation (SD), range, and proportions will be determined as 
appropriate. Categorical variables will to be analyzed using the chi-squared test with Yates’ 
correction as applicable while continuous data will be analyzed using student t test or Mann–
Whitney U test. 
 
 
 
 
 
 
 
 
 
 
 
44 
 
 
 
 
 
 
 
 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
45 
 
                                                                 Results 
The present study included various gastrointestinal (GI) and hepato-pancreato-biliary (HPB) 
tract malignancies which came to the departments of Medical Gastroenterology and 
Hepatology. Out of 41543 patients newly registered in the departments of Medical 
Gastroenterology and Hepatology from August 2013 to December 2015, a total of 1200 cases 
of newly diagnosed GI and HPB tract malignancies were included during the study period 
(2.8%).  
Table 1 shows median age of 54 years (ranging from age 14 to 89 years).  In the present 
study, 3 cases were below 20 years of age. Most of the malignancies were seen in the age 
group of 41-60 years (58%). The rate of malignancies increased after the age of 20 years 
(table 6). Out of 1200 cases, 841 (70%) were males and 359 (30%) were females. The male: 
female ratio was 2.34:1. Six hundred eight five cases (57%) were from a rural area and five 
hundred fifteen (43%) were from an urban area.  Sixty two percent patients belong to middle 
class of socioeconomic status. 
The median BMI was 21 Kg/m2 (ranging from 8.9 to 36.1). As shown in table 2, 543 (53%) 
cases had normal BMI and 226 (22%) were underweight. 116 (11%) cases were overweight 
and 140 (14%) were obese.  
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Demographic profile 
Table 1: Demographic profile of the individuals with GI and HPB malignancy 
 PARAMETERS NUMBER OF INDIVIDUALS 
AGE 
Median  age  54  years (range 14 to 89 years) 
GENDER 
Male 841 (70%) 
Female 359 (30%) 
SOCIOECONOMIC STATUS 
Upper 52 (4%) 
Middle 746 (62%) 
Lower 402 (34%) 
POPULATION DISTRIBUTION 
Urban 515 (43%) 
Rural 685 (57%) 
 
Table 2: Anthropometric data for individuals 
BMI (Kg/M2) Number of individuals (N-1025, %) 
Underweight (< 18) 226 (22%) 
Normal (18-22.9) 543 (53%) 
Overweight (23-25) 116 (11%) 
Obese (>25) 140 (14%) 
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Table 3: Gender distribution of GI and HPB malignancy 
Gend
er 
Esop
hagus  
 
Stom
ach  
Colon
ic 
HCC  Small 
intesti
ne 
Pancre
atic 
Peria
mpull
ary  
Cholan
giocarc
inoma 
Gall 
bladder 
cancer  
Male 164 185 155 184 21 47 50 18 18 
Femal
e  
58 112 74 23 8 33 19 5 27 
M:F 
ratio 
2.82:1 1.65:1 2.09:1 8:1 2.62:1 1.42:1 2.63:1 3.60:1 0.66:1 
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As shown in figure 2 and 3, history of smoking was present in 62% of the patients. There was 
history of significant alcohol intake in 13% of the patients. 
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Figure 4 shows that family history of GI malignancy was present in 2% cases. 
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The distribution of type of malignancy according to state is shown in table 4. Most cases 
were from West Bengal 384(32%) and Tamil Nadu 270 (23%). These were followed by 
Jharkhand 158 (13%) and Andhra Pradesh 80 (7%).  
Table 4: Distribution of GI and HPB malignancy according to state 
STATE NUMBER (%) 
West Bengal 384 (32%) 
Tamil Nadu 270 (23%) 
Jharkhand 158 (13%) 
Assam 83 (7%) 
Kerala 72 (6%) 
Andhra Pradesh 80 (7%) 
Meghalaya 30 (3%) 
Bihar 38 (3%) 
Tripura 19 (2%) 
Arunachal Pradesh 14 (1%) 
Uttar Pradesh 8 (1%) 
Chhattisgarh 8 (1%) 
Maharashtra 3 (0.25%) 
Mizoram 3 (0.25%) 
Orissa 15 (1%) 
Karnataka 9 (1%) 
Madhya Pradesh 2 (0.17%) 
Other 4 (0.33%) 
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The distribution of type of malignancy according to sites is shown in figure 5.  Most common 
malignancy was stomach (25%), and second most common malignancy was colorectal 
(19%). These were followed by malignancy of esophagus (18%), hepatocellular carcinoma 
(17%), pancreas (7%), periampullary (6%), gall bladder (4%), small intestine (including 
duodenal malignancy) (2%) and cholangiocarcinoma (2%).  
 
Table 5 shows distribution or type of GI and HPB malignancy according to state. Most of 
esophageal malignancies were from West Bengal 51 (23%). It was followed by Assam 48 (22 
%) and Tamil Nadu 45 (20%). Most of stomach malignancies were from West Bengal 101 
(34%). It was followed by Tamil Nadu 88 (30%) and Jharkhand 38 (13%).  Most of the 
colonic malignancies were from West Bengal 89(39%). It was followed by Tamil Nadu 47 
(21%) and Jharkhand 31 (14%).  Most of the HCC cases were from Tamil Nadu 53 (26%). It 
was followed by West Bengal 50 (24%) and Kerala 28 (14%). Most of the small intestine 
malignancies (including duodenal malignancy) were from West Bengal 9 (31%). It was 
followed by Tamil Nadu 6 (21%) and Jharkhand 6 (21%). Most of pancreatic malignancies 
were from West Bengal 29 (36%). It was followed by Tamil Nadu 14 (18%) and Jharkhand 
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14 (18%). Most of periampullary malignancies were from West Bengal 26 (38%). It was 
followed by Jharkhand 15 (22%) and Tamil Nadu 13 (19%). Most of cholangiocarcinomas 
(CCA) were from West Bengal 10 (43%). It was followed by Jharkhand 3 (13%) and Tamil 
Nadu 3 (13%). Most of gall bladder malignancies were from West Bengal 19 (42%). It was 
followed by Jharkhand 13 (29%) and Bihar 3 (7%). Gall bladder malignancy was less 
common in south India. 
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Table 5: Distribution of type of GI and HPB malignancy according to state (N-1200) 
State Esoph
ageal 
(%) 
 
Stoma
ch (%) 
 
Colo
nic 
(%) 
HCC (%)  Small 
intestine 
(%) 
Pancreat
ic (%) 
Periampulla
ry (%) 
CCA 
(%) 
GBC 
(%) 
West Bengal 23 34 39 24 31 36 38 43 42 
Tamil Nadu  20 30 21 26 21 18 19 13 4 
Jharkhand  7 12 14 10 21 18 22 13 29 
Assam  22 5 2 1 5 3 7 - - 
Kerala  5 2 6 14 - 6 4 4 4 
Andhra 
Pradesh  
6 5 6 9 8 3 3 9 2 
Meghalaya  8 1 2 1 - 4 - - 2 
Bihar  2 3 3 4 3 3 1 - 7 
Tripura  1 1 2 1 10 1 3 - - 
Arunachal 
Pradesh  
1 1 1 3 - 1 - - - 
Uttar 
Pradesh  
1 1 1 - - 1 - - 2 
Chhattisgarh  1 1 - 2 - - - 5 3 
Maharashtr
a  
- - 1 1 - - - - - 
Mizoram  1 - - 1 - - - - 2 
Orissa  - 3 - 2 - 4 3 - - 
Karnataka 1 - 1 1 1 - - 9 3 
Madhya 
Pradesh 
- - 1 - - 1 - - - 
other 1 1 - - - 1 - 4 - 
 
Table 6 showed incidence of GI malignancy according to age. Most malignancies were seen 
in age group of 41-60 years (58%). The rate of malignancies increased after the age of 20 
year. Malignancies were rare before 20 years age and after 81 years of age.  
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Table 6: Incidence of GI and HPB malignancy according to age 
Age 
(year
s) 
Esop
hagea
l 
Stom
ach  
 
Colon
ic  
HCC Small 
intesti
ne  
Pancre
atic  
Peria
mpull
ary 
CCA GBC 
<20  1 1 1 - - - - - - 
20-40  26 55 50 26 9 16 13 4 4 
41-60  134 152 112 98 16 49 44 16 30 
61-80  61 88 62 81 4 15 12 3 9 
>81   - 1 4 2 - - - - 2 
Medi
an 
Age(y
ears)  
55 54 53 58 49 52 52 53 54 
range 14-78 18-85 18-89 22-86 27-69 29-74 22-74 25-75 30-84 
 
Esophagus malignancy: 
As shown in the table 3, there were 222 (18%) cases of esophageal malignancy. Male: female 
ratio was 2.82:1.  
As shown in the table 6, the median age was 55 years (range from 14-78). Most of the cases 
were in 41-60 years age group (60%). 
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Table 7: Percentage of occurrence of symptoms in esophagus cancer (N-222) 
Symptoms Total incidence (%) 
Dysphagia 207 (93%) 
Weight loss 182 (81%) 
Hematemesis 10 (5%) 
Vomiting 140 (64%) 
Odynophagia 10 (5%) 
Chest pain 11 (5%) 
 
As shown in the table 7, most common presenting symptoms were dysphagia (93%) and 
weight loss (81%).  
 Three patients had family history of esophageal malignancy.  One patient had past history of 
esophageal stricture prior to esophageal malignancy. 
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As showed in figure 6, esophageal malignancy was centred around the lower and mid 
esophagus (30% and 26% respectively), followed by GE junction (23%). The cervical site 
was least common site for esophageal malignancy. 
Distribution of type of esophageal cancer according to histology type: 
   
Figure 7 showed that squamous cell carcinoma was most common histology type (69%). 
Sixty three (26%) patient had Adenocarcinoma. Four (2%), one (0.45%) and one (0.45%) 
patient had Neuroendocrine tumour (NET), gastrointestinal stromal tumor (GIST) and B-cell 
lymphoma respectively. 
All Adenocarcinomas were located in the GE junction (N-49) and lower esophagus (N-14). 
None of the patient had adenocarcinoma at other site. Most cases of the squamous cell 
carcinoma were located at mid esophagus (N-54) and lower esophagus (N-50). 
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Figure 8: Distribution of squamous cell carcinoma and adenocarcinoma (N): 
 
Table 8: Male to female distribution: 
Characteristic Gender(N) 
Squamous cell carcinoma 
Male 108 
Female 45 
M: F ratio 2.4:1 
Adenocarcinoma 
Male 52 
Female 11 
M:F ratio 4.7:1 
 
Table 8 showed male:female ratio was 2.4:1 in squamous cell carcinoma. In adenocarcinoma, 
the male to female ratio was 4.7:1. 
Stomach malignancy: 
As shown in the table 3, there were 297 (25%) cases of stomach malignancy. Male:female 
ratio was 1.65:1.  
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As shown in the table 6, the median age was 54 years (range from 18-85). Most of the cases 
were in 41-60 years age group (51%). 
Table 9: Percentage of occurrence of symptoms in stomach cancer (N-297) 
Symptoms Total incidence (%) 
dysphagia 16 (5%) 
Weight loss 254 (86%) 
Abdomen pain 249 (84%) 
vomiting 257 (87%) 
anorexia 214 (72%) 
Gi bleed 41 (14%) 
Abdomen distension 23 (8%) 
 
As shown in the table 9, most common presenting symptoms were vomiting (87%) and 
weight loss (86%). The least common symptoms were abdomen distension (8%) and 
dysphagia (5%). 
 
As shown in Figure 9, distal part of body was most common site (92%) of gastric malignancy 
location. The proximal part was involved in 25 (8%). 
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Seven patients had associated H. pylori infection in the biopsy. Three patients had family 
history of gastric malignancy. One patient had pernicious anaemia and another history of 
gastric resection. 
The adenocarcinoma (N-260, 88%) was most common histology type followed by B-cell 
lymphoma (N-23, 8%). Seven (2%) patient had NET and GIST. 
  
Colonic malignancy: 
As shown in the table 3, there were 229(19%) case of colonic malignancy. Male:female ratio 
was 2.09:1.  
As shown in the table 6, the median age was 53 years (range from 18-89). Most of the cases 
were in 41-60 years age group (49%). 
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Table 10: Percentage of occurrence of symptoms in colonic cancer (N-229) 
Symptoms Total incidence (%) 
GI bleed 148 (65%) 
Abdomen pain 111 (48%) 
Weight loss 154 (67%) 
Loss of appetite 152 (66%) 
Diarrhea 67 (29%) 
Constipation 38 (17%) 
 
As shown in the table 10, most common presenting symptom was weight loss (67%) and 
anorexia (66%). The least common symptom was constipation (17%). 
 
The figure 11 showed rectum (51%) was most common location of colonic malignancy, 
followed by the ascending colon (21%). The descending colon (4%) was least common site 
of colonic malignancy. 
Nine Patients (0.39%) had family history of colonic malignancy.  Six patients (0.26%) had 
polyposis coli, possibly familial adenomatous polyposis (FAP). None of the patient had 
ulcerative colitis or Crohn´s disease. 
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Histological distribution of colonic malignancy (%) 
 
As shown in figure 12, adenocarcinoma was the most common histology (N-214), the 
majority of which were moderately differentiated (N-137). Twelve patients had Lymphoma 
(B-cell type) and two patients had neuroendocrine tumor (NET). 
Carcinoembryonic Antigen (CEA) was tested in 193 of 214 (90%) patients with colonic 
malignancy.  Median CEA value was 5 ng /ml (range 1 to 5270). In 98 patients (46%), it was 
within normal limits (<5 ng /ml). 
Small intestine malignancy including duodenal malignancy: 
Twenty nine patients (2%) were diagnosed with a small intestinal malignancy including 
duodenal malignancy. As shown in the table 3, male:female ratio was 2.62:1.  
As shown in the table 6, the median age was 49 years (range from 27-69). Most of the cases 
were in 41-60 years age group (55%). 
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Table 11: Percentage of occurrence of symptoms in small intestine cancer (N-29) 
Symptoms Total incidence (%) 
Weight loss 25 (86%) 
Abdomen pain 24 (83%) 
Vomiting 26 (90%) 
Anorexia 23 (79%) 
GI bleed 5 (17%) 
Early satiety 16 (55%) 
 
As shown in the table 11, most common presenting complaints were vomiting (90 %) 
followed by weight loss (86 %). The least common symptom was GI bleed (17 %). 
 
Figure 13 showed duodenum (N-26) was most common location for small intestine tumor, 
most being located in D1 followed by D2. None of the patients had tumor in the jejunum, 
while three patients had ileal tumours (carcinoid in two).  
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As shown in figure 14, the adenocarcinoma (59%) was most common histology. 17% had B-
cell lymphoma and NET. 
Hepatocellular carcinoma (HCC): 
As shown in the table 3, there were 207 cases (17%) of hepatocellular carcinoma. Male: 
female ratio was 8:1.  
As shown in the table 6, the median age was 58 years (range from 22-86). Most of the cases 
were in 41-60 years age group (47%). 
Table 12: Percentage of occurrence of symptoms in HCC cancer (N-207) 
Symptoms Total incidence (%) 
Abdomen pain or discomfort 98 (47%) 
Weight loss 113 (43%) 
Abdomen distension (ascites) 88 (55%) 
Gi bleed 35 (17%) 
Jaundice 75 (36%) 
Altered sensorium 12 (6%) 
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As shown in the table 12, most common presenting complaints were abdominal distension 
(55%) followed by abdominal pain (47%). The least common symptom was altered 
sensorium (6%). 
 
As shown in figure 15, most of the patients were in CTP-A class. Median MELD score was 
12 (range from 6 to 36). 
Table 13: AFP value 
AFP value( IU/ml) Number (204) 
<6 38 (19 %) 
7-200 52 (25 %) 
>200 114 (56 %) 
 
As shown in table 13, thirty eight (19%) patients had AFP within normal limits. One hundred 
fourteen (56%) patient had AFP value more than 200 IU/ml. Median AFP value was 281 
(range 1-300000). 
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As shown in figure 16, most common etiology for HCC was hepatitis B (n-74, 37%). Fifty 
two (26%) patients had cryptogenic CLD related HCC. Twenty (10%) patients had HCV 
related HCC. 
Four patients had family history of HCC. Twenty nine (14%) patients had biopsy proven 
HCC.  In 72 patients with HBsAg related HCC, twenty two were HBeAg positive.  HBV-
DNA was done in 42 patients and median value was 145000 (range from 10 to 100000000). 
In cryptogenic HCC, ten patients were anti-HBc-Ag positive. 
Of 207 cases of HCC, only 66 (32%) patients were within criteria for a potentially curative 
treatment strategy at presentation. Twelve patients (6%) were ideal candidates for 
radiofrequency ablation (RFA) and 8 patients (4%) were suitable for surgical resection.  Forty 
six patients (22%) meet the Milan criteria for liver transplantation. Therefore, 141 (68%) 
patients had only a palliative option available to them, due to the advanced nature of the HCC 
at presentation.  
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Pancreatic malignancy: 
As shown in the table 3, there were 80 cases (7%) of pancreatic malignancy. Male:female 
ratio was 1.42:1.  
As shown in the table 6, the mean age was 52 years (range from 29-74). Most of the cases 
were in 41-60 years age group (61%). 
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Table 14: Percentage of occurrence of symptoms in pancreatic cancer (N-80) 
Symptoms Total incidence (%) 
Weight loss 63 (79%) 
Abdomen pain 71 (89%) 
Vomiting 64 (80%) 
Anorexia 56 (77%) 
Jaundice 30 (38%) 
Cholangitis 6 (8%) 
Early satiety 45 (56%) 
Abdomen distension 4 (5%) 
 
As shown in the table 14, most common presenting symptoms were abdominal pain (89%) 
and vomiting (80%). Thirty patients (38%) had jaundice and six patients (8%) had 
cholangitis. The least common symptom was abdominal distension (5%).  
 
 
As shown in the figure 19, 66% of the pancreatic tumors were located in the head of the 
pancreas. It was followed by body of the pancreas (20%). The least common site was tail of 
the pancreas. 
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Figure 20: Type of pancreatic malignancy (%) 
 
As shown in the figure 20, 77% had adenocarcinoma. Nine (12%) patient had NET. 
Four (5%) had IPMN and three (4%) had mucinous cystadenocarcinoma. 
One patient had family history of pancreatic malignancy. Thirteen patients (16%) had 
associated chronic pancreatitis. Sixty one patients (77%) had biopsy proved pancreatic 
malignancy. 
CA 19-9 was done in 64 (83%) cases. The median CA 19-9 values were 336 U/ml (range 1- 
33900). 
Out of 80 cases of pancreatic malignancy, 30 cases (38%) were within criteria for operability 
with potentially curative intent while 32 (40%) had relative contraindications to surgery due 
to locally advanced disease (vessel encasement or local lymph node spread). Eighteen cases 
(22%) had liver metastasis.  
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Periampullary carcinoma: 
As shown in the table 3, there were 69 cases (6%) of periampullary malignancy. Male:female 
ratio was 2.63:1.  
As shown in the table 6, the median age was 52 years (range from 22-74). Most of the cases 
were in 41-60 years age group (64%). 
Table 15: Percentage of occurrence of symptoms in periampullary carcinoma (N-69) 
Symptoms Total incidence (%) 
Weight loss 64 (93%) 
Abdomen pain 58 (84%) 
Vomiting 51 (74%) 
Jaundice 62 (90%) 
Cholangitis 15 (22%) 
Early satiety 41 (59%) 
Abdomen distension 1 (1%) 
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As shown in the table 15, the most common presenting symptoms were weight loss (93%) 
and jaundice (90%). Fifteen patients (22%) had cholangitis. The least common symptom was 
abdominal distension (1%). 
One patient had family history of periampullary malignancy.  
 
As shown in the figure 22, forty (58%) patients had moderately differentiated 
adenocarcinoma. Twenty seven (39%) patients had well differentiated adenocarcinoma and 
two (3%) patients poorly differentiated adenocarcinoma. 
CA 19-9 was done in 47(68%) cases (normal value upto 32 U/ml) and median CA 19-9 value 
was 99 U/ml (range 2-71400). 
Out of 69 cases of periampullary malignancy, 50 cases (73%) were within criteria for 
operability with potentially curative intent and 10 cases (15%) had liver metastasis. In three 
cases (5%), available radiological data was insufficient to stage accurately.  In three cases 
(5%), para-aortic lymph nodes were involved and two cases SMV were encased. In one 
patient (2%) had ascites and infiltrating into pancreas and IVC. 
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Cholangiocarcinoma (CCA): 
As shown in the table 3, there were 23 cases (2%) of cholangiocarcinoma. Male to female 
ratio was 3.60:1.  
As shown in the table 6, the median age was 53 years (range from 25-75). Most of the cases 
were in 41-60 years age group (70%). 
Table 16: Percentage of occurrence of symptoms in cholangiocarcinoma (N-23) 
Symptoms Total incidence (%) 
Weight loss 22 (96%) 
Abdomen pain 21 (91%) 
Vomiting 18 (78%) 
Anorexia 15 (65%) 
Jaundice 19 (83%) 
Cholangitis 6 (26%) 
Early satiety 18 (18%) 
Abdomen distension 3 (13%) 
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As shown in the table 16, most common presenting symptoms were weight loss (96%) and 
abdominal pain (91%). The least common symptom was abdominal distension (13%). Six 
patients (26%) were presented in cholangitis. 
Ten patients (39%) had biopsy proven cholangiocarcinoma. Twenty one (91%) had 
extrahepatic and two patient (9%) had intra hepatic CCA. 
CA 19-9 was done in 19 (82%) cases. The median CA 19-9 values were 345 U/ml (range 2- 
20100). 
 Out of 23 cases of CCA, only 3 cases (13%) were within criteria for operability with 
potentially curative intent and 7 cases (30%) had liver metastasis.  In two cases (9%), 
available radiological data was insufficient to stage accurately.  In eleven cases (48%), para-
aortic lymph nodes were involved and major blood vessel were encased.  
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Gall bladder cancer: 
As shown in the table 3, there were 45 cases (4%) of gall bladder carcinoma.  Male to female 
ratio was 0.66:1.  
As shown in the table 6, the median age was 54 years (range from 30-84). Most of the cases 
were in 41-60 years age group (67%). 
Table 17: Percentage of occurrence of symptoms in gall bladder cancer (N-45) 
Symptoms  Total incidence (%) 
Weight loss 44 (98%) 
Abdomen pain 39 (87%) 
vomiting 41 (91%) 
anorexia 33 (73%) 
Jaundice 34 (76%) 
Cholangitis 10 (22%) 
Early satiety 27 (60%) 
Abdomen distension 2 (4%) 
 
As shown in the table 17, most common presenting symptoms were weight loss (98%) and 
vomiting (91%). The least common symptom was abdominal distension (4%). Ten patients 
(22%) presented with cholangitis. 
Sixteen patients (38%) had gall bladder stones and one patient had porcelain gallbladder. 
Twenty three patients (51%) were biopsy proven gall bladder malignancy. 
Out of 45 cases of gall bladder malignancy, only one patient (2%) was within criteria for 
operability with potentially curative intent. and 23 cases (51%) had liver metastasis.  In one 
case (2%), available radiological data was insufficient to stage accurately.  In twenty cases 
(45%), para-aortic lymph nodes were involved and major blood vessel were encased.  
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Distribution of lymphoma according to site: 
As shown in the figure 26, of 41 cases of lymphoma, all were B-cell origin, most common 
sites stomach (N-23, 57%), colon (N-12, 29%). The least common site was esophagus (N-1, 
2%). 
 
2
57
12
29
Figure 26: Location of lymphoma(%)
esophagus
stomach
small intestine
colon
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Distribution of gastrointestinal stromal tumor (GIST) according to site: 
 
As shown in the figure 27, of 10 cases of GIST, most common sites stomach (N-7, 70%), 
small intestine (N-2, 20%) and esophagus (N-1, 1%). 
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Distribution of neuroendocrine tumor (NET) according to site: 
 
As shown in the figure 28, of 27 cases of NET, most common sites pancreas (N-9, 33%), 
stomach (N-7, 26%) and small intestine (N-2, 19%). 
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DISCUSSION 
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                                                              Discussion 
The present study was an observational study which was intended to analyse the clinico-
pathological profile of gastrointestinal (GI) and hepato-pancreato-biliary (HPB) tract 
malignancies. Out of 41543 patients newly registered in the departments of Medical 
Gastroenterology and Hepatology from August 2013 to December 2015, a total of 1200 cases 
of newly diagnosed GI and HPB tract malignancies were included during the study period 
(2.8%).  
In the present study, most malignancies were seen in age group of 41-60 years (58%), 
peaking in the sixth decade. The overall male : female ratio was 2.34:1. These findings were 
compared with multiple studies (Table 18). Theses finding were comparable with other 
studies except the study by Kalyani R et al (1).  The male preponderance is similar to that 
seen in many studies (1, 5, 7 and 8).   
In present study, the most common malignancy was gastric (25%), and second most common 
malignancy was colorectal (19%). These were followed by malignancy of the esophagus 
(18%), liver, ie HCC (17%), pancreas (7%), periampullary (6%), gall bladder (4%), small 
intestine (2%) and cholangiocarcinoma (2%). These findings were compared with earlier 
Indian studies (Table 18). Most studies from India analysing GI malignancies in particular 
were hospital based pathology centric and retrospective in design.    
In our study, the most common malignancy was gastric, which was similar to what was seen 
in the study from Surat, Gujarat by Patel et al (8). In most studies from our country, 
esophageal malignancies occupied the top position. This difference may be due to large 
number of patients coming to our hospital from north-eastern part of India. Certain regions of 
India have recorded a high incidence, especially the north eastern states. From the North-
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East, a high incidence of cancers in general from different sites, especially tobacco related 
cancers, have been reported.   
Interestingly, in the present study, the second and third position was shared by colo-rectal and 
esophageal malignancies. Colo-rectal malignancies were also prominent in the study from 
Karnataka by Kalyani et al (1). Rectal neoplasms far outweighed colonic, as seen in other 
studies as well. It must be highlighted that both this and our study were one in the 21
st
 
Century, where lifestyle changes and better diagnostic facilities exist.  
The fourth position was occupied by HCC (17%) in our study. In studies done earlier in the 
1960-90s’, HCC occupied a much lower position (2-4%). This again could be related to both 
diseases related to life style changes and better awareness and detection strategies.  
In a review article by Mohandas KM and Jagannath P, published in the Indian Journal of 
Gastroenterology in the year 2000, on the epidemiology of GI cancers in India and the 
projected burden in the coming millennium, the author stated that while esophageal and 
gastric cancer were the most common GI malignancies in the 80-90s’ and would continue to 
remain so, their incidence will probably fall while that of colon, liver, gall  bladder and 
pancreas was likely to increase in most parts of our country in the 21
st
 century(3). Our study 
confirms this pattern. 
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Table 18: Comparison of data for gastrointestinal malignancies from present study to 
published literature from India 
Characteristic 
 
  
Malhotra 
SL et al(7) 
Rawal et 
al(5) 
Kalyani R 
et al(1) 
Patel MM 
et al(8) 
Present 
study 
Study period 1960-64 1984-
1993 
1997-2006 2006-2010 2013-2014 
Region Eight 
railway 
zones 
New 
Delhi 
Karnataka  Gujarat Vellore 
Type of study Retrospecti
ve 
Retrospe
ctive  
Retrospect
ive 
Retrospect
ive 
Prospecti
ve 
Study setting Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Number of patients 470 1751 630 244 1200 
Median age(years) 48  49  66  54   53  
M:F ratio 3.39:1 - 1.39:1 1:0.6 2.34:1 
Type of 
malignanc
y 
(%) 
Esophagus 39 36 11 28 18 
Stomach  17 20 18 48 25 
Small intestine  7 3 1 2 2 
Colo-rectal 33 10 14 12 19 
HCC  - 2 4 5 17 
Gall bladder  - 5 2 1 4 
Cholangiocarc
inoma  
- - - - 2 
Pancreatic  - - 1 1 7 
Periampullary  - 6 - - 6 
 
Esophageal malignancy:  In present study, male:female ratio was 2.82:1 and the median age 
was 55 years (range from 14-78). These findings were comparable with earlier studies (Table 
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19). The male predominance demonstrated in this study was in keeping with previous 
observations reported in earlier studies performed elsewhere (12, 17 and 19). The male 
predominance in present study can be explained by the fact that most of the known risk 
factors for esophageal cancer are related to behavior - smoking and excessive alcohol 
consumption, both of which are more common in males.  
Table 19: Comparison of data for esophagus malignancies from present study to earlier 
studies 
Characteristic Tony J et al 
(19) 
Cherian JV 
et al  (17) 
Giri et al 
(12) 
Present study 
Study period 1985-2004 1989-2004 2007-2011 2013-2014 
Region Kerala Tamil Nadu Maharashtra Vellore 
Type of study Retrospectiv
e 
Retrospecti
ve 
Retrospective Prospective 
Study setting Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital based 
M : F ratio 2.77:1 2.16:1 
 
1.4:1 2.82:1 
Most common symptom - - - Dysphagia 
 
Type of 
histology 
(%) 
76 92 Squamous 
cell 
carcinoma  
- 69 
24 8 Adenocarci
noma 
- 27 
- - NET - 2 
- - Lymphoma - .45 
- - GIST - .45 
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The two most common symptoms present in all our patients were dysphagia and weight loss 
which is similar to a previous study from Iran (18). 
The present study showed that most common location of the esophageal malignancy was 
lower esophagus (29%) followed by middle esophagus (26%) and cervical esophagus (8%). 
The squamous cell carcinoma was most common histology type (69%) followed by 
adenocarcinoma (27%) similar to 0ther studies. In our study, squamous cell carcinoma was 
the most common type of esophageal carcinoma in all age groups. Four (2%), one (1%) and 
one (1%) patient had Neuroendocrine tumour (NET), GIST and B-cell lymphoma 
respectively. These findings were similar to retrospective studies by Cherian JV (17), 
Sepehrvand N et al (18), Tony J et al (19), Pulimood A et al (27) and Kurian S et al (28). 
Stomach cancer: 
The present study showed median age of 54 years (range from 18-85). Most of the cases were 
in age group of 41-60 years (51%). Male:female ratio was 1.65:1. These finding were similar 
to multiple studies and are compared in Table 20. Male preponderance could be due to the 
high incidence of smoking found among the males. 
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Table 20: Comparison of data for gastric malignancies from present study to published 
literature from India 
Characteristic Cherian et 
al (31) 
Saha AK et 
al (30) 
Barad AK 
(27) 
Present 
study 
Study period 1989-2004 2006-2010 2009-2013 2013-2014 
Region Chennai West Bengal  Manipur Vellore 
Type of study Retrospective  Prospective  Retrospective  Prospective  
Study setting Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
M : F ratio 3:1 2.7:1 2.16:1 1.65:1 
Most common symptom - Abdomen 
pain 
Abdomen 
pain 
Vomiting 
Type of 
histology (%) 
adenocarcinoma 100 100 100 88 
lymphoma - - - 8 
NET - - - 2 
GIST - - - 2 
Location (%) Proximal  16 6 17 8 
Distal  84 94 83 92 
 
In present study, most common presenting symptoms were vomiting (87%), anorexia (86%) 
and least common symptoms being abdominal distension (8%) and dysphagia (6%). This 
finding was different from a retrospective study by Barad AK (27) and a prospective study by 
Saha AK et al (30).  Barad et al (27) study showed that upper abdominal pain was most 
common symptoms in 97 (61%) of patients followed by weight loss in 94 patients (60%) and 
dysphagia in 29 (18%) and melena in 25 patients (16%). In Saha AK et al (30) study, most 
common symptom was abdominal pain in 306 patients (66%) followed by indigestion in 212 
patients (46%) and weight loss in 200 patients (43%). Melena was present in 44 patients 
(10%).  This difference may be due to delayed referral and gastric outlet obstruction in some.  
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In the present study, distal part of body of stomach was most common site (92%) of gastric 
malignancy as compared to the proximal part (9%) which was similar to studies by Saha AK 
et al (30), Barad AK (27) and Cherian et al (31).  
In present study, adenocarcinoma (N-260, 88%) was most common histology type followed 
by B-cell lymphoma (N-23, 8%) and followed by NET and GIST (2%). Similar results were 
seen by Barad AK (27). 
Small intestine malignancy: 
The present study showed overall male:female ratio of 2.62:1 and median age of 49 years 
(range from 27-69). Most of the cases were in 41-60 years age group (55%). These finding 
was comparable to multiple studies (Table 21).  
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Table 21: Comparison of data for small intestine malignancies from present study to 
published literature 
Characteristic Cunningham 
JD et al (38) 
Dabaja BS et 
al (36) 
Koo DH et al 
(39) 
Present 
study 
Study period 1970-1991 1978-98 1989-2009 2013-
2014 
Region USA USA Korea Vellore  
Type of study Retrospective  Retrospective  Retrospective  Prospecti
ve  
Study setting Hospital based Hospital based Hospital based Hospital 
based 
M : F ratio 1.5:1 1.58:1 2.7:1 2.62:1 
Most common symptom Abdomen pain Abdomen pain - Vomitin
g 
Type of 
histology 
(%) 
Adenocarcinoma 100 81 100 59 
lymphoma - - - 17 
NET - - -19 17 
GIST - - - 7 
Location 
(%) 
duodenum 52 25 78 89 
jejunum 25 37 22 - 
Ileum 13 38 11 
In the present study, most common presenting symptoms were vomiting (90%) and weight 
loss (86%). These findings was different to a retrospective study by Dabaja BS et al (36) 
where most common symptoms were abdominal pain (66%), obstruction in (40%), and 
bleeding (24%). This difference may be again due to delay in referral. 
 In the present study, duodenum (89 %) was most common location for small intestine tumor 
and none of the patient had tumor in the jejunum. This finding was different to a retrospective 
study by Egberts J-H et al (34) and Dabaja BS et al (36). In a study done by Egberts J-H et al 
(34), 46% tumors were localized to duodenum, 16% in jejunum and 37% in ileum. In a study 
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done by Dabaja BS et al (36), 113 (52%) malignancies were originated in the duodenum, 54 
(25%) in the jejunum, 28 (13%) in the ileum. This difference may be because some patients 
may have presented to the surgical department.  
In the present study, adenocarcinoma (59%) was most common histology. Seventeen percent 
had B-cell lymphoma and NET. This finding was different to a retrospective study by Egberts 
J-H et al (34) and Cunningham JD et al (38). In study by Egberts J-H et al (34), 37% had 
adenocarcinoma (n=16), 28% neuroendocrine tumors (n=12), 23% gastrointestinal stroma 
tumor (GIST) (n=10, 7% lymphoma (n=3) and 5% desmoid tumor (n=2). In study by 
Cunningham JD et al (38), thirteen had duodenal adenocarcinoma. Tumors located in the 
jejunum were most likely adenocarcinomas or lymphomas. Half of the ileal tumors were 
carcinoids. Lymphomas and sarcomas were located most commonly in the jejunum or ileum. 
Colonic malignancy: 
The present study showed mean age of 53 years (range from 18-85 years). Most of the cases 
were in 41-60 years age group (51%). Male:female ratio was 2.09:1.  These finding were 
comparable to multiple studies and compared in Table 22.  
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Table 22: Comparison of data for colonic malignancies from present study to published 
literature 
Characteristic Mukhe
rji A et 
al (49) 
Peedikayi
l MC AK 
et al (45) 
Hussain 
N et al 
(44) 
Zargar 
SA et al 
(47) 
Santos et 
al (40) 
Present 
study 
Study period 2000-
2006 
2001-
2005 
2003-
2010 
2005-
2006 
2006-
2010 
2013-
2014 
Region New 
Delhi 
Kerala  Raipur  Kashmir Brazil  Vellore  
Type of study  Retrospec
tive  
Retrospec
tive 
Prospect
ive  
Retrospec
tive  
Prospect
ive  
Study setting Hospita
l based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Number of patients 324 220 233 212 107 229 
Median age(years)  
- 
58 45  57  59 53 
M : F ratio 1:1 2.09:1 1.35:1 1.2:1 0.84:1 2.09:1 
Most common 
symptom 
Bleedin
g per 
rectum 
Bleeding 
per 
rectum 
- - Abdomin
al pain 
bleeding 
per 
rectum 
Type 
of 
histolo
gy (%) 
Adenocarcin
oma 
100 98 100 100 100 86 
Lymphoma - 2 - - - 12 
NET - . - - - 2 
Most common 
Location 
rectum rectum rectum rectum rectosigm
oid 
rectum 
 
Our study showed most common presenting symptoms were weight loss (67%) and anorexia 
(66%). This finding was similar to multiple studies by Halder SK al (48), Peedikayil MC AK 
et al (45) and Santos AC dos et al (40). 
88 
 
In present study, rectum (51%) was most common location for colonic malignancy. The 
ascending colon (21%) was 2
nd
 most common location of colonic malignancy.  This finding 
was similar to a study from Brazil by Santos AC dos et al (40), Peedikayil MC AK et al (45), 
Halder SK al from Kolkata (48) and Mukherji A et al (49).  The finding was different from a 
retrospective study done by Hussain N et al (44) where 85% colonic malignancy were 
localised to rectum. 
Our study revealed adenocarcinoma (N-214, 94%) was most common histology type 
followed by lymphoma (N-12, 5%). Two (1 %) patients had NET. This finding was different 
from a retrospective study by Santos AC dos et al (40) and Halder SK al (48). Our study 
revealed that most of patients had moderately differentiated adenocarcinoma (N-137). A 
retrospective study done by Hussain N et al (44) showed different results where it showed 
that well differentiated adenocarcinoma was most common followed by moderately 
differentiated and  poorly differentiated adenocarcinoma. CEA levels were normal in 46% 
cases, confirming previous evidence of no diagnostic value of CEA. 
Gall bladder cancer: 
In the present study, male to female ratio was 0.66:1 and median age was 54 years (range 
from 30-84). These findings were comparable to multiple studies (Table 23).  
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Table 23: Comparison of data for gall bladder malignancies from present study to 
published literature from India 
Characteristic Pandey M et 
al (54) 
Sachidananda 
S et al (51) 
Khan I et al 
(52) 
Batra Y et al 
(53) 
Present 
study 
Study period 1990-1993 2001-2010 18 months 10 years 2013-2014 
Region Varanasi  Chennai Kolkata  New Delhi  Vellore  
Type of study Prospective  Retrospective  Prospective Retrospective Prospective  
Study setting Hospital based Hospital based Hospital 
based 
Hospital 
based 
Hospital 
based 
Number of 
patients 
99 61 63 634 45 
Median 
age(years) 
50 60  45  51 54 
M : F ratio 1:3 1.6:1 1: 3.8 0.36:1 0.66:1 
Most common 
symptom 
Abdomen pain  Abdomen pain Abdomen 
pain 
Abdomen 
pain 
Weight loss  
Associated GB 
stone (%) 
- 20 71 54 38 
 
The present study showed that most common presenting symptoms were weight loss (97%) 
and vomiting (91%). Ten patients (22%) presented with cholangitis. This finding was 
different from earlier studies done by Sachidananda S et al (51), Khan I et al (52) , Batra Y et 
al (53) and Pandey M et al (54). In study by Sachidananda S et al (51), right upper quadrant 
pain (42%) was most common symptom followed by jaundice (27%) and a presence of a 
palpable mass (12%). In study by Khan I et al (52), abdomen pain was the commonest 
symptoms  (87%), followed by pallor, lump in right upper quadrant, nausea & vomiting and 
jaundice in 71%, 70%, 67%, 32% patients. In study by Batra Y et al (53), abdomen pain and 
jaundice were most common symptoms in 516 (81%) and 462 (73%) patients. Pruritus was 
90 
 
present in 40%, cholangitis in 18%, ascites in 14%, vomiting in 10% and hematemesis in 1% 
of patients. In study by Pandey M et al (54), abdominal pain (83%) and abdominal mass (74 
%) were the main presenting symptoms. Sixteen patients (38%) had gall bladder stone and 
one patient had porcelain gallbladder. This finding was similar to a retrospective studies by 
Sachidananda S et al (51), Khan I et al (52) and Batra Y et al (53). This underestimation 
could be because cholelithiasis may be missed on sonology when caught up in a gallbladder 
mass or may have been missed by the radiologist as they were not specifically looking for 
them in patients with a gallbladder mass. 
In present study most cases of gall bladder presented in late stage. Only one patient was 
operable (2%) and 23 cases (51%) had liver metastasis. This could be due to referral bias. 
Similar finding was seen in study by Sachidananda S et al (51) and Pandey M et al (54).  
HCC: 
The present study showed mean age of 58 years (range from 18-85). The male:female ratio of 
8:1.  Most of the cases were in 41-60 years age group (51%). This finding was comparable to 
multiple studies (Table 24). This high preponderance of HCC in males reported in this study 
could suggest a gender bias in seeking medical treatment and to risk factors related to 
lifestyle like alcohol and blood borne hepatotrophic viruses.  
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Table 24:  Comparison of data for HCC from present study to published literature from 
India 
Characteristic Paul SB et al 
(62) 
Kumar R et 
al (63) 
 
Sood A et al 
(61) 
Present study 
Study period 1990-2005 1994-2005 2007-2010 2013-2014 
Region New Delhi  New Delhi Punjab Vellore 
Type of study Retrospective  Retrospective  Prospective   Prospective  
Study setting Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital based 
Number of 
patients 
324 191 128 207 
Mean 
age(years) 
52.4 52 48.8 52.92 
M : F ratio 7.1:1 5.1:1 4.8:1 8:1 
Most common 
symptom 
Abdomen 
pain  
Ascites Ascites  Ascites 
Most common 
etiology  
HBV HBV Ethanol  HBV 
AFP value >200 
ng/ml (%) 
36 - 67 56 
Potential 
curative 
strategies 
available at 
presentation (%) 
- - - 32 
 
In our study, most common presenting symptom was abdominal distension (55%). This 
finding was different from to retrospective studies by Sood A et al (61), Paul SB et al (62) 
and Kumar R et al (63). In a study done by Sood A et al (61), most patients (83%) had 
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features of decompensated cirrhosis, 91% patients had ascites, jaundice in 18%, hepatic 
encephalopathy in 21% and upper GI bleed in 9%. In a study done by Paul SB et al (62) 
showed that right upper quadrant pain was the predominant symptom in 53% of the patients, 
ascites in 13% and weight loss in 9%. In a study done by Kumar R et al (63), 51% patients 
had ascites, jaundice in 34% and hepatic encephalopathy in 5% patients.  New onset ascites 
was seen in 57% cases.  Upper GI bleed was present in 22% patients. 
In our study, most of the patients were in CTP-A class (50%). This finding was similar to a 
retrospective study by Paul SB et al (62). 
The present study showed that AFP value was within normal limits in thirty eight (19%) 
patients. One hundred fourteen (56%) patient had AFP value more than 200 IU/ml. This 
finding was similar to a retrospective study by Sood A et al Punjab (61), and Paul SB et al 
(62). 
The present study revealed that most common etiology for HCC was hepatitis B (n-74, 37 
%). Fifty two (26%) patients had cryptogenic CLD related HCC. Twenty (10%) patients had 
HCV related HCC. This finding was similar to a retrospective study by Paul SB et al (62).  
This finding was different from a retrospective study by Sood A et al (61) and Kumar R et al 
(63). According to study by Sood A et al (61), Alcohol was most common etiological factor 
(45%), followed by HCV (25%). HBV related HCC was present in 3% and NAFLD had 3%. 
5% had cryptogenic chronic liver disease. In study by Kumar R et al (63), most under lying 
etiology was HBV related HCC (N-107, 73%). Twenty two patients (15%) had HCV related 
HCC. Sixteen patients (11%) was cryptogenic cirrhosis. 
In present study, only 12 patients (6%) were ideal candidate for radiofrequency ablation 
(RFA) and 8 patients (4%) were suitable for surgical resection. 46 patients (22%) met 
the Milan criteria for liver transplantation. This meant that 141 (68%) patients had only 
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palliative treatment options available to them at presentation.  This was similar to what was 
seen in the study by Sood et al (61).  In the study Paul SB et al from AIIMS, 50 % of the 
HCC patients were in BCLC stage A and B ie, had a potentially curative option (62). 
Pancreatic malignancy: 
The present study showed male:female ratio of 1.42:1. The present study showed the median 
age of 52 years (range from 29-74). Most of the cases were in 41-60 years age group (61%).  
These finding were comparable to multiple studies and compared in Table 25. 
Table 25: Comparison of data for pancreatic malignancies from present study to 
published literature 
Characteristic Sener SF et al 
(68)  
Yeo CJ et al 
(69) 
Mukherjee S et 
al (70) 
Present study 
Study period 1985-1995 1990-1996 2009-2011 2013-2014 
Region USA USA UK Vellore 
Type of study Retrospective  Prospective  Prospective  Prospective  
Study setting Population 
based 
Hospital based Hospital based Hospital based 
Number of 
patients 
100313 650 74 80 
Median 
age(years) 
75 63 63.1 52 
M : F ratio - 1.22:1 0.88:1 1.42:1 
Most common 
symptom 
- - - Abdomen pain 
 
In the present, most common presenting symptoms were abdomen pain (89%) and vomiting 
(80%). Thirty patients (37%) had jaundice and six patients (8%) had cholangitis. These 
finding was similar to a study by Ryan DP et al (65). 
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The present study showed that 66 % of the pancreatic tumors were located in the head of the 
pancreas. It was followed by body of the pancreas (20%). The least common site was tail of 
the pancreas. This finding was similar to a retrospective study by Sener SF et al (69) and 
Mukherjee S et al (70). 
Out of 80 cases of pancreatic malignancy, 30 cases (38%) were within criteria for operability 
with potentially curative intent while 32 (40%) had relative contraindications to surgery due 
to locally advanced disease (vessel encasement or local lymph node spread). 18 cases (23%) 
had liver metastasis.  In a study by Yeole and Kumar looking at the Mumbai population 
based cancer registry, only 3 % of cases of pancreatic malignancies were localized to the 
pancreas at presentation and 18 % had regional spread while 49% had distant metastasis (4). 
Periampullary carcinoma: 
The present showed the male:female ratio was 2.63:1 and mean age of 52 years (range from 
22-74). Most of the cases were in 41-60 years age group (64%).  These finding were 
comparable to multiple studies and compared in Table 26. 
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Table 26: Comparison of data for periampullary malignancies from present study to 
published literature 
Characteristic Chauhan A 
et al (73) 
Yeo CJ et al 
(75) 
Riall TS et 
al (76) 
Klein F et al 
(74) 
Present 
study 
Study period 3 years 1970-1992 1970-1999 1992-2007 2013-2014 
Region Manipal USA USA Germany Vellore 
Type of study Retrospective  Retrospective  Retrospective  Retrospective  Prospective  
Study setting Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Number of 
patients 
24 242 242 143 69 
Median 
age(Years) 
55  64 65 64 52 
M :F ratio 1.41:1 1.22:1 1.25:1 1.55:1 2.63:1 
Most common 
symptom 
Jaundice  - - Jaundice  Weight loss 
and 
jaundice 
 
The present study showed that most common presenting symptoms were weight loss (93%) 
and jaundice (90%). This finding was different from retrospective study by Chauhan A et al 
(73) and Klein F et al (74). In study by Chauhan A et al (73), all of the patients (100%) had 
jaundice, pruritus in 67%, abdominal pain in 54%, and vomiting in 29 %.  In study by Klein F 
et al (74), Seventy five (52%) patients presented with jaundice, and 88 (62%) patients had 
nonspecific epigastric pain. 
In the present study, forty (58%) patients had moderately differentiated adenocarcinoma. 
Twenty seven (39%) patients had well differentiated adenocarcinoma and two (3%) patients 
poorly differentiated adenocarcinoma. This finding was different from a retrospective study 
by Yeo CJ et al (75) and Riall TS et al (76). In study by Yeo CJ et al (75), Twelve percent 
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were well-differentiated adenocarcinoma. 88% of the tumors were moderately or poorly 
differentiated adenocarcinoma. In study by Riall TS et al (76), Sixty eight percent were 
moderate to well differentiated and thirty two percent were poorly differentiated. 
In present study, 50 cases (72%) were operable and only 10 cases (14%) had liver metastasis. 
Similar finding was seen in study by Klein F et al (74). 
Cholangiocarcinoma:  
The present showed the male to female ratio was 3.60:1 and mean age of 53 years (range 
from 25-75). Most of the cases were in 41-60 years age group (70%).  These finding were 
comparable to multiple studies and compared in Table 27. 
Table 27: Comparison of data for cholangiocarcinoma from present study to published 
literature 
Characteristic Nakeeb A et 
al (77)  
DeOliveira 
ML et al 
(83) 
Yusoff AR 
et al (82) 
Rasoulian J 
M et al (84) 
Present 
study 
Study period 1973-1995 1973-2004 1998-2002 2010-2011 2013-2014 
Region USA USA Malaysia Iran  Vellore 
Type of study Retrospective  Retrospective Retrospective  Retrospective Prospective  
Study setting Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Hospital 
based 
Number of 
patients 
294 564 69 22 23 
Median 
age(years) 
62.2 65  61 68.55 53 
M:F ratio 1.20:1 1.21:1 1.21:1 1.21:1 3.60:1 
Most common 
symptom 
Jaundice  Jaundice jaundice Jaundice 
 
Weight loss 
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The present study showed that most common presenting symptoms were weight loss (96%) 
and abdomen pain (91%). The least common symptom was abdomen distension (13%). Six 
patients (26%) were presented in cholangitis. These finding was different to a retrospective 
study by Nakeeb A et al (77), Yusoff AR et al (82), and DeOliveira ML et al (83). In study by 
Nakeeb A et al (77), most common presenting complaints were jaundice (84%) followed by 
abdominal pain (35%), weight loss (33%), and fever (10%). In a study done by Yusoff AR et 
al (82), most common symptoms were jaundice (78%), anorexia (57%), weight loss (52%), 
abdominal pain (44%), abdominal mass (44%), itching (25%), vomiting (9%) and fever (7%). 
In study by DeOliveira ML et al (83), the most common symptoms were jaundice (84%), 
abdominal pain (30%) and weight loss (35%). 
In study most cases of CCA presented in advanced stage and only 3 cases (13%) were 
potentially operable. 7 cases (30%) had liver metastasis. 
Lymphoma: 
In our study, most common sites for lymphoma was stomach (N-23) followed by colon (N-
12). The least common site was esophagus (N-1).  This finding was different from a large 
retrospective study by Pulimood A et al (28). In this study, none of the patient had esophageal 
lymphoma. In this study, the commonest site was stomach in 180 patients (54%), followed by 
small intestine in 79 patients (24%) and large intestine in 68 patients (20%). This finding may 
be due to referral bias of all hematological cases to our hospital. 
GIST: 
In present study, most common sites for GIST was stomach (N-7) followed by small intestine 
(N-2). The least common site was esophagus (N-1). The finding was different from a 
retrospective study by Kurian S et al (29) where GISTs were almost equally prevalent in the 
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stomach and the small intestine (40%). The colorectal had only 9% of the tumors and, much 
less frequently, GISTs were present in the anal canal (three patients) and in the esophagus 
(two patients). 
 NET: 
In present study, most common sites for NET was pancreas (N-9) followed by stomach (N-7). 
The least common site was small intestine (N-2).  A nationwide survey by Ito T et al (71) 
showed similar results. 
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                                              Summary and Conclusion 
Out of 41543 patients newly registered in the departments of Medical Gastroenterology and 
Hepatology from August 2013 to December 2015, a total of 1200 cases of newly diagnosed 
GI and HPB tract malignancies were included during the study period (2.8%).  
Most of the malignancies were seen in the age group of 41-60 years (58%). The male: female 
ratio was 2.34:1 and varied from 8:1 in HCC to 0.66:1 in gall bladder cancer. Six hundred 
eighty five cases (57%) were from a rural area. Seven hundred forty six (62%) patients 
belong to the middle class, based on socioeconomic scale. 
While 543 (53%) cases had a normal BMI, 226 (22%) were underweight. One hundred 
sixteen (11%) cases were overweight and 140 (14%) were obese. There was history of 
significant alcohol intake and smoking in 13% and 62% of the patients respectively.  A 
family history of GI malignancy was present in 2 % of cases. 
The most common malignancy was stomach-297 (25%), followed by colorectal-229 (19%), 
esophagus-222 (18%) and HCC-207 (17%). Others included pancreas-80 (7%), 
periampullary-69 (6%), gall bladder-45 (4%), small intestinal malignancy, including 
duodenal-29 (2%) and cholangiocarcinoma-23 (2%). 
Esophageal malignancy:  The most common presentation was dysphagia (93%). The most 
common site was lower and mid esophagus (30% and 26% respectively). The most common 
histology was SCC (69%). 
Stomach malignancy:  Most of the gastric malignancies were localised to the distal part 
(92%) and adenocarcinoma (88%) was most common histology. The most common symptom 
was vomiting (87%).  
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Colo-rectal malignancy: Rectum (51%) was the most common site followed by ascending 
colon (21%). Weight loss (67%) and per rectal bleeding (65%) were most common 
symptoms. Adenocarcinoma (93%) was the most common histology. Nine Patients (0.39%) 
had a family history of colonic malignancy.  Six patients (0.26%) had polyposis coli. None of 
the patient had ulcerative colitis or Crohn´s disease. CEA levels were normal in 46% cases. 
Small intestine (including duodenum):  The most common presenting complaints were 
vomiting (90%) and weight loss (86%). The most common location was D1 (48%) followed 
by D2 (41%). Three patients had ileal tumours (carcinoid in two).  
HCC:  The male to female ratio was 8:1. The median age was 58 years (range from 22-86). 
Most of the cases were in the 41-60 year age group (47%). Abdomen distension (55%) was 
most common symptom. Fifty one percent of patients were in CTP-A class. The median 
MELD score was 12 (range from 6 to 36). Thirty eight (19%) patients had AFP within 
normal limits.  One hundred fourteen (56%) patient had AFP value more than 200 IU/ml. The 
most common etiology was HBV (37%) followed by cryptogenic CLD related HCC (26%). 
Only 66 (32%) patients were within criteria for a potentially curative treatment strategy at 
presentation. Twelve patients (6%) were ideal candidates for radiofrequency ablation (RFA) 
and 8 patients (4%) were suitable for surgical resection.  Forty six patients (22%) met 
the Milan criteria for liver transplantation. 
Pancreatic malignancy: The most common presenting symptom was abdominal pain (89%). 
Sixty six percent of the pancreatic tumors were located in the head of the pancreas. One 
patient had family history of pancreatic malignancy. Thirteen patients (16%) had associated 
chronic pancreatitis. Sixty one patients (77%) had biopsy proven pancreatic malignancy. 
Thirty cases (38%) were within criteria for operability with potentially curative intent while 
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32 (40%) had relative contraindications to surgery due to locally advanced disease (vessel 
encasement or local lymph node spread). Eighteen cases (22%) had liver metastasis.  
Periampullary malignancy:  The most common presenting symptoms were weight loss (93%) 
and jaundice (90%).  Out of 69 cases of periampullary malignancy, 50 cases (73%) were 
within criteria for operability with potentially curative intent and 10 cases (15%) had liver 
metastasis. In three cases (5%), available radiological data was insufficient to stage 
accurately.  Five cases (7%) had relative contraindications to surgery due to locally advanced 
disease (vessel encasement or local lymph node spread). 
CCA:  The most common presenting symptoms were weight loss (96%) and abdominal pain 
(91%). Ten patients (39%) had biopsy proven cholangiocarcinoma. Out of 23 cases of CCA, 
only 3 cases (13%) were within criteria for operability with potentially curative intent and 7 
cases (30%) had liver metastasis. In two cases (9%), available radiological data was 
insufficient to stage accurately. Eleven cases (48%) had locally advanced disease. 
Gall bladder malignancy:  Weight loss (98%) and abdomen pain (87%) were most common 
presentation. Gall stones were associated in 38% of cases. Out of 45 cases of gall bladder 
malignancy, only one patient (2%) was within criteria for operability with potentially curative 
intent. and 23 cases (51%) had liver metastasis. In one case (2%), available radiological data 
was insufficient to stage accurately. Twenty cases (45%) had locally advanced disease. 
Compared to earlier studies from India, while gastric and esophageal malignancies continue 
to remain common GI malignancies, rectal and liver carcinomas appear to show an increased 
incidence. HPB malignancies continue to present at an advanced stage in the majority.   
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MASTER SHEET 
Esophageal malignancy: 
s.no hsp a s sc st ha al S
m 
f BMI 
p b A B C D E F G 
1 637605f 50 2 2 13 2 2 2 2 20.2 4 2 1 1 2 2 2 2 2 
2 640097f 69 1 2 18 1 1 1 2 18.1 2 2 1 1 2 2 2 2 2 
3 644533f 74 2 3 1 2 2 2 2  2 9 1 1 2 2 2 2 2 
4 638544f 61 1 3 1 2 2 1 2 18.8 5 5 2 2 1 1 1 2 2 
5 224899f 49 1 3 4 2 2 1 2 20.5 3 3 1 2 2 2 2 2 2 
6 655541f 38 2 2 6 1 2 2 2  1 2 1 1 2 1 1 2 2 
7 663196f 44 1 2 13 2 1 1 2 29 3 2 1 1 2 2 2 2 2 
8 606430f 60 1 3 1 2 1 1 2 19.1 5 6 1 2 2 1 2 2 2 
9 668210f 48 2 2 13 2 2 2 2 17.4 3 3 1 1 2 1 1 2 2 
10 668555f 71 2 3 1 2 2 2 2 17.8 3 2 1 1 1 2 2 2 2 
11 647578f 71 1 3 1 2 2 1 2 13.4 5 5 1 1 2 1 2 2 2 
12 537666d 53 1 3 4 2 2 1 2 17.9 2 2 1 1 2 1 1 2 2 
13 665124f 30 1 3 1 2 2 2 2 15.7 4 5 1 1 2 1 1 2 2 
14 838849d 62 1 2 4 1 2 2 2 16.3 3 1 1 1 2 2 1 2 2 
15 654490f 71 1 2 1 1 2 2 2 21.3 5 6 1 1 2 1 1 2 2 
16 667688f 32 1 3 6 2 1 1 2 23.5 5 6 1 2 2 1 1 2 2 
17 668409f 53 1 3 7 2 2 1 2 18.4 3 2 1 1 2 1 2 2 2 
18 650511f 63 1 3 1 2 2 1 2 19.5 4 8 2 1 2 1 1 2 2 
19 649075f 59 2 3 13 2 2 2 2 17.8 3 3 1 1 2 1 1 2 2 
20 634689f 52 1 3 4 2 2 2 2 20.1 5 6 2 1 2 1 1 2 2 
21 692885f 55 2 3 6 2 2 2 2 23.2 3 2 1 1 1 2 1 2 2 
22 697957f 55 1 3 2 1 1 1 2 16.7 4 2 1 1 2 1 1 2 2 
23 685642f 65 1 2 4 1 2 2 1 17.9 4 2 1 1 2 2 2 2 2 
24 842477f 61 2 2 1 1 2 2 2 18.2 3 2 1 1 2 2 1 2 2 
25 786838f 57 1 2 2 1 2 1 2 17.8 2 3 1 1 2 2 1 2 2 
26 694205f 45 1 3 4 2 2 1 2 20.1 3 2 1 2 2 2 2 2 2 
27 677685f 64 1 2 2 1 2 1 2 24.7 5 6 1 1 2 2 1 2 2 
28 884009c 52 2 2 4 1 2 2 2 16.8 4 2 1 1 2 2 1 2 2 
29 700150f 48 2 3 1 2 2 2 2 17.1 5 4 1 1 2 1 1 2 1 
30 698797f 41 1 3 2 2 2 1 2 19.8 2 3 1 1 2 1 2 2 2 
31 794957f 49 1 3 4 2 2 1 2 16.8 4 2 1 1 2 1 2 2 2 
32 792255f 73 2 3 13 2 2 2 2 22.3 3 2 1 2 2 1 2 2 2 
33 793415f 47 1 3 1 2 2 1 2 16.4 3 2 1 1 2 1 1 2 2 
34 795136f 62 1 3 4 2 2 1 2 13.7 3 2 1 1 2 2 1 2 2 
35 793602f 34 1 3 4 2 2 1 1 15.4 4 5 1 1 2 1 1 2 2 
36 795797f 59 1 3 4 2 2 1 2 17.4 4 3 1 1 2 2 1 2 2 
37 796865f 59 1 3 4 2 2 1 2 15.4 3 2 1 1 2 2 2 2 2 
38 790256f 60 1 2 1 1 2 1 2 16.8 4 2 1 1 2 2 1 2 2 
120 
 
39 786838f 57 1 2 2 2 2 1 2 17.8 2 3 1 1 2 2 2 2 2 
40 793644F 55 1 3 4 2 2 2 2 17.8 4 2 1 1 2 1 1 2 2 
41 790546F 57 1 3 1 2 1 1 2 24.2 4 2 1 1 2 1 1 2 2 
42 830924f 51 2 2 3 1 2 2 2  2 3 1 1 2 2 1 2 2 
43 836353f 61 1 3 2 2 1 1 2 21 4 4 1 1 2 2 1 2 2 
44 826751f 39 1 3 1 2 2 2 2 24.1 5 5 1 1 2 1 1 2 2 
45 836372f 42 1 2 2 1 2 1 2  5 5 2 1 2 1 1 2 2 
46 722066f 58 1 2 13 1 2 1 2 13.4 3 2 1 1 2 2 1 2 2 
47 722197f 70 1 3 1 2 2 1 2 19.6 5 5 1 1 2 1 2 2 2 
48 866311b 61 1 2 4 2 2 1 2 17.9 2 1 1 1 2 2 1 2 2 
49 816848f 49 2 3 2 2 2 2 2 29.8 3 3 1 1 2 1 2 2 2 
50 801926f 49 1 3 4 2 2 2 2 18.8 5 3 1 2 2 1 2 2 2 
51 718588f 52 1 2 2 2 2 1 2 16.8 4 3 1 1 2 2 2 2 2 
52 814453f 60 1 3 9 2 1 2 2 16 5 5 1 1 2 1 1 2 2 
53 816167f 56 1 3 1 2 2 1 2 17.8 1 3 1 1 2 1 1 2 2 
54 814696f 70 1 2 1 1 2 2 2 23.2 2 2 1 1 2 1 2 2 2 
55 814178f 49 1 3 1 2 1 1 2 19.2 2 3 1 1 2 1 1 2 2 
56 310970b 73 2 3 2 1 2 2 2 18.9 5 5 1 1 2 1 1 2 2 
57 371146f 53 1 3 4 2 2 2 2 21.4 3 3 2 1 2 2 1 1 2 
58 763196f 55 1 2 1 2 2 1 2 17.5 4 3 1 1 2 1 1 2 2 
59 761464f 58 2 2 1 1 2 1 2 16.5 1 1 1 1 2 1 2 2 2 
60 762301f 65 1 3 4 2 2 2 2 17.2 3 2 1 1 2 2 1 2 2 
61 748999f 55 2 3 1 2 2 2 2 18.4 4 2 1 1 2 1 2 2 2 
62 258848f 52 1 2 1 1 2 1 2 20.7 5 5 1 1 2 1 1 2 2 
63 703730f 43 1 2 13 1 2 1 2 16.9 2 2 1 1 2 1 1 2 1 
64 760027f 58 1 3 12 2 2 1 2 20.5 5 2 2 1 2 2 1 2 2 
65 924563b 76 1 2 20 1 2 1 2 19.5 3 2 1 1 2 1 1 2 2 
66 640097f 69 1 2 18 1 1 1 2 18.1 2 2 1 1 2 2 2 2 2 
67 742072f 25 2 2 6 1 2 2 2 17.9 5 1 1 1 2 1 1 2 2 
68 456577f 49 1 2 13 1 2 1 2 16.8 4 2 1 1 2 1 1 2 2 
69 745970f 50 2 3 4 2 2 2 2 20.2 3 2 1 1 2 1 1 2 2 
70 726156f 46 2 3 2 2 2 2 2 15.8 5 6 1 1 1 2 1 2 2 
71 763236f 65 1 3 3 2 2 1 2 18.9 5 5 1 1 2 2 1 2 2 
72 760493f 55 2 3 4 2 2 1 2 18.9 3 3 1 2 2 1 1 2 2 
73 478577f 51 1 2 4 1 2 1 2 16.5 3 2 1 1 2 1 1 2 2 
74 904092a 66 2 2 2 2 2 2 2 18.9 3 2 1 1 2 2 1 2 2 
75 763196f 55 1 3 1 2 2 1 2 17.5 5 3 1 1 2 1 2 2 2 
76 721970f 37 1 1 2 1 2 1 2 17.6 5 6 1 1 2 1 1 2 2 
77 778246f 45 1 3 1 2 2 1 2 16.4 5 6 1 2 2 1 1 2 2 
78 751275f 60 2 2 2 1 2 2 2 18.4 5 4 1 1 2 1 1 1 2 
79 774031f 49 1 2 1 2 1 1 2 19.3 3 2 1 1 2 1 1 2 2 
80 775559f 52 1 2 2 2 2 1 2 16 3 3 1 1 2 1 1 2 2 
81 916205d 60 1 2 8 1 2 1 2 23.3 4 3 1 1 2 1 2 2 2 
82 775084f 69 1 3 1 2 2 1 2 21.9 4 1 1 1 2 1 1 2 2 
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83 774150f 62 1 3 9 2 2 1 2 18.9 4 5 1 1 2 1 2 2 2 
84 709553f 40 2 3 4 2 2 2 2 22.8 5 5 1 1 2 1 1 2 2 
85 708003f 52 1 3 4 2 1 1 2 24.8 4 2 1 1 2 1 1 2 2 
86 602000f 33 2 2 6 1 2 2 2 18.8 1 2 1 1 2 1 1 2 2 
87 727700f 60 1 2 1 2 2 1 2 18.4 4 1 1 1 2 1 1 2 2 
88 287716d 40 2 2 2 1 2 2 2 19.1 4 6 1 1 2 1 1 2 2 
89 716922f 30 1 3 4 2 1 1 2 17.4 3 1 2 1 2 1 1 1 2 
90 770777f 45 2 2 3 1 2 2 2 19.4 5 4 1 1 1 1 2 2 2 
91 781852f 41 1 2 1 1 2 1 2 18.9 4 2 1 1 2 2 2 1 2 
92 783700f 49 1 2 1 1 2 1 2 18.7 3 2 1 2 2 2 1 2 2 
93 784591f 59 1 2 4 1 2 1 2 19.3 3 2 1 2 2 1 1 2 2 
94 333101 65 1 3 2 2 2 1 2 16.4 2 2 1 1 2 1 1 2 2 
95 903925b 49 1 3 2 2 2 1 2 25 4 2 1 2 2 1 1 2 2 
96 784116f 60 1 2 2 1 2 1 2 21.4 3 3 1 1 2 1 2 1 2 
97 714519f 62 1 3 1 2 2 1 2 16.5 5 4 1 1 2 1 1 2 2 
98 815130f 58 1 2 13 2 2 1 2 18.4 3 3 1 1 2 2 1 2 2 
99 813179f 74 1 1 5 1 2 2 2 25.9 4 8 1 2 2 2 2 2 2 
100 806810f 62 1 3 1 2 2 2 2 21.2 2 3 1 1 2 1 2 1 2 
101 799992f 55 1 3 9 2 2 1 2 17.3 4 5 1 2 1 2 2 2 2 
102 640695f 53 1 3 13 2 2 1 2 17.8 4 2 1 2 2 1 2 2 2 
103 459749f 60 2 2 3 1 2 1 2 14.7 3 2 1 1 2 2 2 2 1 
104 712028f 56 1 2 6 2 2 1 2 17.8 1 3 1 1 2 1 2 2 2 
105 859334f 40 2 2 3 1 2 2 2 18.6 4 4 1 1 2 2 2 2 2 
106 816848f 49 2 2 2 1 2 2 2 29.8 2 3 1 1 2 2 1 2 2 
107 710574b 56 2 3 2 2 2 2 2 20.1 3 2 1 1 2 2 2 2 2 
108 860038f 63 1 3 6 2 2 1 2 16.8 2 2 1 1 2 1 1 2 2 
109 209839f 64 1 3 4 2 2 1 2 18.4 4 2 1 1 2 2 1 2 2 
110 370323f 65 1 2 1 2 2 2 2 22.2 1 3 1 2 2 2 2 2 2 
111 859793f 56 2 2 4 1 2 2 2 18.3 1 1 1 2 2 2 2 2 2 
112 770920F 34 2 2 5 1 2 2 2  5 6 1 1 2 1 1 2 2 
113 772704F 48 1 2 3 2 2 1 2 21.5 5 5 1 1 2 1 1 2 2 
114 769092F 53 1 3 6 2 2 1 2 22.6 5 5 1 1 2 1 1 2 2 
115 367343F 61 2 3 6 2 2 2 2 17.9 4 3 1 1 2 2 2 2 2 
116 764409F 55 1 3 6 2 1 1 2 17.9 4 2 1 1 2 1 1 2 2 
117 826018F 55 1 2 6 1 1 1 2 16.7 2 2 1 1 2 1 1 2 2 
118 823757F 58 1 3 4 2 2 1 2 17 4 2 1 1 2 1 1 2 2 
119 826751F 39 1 2 1 2 2 2 2 24.1 4 5 1 1 2 1 1 2 2 
120 667688F 32 1 2 6 2 1 1 2 23.5 5 6 1 1 2 2 1 2 2 
121 755673F 64 1 2 5 1 2 1 2 23.9 5 5 1 1 2 2 1 2 2 
122 755684F 40 1 2 13 2 2 2 2 15.7 4 2 1 1 2 2 1 2 1 
123 828037F 49 2 3 2 2 2 2 2 18.9 2 1 1 1 2 1 1 2 2 
124 823969F 44 1 2 1 2 2 1 2 17.9 4 6 1 1 2 1 1 2 2 
125 835057F 63 1 3 2 2 1 1 2  3 2 1 1 2 1 1 2 2 
126 833384F 59 1 2 4 2 2 1 2 20.3 4 2 1 1 2 1 1 2 2 
122 
 
127 833306F 64 1 2 1 2 1 1 2 18.9 5 6 1 1 2 1 1 2 1 
128 748594f 71 1 3 4 2 2 1 2 17.4 2 2 1 1 2 1 1 2 2 
129 953421d 45 2 2 6 2 2 2 2 16.7 1 2 1 1 2 1 1 2 2 
130 838168f 78 1 2 2 1 2 2 2 18.3 4 3 1 1 2 2 1 2 2 
131 839641f 48 1 2 13 2 2 1 2 17.3 4 3 1 1 2 1 1 2 2 
132 841784f 37 2 2 2 2 2 2 2 17.6 3 2 1 1 2 1 1 2 2 
133 021999l 60 2 3 2 2 2 2 2 18.5 4 3 1 1 2 2 1 2 2 
134 865450f 47 1 2 1 2 2 1 2 19.3 3 2 1 2 2 1 1 2 2 
135 854245f 60 1 3 4 2 1 1 2 14.9 1 2 1 1 2 1 1 2 2 
136 863955f 57 1 2 4 2 2 1 2 17.5 3 1 1 2 2 2 2 2 2 
137 771642f 60 2 2 13 2 2 2 2 23.3 1 2 1 1 2 2 2 1 2 
138 843762f 58 1 2 3 1 2 2 2 23.2 2 2 1 1 2 2 1 2 2 
139 848795f 62 1 3 4 2 2 1 2 17.4 2 2 1 1 2 1 1 2 2 
140 844581f 53 1 3 4 2 2 1 2 20.1 4 2 1 1 2 2 1 2 2 
141 699238f 47 1 2 13 2 1 1 2 21.5 4 2 1 1 2 1 2 2 2 
142 603079f 55 1 2 4 2 2 1 2 28.4 2 2 1 2 2 1 2 2 2 
143 689669f 54 1 2 4 2 2 1 2 21.2 4 2 1 1 2 1 1 2 2 
144 324418f 62 1 2 5 1 2 1 2 23 3 3 1 1 2 1 2 2 2 
145 666121f 51 1 2 2 2 1 2 2 20.5 5 4 1 2 1 2 1 2 2 
146 677910f 56 1 2 1 2 2 1 2 18.9 2 1 1 1 2 1 1 2 2 
147 670122f 65 1 2 7 2 1 1 2 21.7 4 2 1 1 2 1 2 2 2 
148 642049f 45 1 2 2 1 2 2 2 18.7 1 1 1 1 2 1 1 2 2 
149 654343f 55 2 3 1 2 2 1 2 19.3 3 2 1 1 2 1 1 2 2 
150 006050f 67 1 2 5 1 2 1 2 24.2 5 5 1 1 2 1 2 1 2 
151 411823f 40 2 3 4 2 2 1 2 15.2 3 2 1 1 2 1 1 2 2 
152 683932f 43 2 3 2 2 2 2 2 16.6 1 3 1 1 2 1 2 2 2 
153 675533f 49 1 2 3 2 2 2 2  5 5 1 1 2 1 1 2 2 
154 678391f 58 1 3 4 2 1 1 2 20.2 3 3 1 1 2 1 1 1 1 
155 324418f 62 1 2 5 1 2 2 2 26 3 3 1 1 1 1 2 2 2 
156 709764f 33 1 2 5 1 1 1 2 25 5 6 1 2 2 2 2 2 2 
157 523209c 43 1 3 2 2 2 1 2 21.6 4 2 1 2 2 1 2 1 2 
158 843545f 57 1 2 1 2 2 1 2 19.8 3 3 1 1 2 2 1 2 1 
159 850345f 66 1 3 2 2 2 1 2 20.6 4 2 1 1 2 1 2 2 2 
160 869877f 60 1 2 2 2 2 2 2 21.4 5 5 2 1 2 1 1 2 2 
161 411823f 40 2 3 4 2 2 2 2 20.1 3 2 1 1 2 2 1 2 2 
162 683932f 43 2 3 2 1 2 2 2 18 1 3 1 1 2 2 1 2 2 
163 665300f 51 1 3 3 2 2 1 2 21.3 5 5 1 2 2 2 2 2 2 
164 675533f 49 2 2 3 1 2 2 2 18.2 5 2 1 1 2 2 1 2 2 
165 679381f 58 1 2 4 1 1 1 1 20.4 3 3 1 1 2 2 1 2 2 
166 677685f 64 1 3 2 2 2 1 2 24.7 5 3 1 2 2 2 2 2 2 
167 324418f 62 1 2 5 1 2 2 2 26 3 3 1 2 2 2 2 2 2 
168 666121f 51 1 3 2 2 1 2 2 20.8 4 4 1 2 2 2 2 2 2 
169 677910f 56 1 2 1 2 2 1 2 17.4 2 2 2 2 2 2 2 2 2 
170 670122f 65 1 3 7 2 2 1 2 21.4 4 2 1 2 2 2 2 2 2 
123 
 
171 642069f 45 1 3 2 2 2 2 2 18.7 1 1 1 1 2 2 1 2 2 
172 371146f 53 1 2 4 2 2 2 2 21.4 3 3 1 2 2 2 2 2 2 
173 654343f 55 2 3 2 2 2 1 2 22.3 2 2 1 2 2 2 2 2 2 
174 006050f 67 1 2 5 2 2 2 2 18.7 5 6 1 1 2 2 1 2 2 
175 891894f 78 1 3 1 2 2 2 2  4 3 1 1 2 1 1 2 2 
176 511004f 46 2 3 2 2 2 2 2 20.5 5 5 1 1 2 1 1 2 2 
177 040657g 47 1 2 4 2 2 1 2 12.4 2 2 1 1 2 1 1 2 2 
178 042541g 57 1 2 1 2 2 1 2 17.9 4 4 1 1 2 1 1 2 2 
179 051995g 54 1 2 13 1 2 1 2 15.9 4 2 1 1 2 1 1 2 2 
180 048131g 70 1 2 4 2 2 2 2 20 5 5 1 1 2 1 1 2 2 
181 036958g 35 1 2 9 2 2 1 2 23.2 5 5 2 1 2 1 1 2 2 
182 049371g 45 2 2 4 2 2 2 2 15 4 2 1 1 2 1 1 2 2 
183 044892g 55 1 2 1 2 2 1 2 18.4 5 4 1 1 2 1 1 2 2 
184 046159g 33 2 3 4 2 2 2 2 19.9 4 2 1 1 2 1 1 2 2 
185 899799f 52 1 3 3 2 2 1 2 18.7 5 5 1 1 2 1 1 2 2 
186 616812f 65 1 2 2 1 2 1 2 16.7 4 1 1 1 1 1 2 2 2 
187 001651g 55 1 2 12 2 1 1 2 22.6 1 3 1 1 2 2 2 2 2 
188 003201g 50 2 2 2 1 2 2 2  1 1 1 1 2 1 2 2 2 
189 073399g 62 1 3 1 2 2 2 2 18.5 4 5 1 1 2 1 1 2 2 
190 924812f 52 1 2 13 1 1 1 2 22.1 1 2 1 2 2 1 2 2 2 
191 080617G 60 2 2 4 2 2 2 2  4 2 1 2 2 2 2 2 2 
192 072672G 60 1 2 3 2 1 1 2 22.3 5 4 2 1 2 2 2 2 2 
193 249632F 55 2 2 2 1 2 2 2 21.6 3 3 1 1 2 1 2 2 2 
194 150524D 14 1 2 2 1 2 2 2 18.1 3 2 1 2 2 1 1 2 2 
195 085000g 62 2 2 3 1 2 2 2 22.8 5 5 1 1 2 1 1 2 2 
196 072672g 60 1 2 3 1 2 1 2 22.3 5 4 1 1 2 1 1 2 2 
197 090632f 73 1 3 1 2 2 2 2 24.2 2 3 1 1 2 2 2 2 2 
198 091216g 46 1 1 16 1 2 1 2 24.2 3 2 1 2 2 2 2 2 2 
199 929757f 50 2 2 16 1 2 2 2  4 2 2 1 2 1 1 2 1 
200 929651f 54 2 2 4 2 2 2 2 20.6 3 2 1 1 2 2 2 2 2 
201 089101g 54 1 2 1 2 2 1 2 20.2 3 2 1 1 2 1 1 2 2 
202 883662F 54 1 2 11 2 1 2 2 21.1 3 2 1 1 2 2 1 2 2 
203 885050F 38 1 3 1 2 2 2 2 20.3 3 8 1 1 2 1 1 2 2 
204 878852F 49 1 2 2 1 2 2 2 25 4 2 1 1 2 1 1 2 2 
205 884792F 60 1 2 12 2 2 1 2 24.5 4 2 1 1 2 2 2 2 2 
206 042541G 57 1 2 1 1 1 1 2 17.9 4 4 1 1 2 1 2 2 2 
207 059225G 71 1 2 9 1 1 1 2  3 2 1 1 2 1 1 2 2 
208 057622G 54 1 2 3 2 2 2 2 17.3 5 6 1 1 2 2 2 2 2 
209 065692G 60 1 2 6 2 2 2 2 15.1 5 5 1 2 2 1 1 2 2 
210 063702G 63 1 2 2 2 2 2 2 21.9 5 5 1 1 2 1 1 2 2 
211 066811g 27 1 2 1 2 2 2 2 17.6 5 5 1 2 2 2 2 2 2 
212 056346g 60 1 2 3 1 1 1 2 22.2 5 6 1 1 2 1 1 2 2 
213 057521g 64 1 1 5 1 2 1 2 22.9 5 5 1 1 1 2 2 2 2 
214 916749F 46 1 1 13 1 2 1 2 18.4 4 2 1 2 2 1 2 2 1 
124 
 
215 036466G 70 2 2 4 1 2 2 2 16.4 4 3 1 1 2 1 2 2 2 
216 031162G 64 2 2 1 2 2 2 2 14.1 3 2 1 1 2 1 1 2 2 
217 033270G 48 1 3 3 2 2 2 2  4 2 1 1 2 1 2 2 2 
218 031022g 40 2 2 6 2 2 2 2 17.6 4 2 1 2 2 1 2 2 2 
219 877348f 57 1 3 1 2 2 2 2  4 5 2 1 2 1 1 2 1 
220 883476f 64 1 2 4 1 2 2 2 17.3 4 2 1 1 2 1 1 2 2 
221 386125d 64 1 2 2 2 2 2 2 22.4 3 8 2 1 2 2 1 2 1 
222 091790g 40 2 1 3 1 2 2 2 24.3 3 7 2 2 2 1 1 2 2 
 
hsp-hospital number, a-age, s-sex(1-male,2-female),sc-socioeconomic status(1-upper,2-
middle,3-lower), st-state(: 1-West Bengal, 2-Tamil Nadu, 3-Jharkhand, 4-Assam, 5-Kerala, 6-
Andhra Pradesh,7-Arunachal Pradesh, 8-Mizoram, 9-Bihar, 10- Orissa,11-Chattisgarh, 12-
Tripura, 13-Meghalaya, 14-Nagaland, 15-Sikkim,16-Karnataka, 17-Madhya Pradesh,18-Uttar 
Pradesh,19-Maharashatra and 20- Others),al-alcohol(1-yes,2-no),sm-smoke(1-yes,2-no),f-
family history(1-yes,2-no),ha-habitat(1-urban,2-rural),p-part involved(1-cervical (15-20 cm), 2-
upper (20-25 cm), 3-middle (25-30cm), 4-lower (30-40cm), 5- GE junction), A-Dysphagia(1-
yes,2-no),B-Weight loss(1-yes,2-no),C-Hematemesis(1-yes,2-No),D-vomiting((1-yes,2-no),E-
vomiting(1-yes,2-no),F-Odyanophagia(1-yes,2-no),G-Chest pain(1-yes,2-no ),b-biopsy(1-Well 
differentiated squamous cell carcinoma(SCC)2—Modertley differentiated SCC,3—Poorly 
differentiated SCC,4-Well differentiated adenocarcinoma,5-Moderately differentiated 
adenocarcinoma,6- Poorly differentiated adenocarcinoma,7-GIST , 8-NET 9- Lymphoma. 
Stomach carcinoma: 
sno hsp a s sc st ha al sm f BMI p b A B C D E F G H 
1 660636f 54 1 2 4 1 2 2 2 20.4 2 3 2 1 1 2 1 2 2 1 
2 648166f 28 2 3 1 2 2 2 2  2 3 2 1 1 1 1 2 2 2 
3 774654f 30 2 3 2 1 2 2 2 19.2 2 5 2 2 1 1 2 2 2 1 
4 631760f 43 1 3 4 2 2 1 2 18 1 5 2 2 1 1 2 2 2 2 
5 623834f 32 2 2 2 1 2 2 2  2 3 2 1 1 1 2 2 1 2 
6 630001f 75 2 2 5 1 2 2 2  2 2 2 1 1 1 1 2 1 2 
7 633859f 44 2 2 1 2 2 2 2 18.7 2 3 2 1 1 1 2 2 2 2 
8 627044f 74 1 2 1 1 2 1 2 21 2 1 2 1 1 1 1 2 2 2 
9 641458f 56 2 3 1 2 2 2 2 25.1 2 3 2 1 1 2 1 2 2 2 
10 646646f 60 2 3 6 2 2 2 2  2 3 2 1 2 2 2 2 1 2 
11 645479f 46 1 2 1 1 2 2 2  2 6 2 2 2 1 1 1 2 2 
12 645355f 46 1 3 1 2 2 1  20.5 1 2 2 2 1 1 1 2 1 2 
13 647526f 45 2 3 1 2 2 2 2 15.8 2 1 2 1 1 1 1 2 2 2 
14 657962f 34 1 3 2 2 1 1 2 18.2 1 3 2 1 1 2 1 2 1 2 
15 634842f 52 1 2 1 2 2 2 2 20.1 2 2 2 1 1 2 1 2 2 2 
16 659263f 53 2 2 1 1 2 2 2 20.4 2 3 2 1 1 1 1 2 1 2 
17 659536f 60 1 3 2 2 2 2 2 18.5 2 3 2 1 1 2 1 2 2 2 
18 037063f 62 1 3 2 2 1 1 2 26.9 2 3 2 1 1 2 1 2 2 2 
19 652216f 63 1 3 9 2 2 2 2 21 2 2 2 1 1 1 2 2 2 2 
20 665314f 37 1 3 4 2 2 1 2 21 2 2 2 1 1 1 2 2 2 2 
21 641527f 55 1 2 3 1 2 2 2 16.9 2 2 2 1 1 1 1 2 1 2 
125 
 
22 655078f 62 1 3 1 2 2 1 2 20.2 2 1 2 1 1 1 1 2 2 2 
23 659263f 53 2 2 1 2 2 2 2 18.2 2 3 2 1 1 1 1 2 2 2 
24 647360f 45 2 2 2 1 2 2 2  2 3 2 1 1 1 1 2 1 2 
25 656052f 58 1 3 1 2 2 1 2 18.4 2 3 2 1 1 1 2 2 2 2 
26 655365f 36 2 3 9 2 2 2 2 17.1 2 3 2 1 1 2 1 2 1 2 
27 663165f 54 2 3 1 2 2 2 2 18.5 2 6 2 1 2 1 1 1 1 2 
28 647669f 51 1 3 1 2 2 2 2 19.5 2 3 2 1 1 2 2 2 2 2 
29 650166f 39 1 3 1 2 1 1 2 17.6 2 1 2 1 1 1 1 2 2 2 
30 640554f 70 1 3 1 2 2 1 1 18.3 1 1 2 1 1 1 2 2 2 2 
31 650953f 67 1 3 1 2 2 1 2 19.6 1 3 1 1 2 2 2 2 2 2 
32 406211f 78 1 3 2 2 2 2 2 23.6 2 2 2 2 2 2 1 2 1 2 
33 361632b 63 1 3 2 1 1 1 2 20.3 2 2 2 1 1 1 2 2 1 2 
34 181813l 60 1 3 2 2 2 1 2  2 3 2 1 1 2 1 2 2 2 
35 363445f 29 1 3 6 2 2 2 2 25.1 2 3 2 1 1 1 1 2 2 2 
36 298777f 74 2 3 2 1 2 2 2 22.8 2 2 2 1 1 1 1 2 2 2 
37 697820f 37 2 3 1 2 2 1 2 17.3 2 3 2 1 1 1 2 2 1 2 
38 674713f 55 1 2 11 1 2 1 2 29.1 2 3 2 1 1 1 2 2 2 2 
39 705256f 53 1 3 3 2 1 1 2 21.8 2 4 2 2 2 2 2 1 2 2 
40 684829f 45 2 3 3 2 2 2 2 15.2 1 3 2 1 1 1 2 2 1 2 
41 680883f 28 2 3 1 2 2 2 2 27.8 2 3 2 1 1 1 1 2 2 2 
42 848828f 65 1 3 2 1 2 2 2 21 2 2 2 1 2 1 1 1 1 2 
43 853450f 65 1 2 1 1 2 1 2 18.7 2 2 2 1 1 2 1 2 2 2 
44 724548f 34 2 3 2 1 2 2 2 18.6 2 2 2 1 1 1 1 2 1 2 
45 904376f 47 1 3 1 2 1 1 2 21.6 2 2 2 1 1 2 2 2 1 2 
46 858556f 55 1 2 2 1 1 1 2 20 2 1 2 1 1 1 1 2 2 2 
47 840781f 51 1 2 7 1 2 1 2 20.1 2 2 2 1 1 1 2 2 1 2 
48 698273f 55 1 2 3 1 2 2 2 18.9 2 1 2 2 1 1 1 2 2 2 
49 699357f 34 1 2 6 1 2 2 2 22.6 1 3 1 1 1 2 1 2 1 2 
50 637210f 45 1 2 13 1 1 1 2 17.6 2 3 2 2 2 2 2 1 2 2 
51 792082f 42 1 3 2 1 2 1 2 18.4 2 3 2 1 1 1 2 1 1 2 
52 791303f 44 1 3 2 1 1 2 2 21.8 2 3 2 1 2 1 1 2 2 1 
53 753809f 55 1 3 1 2 2 2 2  2 3 2 1 2 1 2 2 2 2 
54 384552c 72 1 3 6 2 2 1 2 21 1 2 1 1 2 1 2 2 2 2 
55 427335f 71 1 3 2 2 2 2 2 17.8 2 3 2 1 1 1 2 2 1 2 
56 084179f 52 1 3 3 2 2 1 2 15.8 2 6 2 1 1 1 2 2 1 2 
57 433017f 66 2 3 1 2 2 2 2 27.2 2 2 2 1 2 1 1 2 1 2 
58 796827f 63 2 2 1 1 2 2 2 22.5 2 2 2 2 2 2 2 1 2 2 
59 796338f 39 1 3 1 2 2 1 2 21.2 2 2 2 1 2 2 1 2 2 2 
60 790277f 59 1 3 1 2 2 1 2 14.3 2 3 2 2 1 1 2 2 2 2 
61 793553f 54 1 2 2 1 1 1 2 20.2 2 2 2 1 1 1 1 2 2 2 
62 753587f 36 1 3 1 2 2 2 2 21 2 3 2 1 1 2 2 2 2 2 
63 868989c 77 1 2 2 1 2 1 2 18.9 2 3 2 1 1 1 1 2 1 2 
64 794342f 38 1 2 1 2 2 1 2 19.8 2 2 2 1 1 1 1 2 2 2 
65 794734F 35 1 3 1 2 2 1 2 21.4 2 3 2 1 1 1 1 2 2 2 
126 
 
66 260113L 70 2 3 2 2 2 2 2 21.2 2 2 2 1 2 1 1 2 2 2 
67 785979F 57 1 2 2 1 2 1 2 19.9 2 2 2 1 1 1 2 2 1 2 
68 850313 50 2 2 2 1 2 2 2 17.3 1 3 1 1 2 1 1 2 2 2 
69 783672F 61 2 3 3 2 2 2 2 24.9 2 3 2 1 1 1 1 2 2 2 
70 783649F 56 2 3 1 2 2 2 2 22.2 2 2 2 1 1 2 1 2 1 2 
71 319558B 78 1 3 2 1 2 2 2  2 2 2 1 1 1 2 2 1 1 
72 826005f 72 2 2 2 1 2 2 2 20.8 2 2 1 1 2 2 2 2 2 2 
73 827263f 77 1 3 2 2 2 2 2 16.8 2 3 2 1 1 2 1 2 2 2 
74 828655f 59 1 3 18 2 2 2 2 24.2 2 3 2 1 2 1 2 1 2 2 
75 836689f 54 2 3 1 2 2 2 2  2 3 2 1 1 1 2 2 2 2 
76 722270f 40 1 3 9 2 2 1 2 14.1 2 3 2 1 2 1 1 2 2 2 
77 725555f 62 1 3 3 2 2 2 2 16.2 2 2 2 1 1 1 1 2 2 2 
78 049848g 59 1 2 1 1 2 1 2 26.6 2 2 2 1 1 1 1 2 2 2 
79 728522c 72 2 2 2 1 2 2 2 18.2 2 3 2 1 1 1 1 2 2 2 
80 806132f 60 2 2 3 2 2 2 2 17.8 2 4 2 1 1 1 2 2 1 2 
81 814966f 61 2 3 4 2 2 2 2 14.8 2 2 2 2 1 1 2 2 2 2 
82 814180f 55 2 3 1 2 2 2 2 25.9 2 3 2 1 1 2 2 2 2 2 
83 807053f 50 1 2 1 1 2 1 2 18.9 2 3 2 1 1 1 2 2 1 2 
84 806212f 43 1 2 2 1 2 1 2 21.8 2 2 2 1 1 1 2 2 2 2 
85 759199f 29 1 2 2 2 2 1 2  2 1 1 1 1 1 1 2 1 2 
86 790134f 34 2 2 3 1 2 2 2 16.6 2 2 2 1 1 1 2 2 2 2 
87 819830f 76 1 3 2 1 1 1 2 18 2 2 2 1 1 1 2 2 1 2 
88 820957f 36 2 3 1 2 2 2 2 16.7 2 2 2 2 1 1 2 1 2 2 
89 748460f 48 2 3 1 2 2 2 2 22.2 2 5 2 1 1 2 1 2 2 2 
90 760611f 32 2 3 1 2 2 2 2 20.9 2 4 2 1 1 1 1 2 2 2 
91 742488f 51 1 2 2 1 2 2 2 18.6 2 1 2 1 1 1 1 2 1 2 
92 763912f 51 1 3 1 2 2 2 2 22.5 2 2 2 1 1 1 1 1 2 2 
93 743191f 53 2 2 9 2 2 2 2 20.7 2 2 2 1 1 1 1 2 2 2 
94 746010f 66 2 2 2 1 2 2 2 20.3 2 6 2 1 1 1 1 2 1 2 
95 471838f 41 2 2 4 1 2 2 2 20.1 2 6 2 2 1 1 1 2 2 2 
96 748504f 51 2 2 6 1 2 2 2 24.7 2 5 2 1 1 1 1 2 1 2 
97 909809c 47 2 2 2 1 2 2 2 18.4 2 2 2 1 1 1 1 2 1 2 
98 764748f 44 1 3 1 2 2 1 2 15.6 2 2 2 1 1 1 2 2 1 2 
99 854305d 26 2 3 1 2 2 2 2 18.8 2 3 2 1 1 1 1 2 2 2 
100 763988f 53 1 3 1 2 2 1 2 19 2 6 2 1 1 1 1 2 2 2 
101 766777f 55 1 3 2 2 2 1 2 18.4 2 2 2 1 1 1 2 2 2 2 
102 746222f 62 1 2 6 1 2 2 2 24.2 2 2 2 1 1 1 1 2 2 2 
103 141402f 77 1 3 6 2 2 1 2 18.5 1 3 1 1 2 1 1 2 2 2 
104 748460f 48 2 3 4 2 2 2 2 22.2 2 5 2 1 1 1 1 2 1 2 
105 748381f 68 1 2 2 1 2 1 2 21.2 2 2 2 1 1 1 2 2 2 2 
106 428980 68 1 2 2 1 2 2 2 31.6 2 2 2 1 1 1 1 2 2 2 
107 742230f 52 1 2 9 1 2 2 2 22.6 2 6 2 1 1 1 1 2 2 2 
108 727531f 56 1 3 18 1 2 1 2 22.8 2 2 2 1 1 1 1 2 2 1 
109 000670d 61 1 2 2 1 2 2 2 21.9 2 2 2 1 1 1 2 2 2 2 
127 
 
110 319558b 78 1 3 2 2 2 2 2  2 2 2 1 1 1 2 2 1 1 
111 802063f 52 1 3 9 2 2 2 2 25 1 2 2 1 1 1 2 2 1 2 
112 461311d 65 1 3 2 2 2 1 2 20.5 1 6 1 1 1 2 1 2 1 2 
113 798520f 54 1 3 1 2 2 1 2 17.8 2 3 2 1 1 1 1 2 1 2 
114 696392f 64 1 3 2 2 2 1 2 18.8 2 3 2 1 1 1 1 1 2 2 
115 779058f 66 1 2 2 1 2 2 2 26.5 2 2 2 1 1 1 1 2 1 2 
116 776280f 65 1 2 5 2 1 2 2 18.3 2 6 2 1 1 1 1 1 1 2 
117 779085f 65 1 2 1 1 1 2 2 22.6 2 1 1 1 2 1 1 2 2 2 
118 196036f 41 1 2 3 2 2 1 2 18.5 2 2 2 1 1 1 1 2 1 2 
119 775562f 45 1 3 1 2 2 1 2 22.3 2 2 2 1 1 1 1 1 2 2 
120 770359f 58 1 3 3 2 2 1 2 16.8 2 2 2 1 1 1 1 2 1 2 
121 750173f 26 2 2 2 2 2 2 2 19 2 2 2 1 1 1 1 2 1 2 
122 776387f 44 1 2 1 1 2 1 2 21.5 2 1 2 1 1 1 1 2 2 2 
123 772002f 46 2 2 10 1 2 2 2 19.4 2 3 2 1 1 2 1 2 2 2 
124 779408f 53 2 3 1 2 2 2 2 15.6 2 6 1 1 1 1 1 2 2 2 
125 770480f 66 1 2 2 2 2 1 2 19.3 2 1 2 1 1 1 1 2 2 2 
126 776996f 35 1 3 2 2 2 2 2 18.9 2 2 2 1 1 1 2 2 1 2 
127 774528f 30 2 2 1 1 2 2 2 15.2 2 3 2 1 1 1 1 2 1 2 
128 761907f 62 1 3 3 2 1 1 2 21.8 2 3 2 1 1 1 2 2 1 2 
129 698273f 56 1 2 3 1 2 2 2 21 2 1 2 2 1 1 1 2 2 2 
130 768632f 42 2 3 4 2 2 2 2 22.6 2 3 2 1 2 1 2 2 2 2 
131 710487f 44 1 3 6 2 1 1 2  2 2 2 1 1 1 1 2 2 1 
132 711198f 45 2 3 2 2 2 2 2 18.9 2 2 2 1 1 1 1 2 2 2 
133 704061f 43 1 2 2 1 1 2 2 21.3 2 2 2 1 1 1 1 1 2 2 
134 700110f 61 2 3 2 1 2 2 2 21.9 2 3 2 1 1 1 1 2 1 2 
135 727659f 57 1 3 1 2 2 1 2 19.7 2 2 2 1 1 1 1 2 1 2 
136 829971a 47 1 2 2 2 2 2 2 18.6 2 1 2 1 1 1 1 2 2 2 
137 744568f 57 1 2 1 2 2 2 2  2 2 2 1 1 1 1 2 1 2 
138 720511f 63 1 2 2 2 2 1 2 17 2 3 2 1 1 2 2 2 2 2 
139 722201f 43 1 3 1 2 2 2 2 16.4 2 2 2 1 1 1 1 2 1 2 
140 339833f 63 1 2 2 2 2 2 2 20.7 2 3 2 1 1 1 1 2 1 2 
141 717446f 68 1 3 1 2 2 1 2 17.1 2 1 2 1 1 1 1 2 1 2 
142 717669f 38 2 3 1 2 2 2 2 17.5 2 3 2 1 1 1 1 2 1 1 
143 722228f 47 1 3 1 2 1 1 2 21 2 3 2 2 1 1 1 1 1 2 
144 244013l 34 2 3 2 2 2 2 2  2 2 2 1 1 1 2 2 2 2 
145 781072f 64 2 3 2 2 2 2 2 17.9 2 3 2 1 1 1 2 2 1 2 
146 785311f 54 1 3 4 2 2 1 2 21.3 2 2 1 1 1 1 2 2 2 2 
147 812892f 55 2 3 2 2 2 2 2 18.3 2 1 2 1 1 1 1 2 1 2 
148 811271f 74 1 3 1 2 2 1 2 18.3 2 2 2 1 1 1 2 2 1 2 
149 810716f 54 1 3 1 2 2 1 2 16.6 2 2 2 2 1 2 2 2 2 2 
150 378189d 56 1 3 2 1 2 1 2 21.8 2 3 2 1 1 1 1 2 2 2 
151 808281f 50 1 2 1 1 2 2 2 25.7 2 6 2 2 1 1 2 2 2 2 
152 810201f 50 1 2 3 1 1 2 2 21.6 2 1 2 1 1 1 1 2 2 2 
153 798520f 54 1 2 1 1 2 1 2 21.2 2 3 2 2 1 1 2 1 2 2 
128 
 
154 799879f 55 1 3 1 2 2 1 2 18.3 2 1 2 1 1 1 1 2 1 2 
155 768496f 66 1 3 1 2 2 1 2 16.8 2 3 2 2 1 1 1 2 2 2 
156 320008f 56 2 3 1 2 2 2 2 16 2 3 2 1 1 1 1 2 2 2 
157 714077f 47 2 2 1 1 2 2 2 15.6 2 3 2 1 1 1 1 2 2 2 
158 401322f 56 1 3 2 2 2 1 2 23 2 3 2 1 1 1 1 2 2 1 
159 854560f 75 1 3 2 1 1 1 2 17.1 2 2 2 2 1 1 2 2 2 2 
160 904200f 64 2 3 2 2 2 2 2 17.8 2 2 2 1 1 1 2 2 2 2 
161 904801f 22 2 3 3 2 2 2 2 12.7 2 6 2 1 1 1 1 2 2 2 
162 864215f 53 2 2 2 1 2 2 2 22.3 2 3 2 1 1 1 1 2 2 2 
163 904854f 25 2 2 2 1 2 2 2  2 3 2 1 1 1 1 2 2 2 
164 861118f 27 2 3 1 2 2 2 2 17.8 2 3 2 1 2 1 1 1 2 2 
165 852385f 35 2 2 6 2 2 2 2 16.4 2 3 2 1 1 2 1 2 1 1 
166 713537F 74 2 3 6 2 2 2 2 21.8 1 2 2 1 2 2 2 1 2 2 
167 827610F 31 2 2 10 1 2 2 2 19.5 2 3 2 1 1 1 1 1 2 2 
168 824881F 55 2 1 5 1 2 2 2 27.1 2 4 2 2 1 1 2 2 2 2 
169 827432F 64 1 2 1 1 2 2 2 22.6 2 2 2 1 2 1 1 2 2 1 
170 812661F 40 2 3 3 2 2 2 2  2 3 2 1 1 1 1 2 1 2 
171 060583F 37 1 3 2 2 2 1 2 17.8 2 2 2 1 1 1 2 2 2 2 
172 748696f 66 1 2 1 2 2 1 2 21.5 2 3 2 1 1 1 1 2 1 2 
173 767019f 49 1 3 3 2 2 1 2 19.5 2 3 2 1 1 1 1 1 2 2 
174 839918f 54 1 2 4 2 2 1 2 17 2 2 2 1 1 1 1 2 2 2 
175 836695f 60 2 2 6 1 2 1 2 26.1 2 6 1 1 1 1 1 2 2 2 
176 837662f 40 2 2 2 2 2 2 2 20 2 3 2 1 1 1 1 1 1 2 
177 295539f 58 1 2 6 2 2 2 2 26.9 2 3 2 1 1 1 1 1 1 2 
178 865646f 52 1 2 9 2 2 2 2 17.6 2 3 2 1 1 1 1 2 1 2 
179 845485f 56 1 2 2 2 2 2 2 22.3 2 2 2 1 1 1 1 2 1 2 
180 262478c 57 2 3 2 2 2 2 2 23 2 1 2 1 2 1 1 1 1 2 
181 840877f 64 1 3 2 2 1 2 2 18.3 2 2 2 1 1 1 1 2 2 2 
182 852668f 55 1 3 3 2 2 2 2 16.9 1 3 2 1 1 1 1 2 1 2 
183 665287f 48 1 2 1 2 2 1 2 18.6 2 2 2 1 1 1 1 1 1 2 
184 324891f 54 2 3 2 2 2 2 2 30.4 1 2 2 1 2 1 1 2 2 2 
185 689606f 54 1 2 1 2 2 2 2 20.6 2 2 1 1 1 1 1 2 2 2 
186 028098b 72 2 2 6 2 2 2 2 31.6 2 3 2 1 2 1 1 2 2 2 
187 396828f 43 1 2 2 1 2 1 2 24.5 2 6 2 1 1 1 2 2 1 2 
188 679539f 63 2 2 2 2 2 2 2 16.8 2 3 2 1 1 1 1 2 1 2 
189 351555d 70 2 3 2 2 2 2 2 17.5 2 1 2 1 1 1 1 2 2 2 
190 668044f 44 1 3 4 2 2 2 1 17.6 2 2 2 1 1 1 1 2 1 2 
191 686658f 30 2 3 3 2 2 2 2  2 2 2 1 1 1 1 2 1 1 
192 643361f 70 1 3 9 2 2 1 2  2 2 2 1 1 1 1 2 1 1 
193 677157f 35 1 3 1 2 2 1 2 24.4 2 2 2 2 1 1 1 2 2 2 
194 685467f 65 1 3 1 2 2 1 2 25.2 2 3 2 1 2 1 1 2 2 2 
195 654636f 73 2 3 2 2 2 2 2 21.3 2 2 2 1 1 1 1 2 2 2 
196 660329f 50 2 3 2 2 2 2 2 20 2 3 2 1 1 1 1 2 2 1 
197 813601f 39 2 2 1 2 2 2 2 16.6 2 3 2 2 2 2 2 1 2 2 
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198 823704f 44 2 2 5 1 2 2 2 23.4 2 6 2 1 1 1 2 1 2 2 
199 706617f 41 1 2 3 2 1 2 2 17.8 2 3 2 1 1 1 1 2 2 2 
200 722695f 45 1 2 13 1 2 1 2 20.9 2 2 2 1 1 1 1 2 1 1 
201 725445f 57 1 2 1 2 2 2 2 19.3 2 3 2 1 1 1 1 2 1 2 
202 818330f 55 1 2 1 2 2 2 2 20 2 2 2 1 1 1 1 1 2 2 
203 822151f 49 1 2 1 2 2 2 2 17.3 1 3 2 1 1 1 1 2 1 2 
204 820325f 60 1 2 1 2 2 1 2 16.8 1 2 2 1 1 1 1 2 1 1 
205 814304f 68 1 2 3 2 2 1 2 16.8 2 2 2 1 1 1 1 2 1 2 
206 835472f 62 1 2 12 2 1 1 2 20.1 2 3 2 1 1 1 1 1 2 2 
207 838276f 47 1 2 1 2 2 1 2 17.9 2 2 2 1 1 1 1 2 1 2 
208 840390f 57 2 2 2 2 2 2 2 21.4 2 6 2 1 1 1 1 2 1 2 
209 873227f 58 1 2 3 2 1 1 2 16.8 2 2 2 1 1 1 1 2 1 2 
210 855062f 60 1 2 3 2 2 1 2 17.3 2 3 2 1 1 1 1 2 1 2 
211 868774f 60 1 2 2 2 2 1 2 22.8 2 2 2 1 1 1 1 2 2 2 
212 873010f 39 2 2 1 1 2 2 2 18.3 2 2 2 2 1 1 1 2 2 2 
213 865551f 53 2 2 1 2 2 1 2 20.8 2 2 2 1 1 1 1 1 1 2 
214 869105f 59 2 2 1 1 2 2 2 20.3 2 3 2 2 1 1 2 2 2 2 
215 805257f 75 1 2 2 1 1 2 2 16.9 2 2 2 1 1 1 1 2 2 2 
216 805003f 53 1 2 6 1 2 2 2 18.3 2 3 2 1 1 1 1 2 1 2 
217 685467f 65 1 3 1 2 2 1 2 19.2 2 3 2 1 1 1 1 2 2 2 
218 680883f 28 2 3 1 1 2 2 2 25.6 2 6 2 1 1 1 1 2 2 2 
219 654636f 73 2 3 2 2 2 2 2 23 2 2 2 1 1 1 1 2 2 2 
220 660329f 50 2 2 1 2 2 2 1 20.5 2 3 2 1 1 1 1 2 2 1 
221 028098b 72 2 3 6 2 2 2 2 18.5 2 3 2 1 1 1 1 2 2 2 
222 679539f 63 2 3 2 2 2 2 2 17.2 2 3 2 1 1 1 2 2 2 2 
223 351555d 70 2 3 2 1 2 2 2 18.6 2 1 2 1 2 1 2 2 1 1 
224 677157f 35 1 2 1 1 1 1 2 24.4 2 2 2 1 1 1 2 2 2 2 
225 668044f 44 1 2 4 2 2 2 2 16.6 2 3 2 1 1 1 2 2 2 2 
226 686658f 30 2 2 3 2 2 2 2  2 3 2 1 2 1 2 2 1 1 
227 643361f 70 1 3 9 2 2 2 2  2 3 2 1 2 1 1 2 1 1 
228 889358f 53 1 3 1 2 1 2 2 19.1 2 2 2 2 2 2 1 2 1 2 
229 890999f 52 1 3 1 2 2 2 2 19.1 2 3 2 1 1 1 1 2 1 2 
230 892418f 27 2 3 4 2 2 2 2  2 3 2 1 2 1 1 2 1 2 
231 846566f 71 2 2 2 1 2 2 2 31.8 2 3 2 1 2 1 1 2 1 2 
232 033082g 60 1 2 1 2 2 1 2 15.8 2 2 2 1 2 1 1 2 1 2 
233 912652f 70 2 2 2 2 2 2 2  2 3 2 1 1 1 1 2 1 1 
234 896317f 54 1 2 4 2 2 1 2  2 3 2 1 1 1 1 2 1 2 
235 002250g 60 1 2 4 2 2 1 2 17.2 2 2 2 2 1 1 1 2 2 2 
236 898865f 40 1 2 1 2 2 1 2 23.2 1 2 2 1 2 2 1 2 2 2 
237 905865f 72 1 2 2 1 2 1 2  2 2 2 1 1 1 1 2 2 2 
238 002178g 61 1 2 1 1 2 1 2 16.9 2 2 2 1 1 1 1 2 2 2 
239 011289g 34 2 2 5 1 2 2 2 16 2 3 2 1 1 1 1 2 2 2 
240 894809f 66 1 2 1 1 2 1 2 18.9 2 2 2 1 2 1 1 2 2 2 
241 926608F 30 1 3 10 2 1 1 2  2 3 2 1 1 1 1 2 1 2 
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242 079128G 57 1 2 10 1 2 1 2 27.3 2 3 2 2 1 1 2 2 2 2 
243 082882G 50 2 1 6 1 2 2 2 26.3 2 6 2 2 1 2 2 2 2 2 
244 080641G 35 1 3 3 2 1 1 2 15.2 2 3 2 1 1 1 1 2 1 2 
245 928173F 65 1 2 9 2 2 2 2 19 2 2 2 1 1 1 1 2 1 2 
246 095194G 43 1 2 3 2 1 2 2  2 2 2 1 2 1 1 2 1 2 
247 433436f 52 1 2 3 1 2 1 2 22.9 2 2 2 2 2 1 1 2 1 2 
248 085165g 48 1 2 18 2 2 2 2 24.7 2 1 2 1 2 1 1 2 1 2 
249 090539g 64 1 1 1 1 2 2 2 17.9 2 3 2 1 1 1 1 2 1 2 
250 584925d 61 1 3 1 2 2 2 2  2 2 2 2 2 2 2 1 2 2 
251 078250g 58 1 2 6 2 1 1 2  2 2 2 1 1 1 1 2 1 2 
252 093754g 55 2 2 4 2 2 2 2 19.2 1 3 2 1 2 1 1 1 2 2 
253 868872F 47 1 2 1 2 1 1 2 29 2 2 2 2 1 1 1 1 2 2 
254 885422F 44 1 2 1 1 2 1 2  1 2 1 1 1 1 1 2 1 2 
255 886539F 58 2 2 2 2 2 2 2  2 1 2 1 1 1 1 2 1 2 
256 888471F 39 2 2 3 2 2 2 2 20.4 2 4 2 1 1 1 1 1 1 2 
257 070955G 44 2 2 3 1 2 2 2 30.3 2 4 2 2 2 2 2 1 2 2 
258 738066B 60 2 2 2 2 2 2 2  2 3 2 1 1 1 1 2 2 2 
259 057563G 57 2 2 2 2 2 2 2 30 1 3 2 1 1 1 2 2 1 2 
260 064317G 48 1 2 1 1 2 2 2 21.1 2 2 2 2 2 1 1 2 1 2 
261 055595G 62 1 2 3 1 2 2 2  2 2 2 1 1 1 1 2 1 2 
262 062676G 42 2 2 3 1 2 2 2 13.8 1 3 2 1 1 1 1 2 1 2 
263 923677F 50 1 3 2 2 2 1 2  1 1 2 1 1 1 1 2 1 1 
264 070945F 61 1 2 12 2 2 2 2 22.4 2 3 2 1 1 1 1 2 1 2 
265 070647G 60 1 2 1 1 2 2 2 21.6 2 2 2 1 1 1 1 2 1 2 
266 068988G 72 1 3 1 2 2 1 2 14.3 2 3 2 1 1 1 1 2 1 2 
267 067055g 53 1 2 20 2 2 1 2  2 6 2 2 1 1 1 2 2 2 
268 062044g 66 1 2 1 1 2 2 2  2 3 2 1 1 1 1 2 2 2 
269 062780g 56 1 1 1 1 2 1 2  2 3 2 2 1 1 1 2 2 2 
270 059285g 62 1 2 3 1 2 1 2  2 3 2 1 1 1 1 1 2 2 
271 057563g 51 2 2 2 2 2 2 2 30 1 3 2 1 1 1 1 2 2 1 
272 922763f 60 1 2 2 1 2 1 2  2 3 2 1 1 1 1 2 1 2 
273 923345f 65 2 2 2 1 2 2 2  2 2 2 1 1 1 1 1 2 2 
274 063643G 48 1 2 1 1 1 1 2 19.2 2 2 2 1 1 1 1 2 2 2 
275 036653G 62 1 2 12 2 1 1 2  2 3 2 1 1 1 1 2 1 2 
276 040577G 30 2 3 1 2 2 2 2 28.9 2 3 2 1 1 1 1 2 1 2 
277 027131G 57 2 2 1 1 2 2 2  2 3 2 1 1 1 2 2 2 2 
278 029245G 69 1 1 3 1 2 1 2 24.2 2 3 1 1 1 1 1 1 1 2 
279 033132G 43 2 2 9 2 2 2 2 17.8 2 2 2 2 1 1 2 2 2 2 
280 042402G 44 2 3 12 2 2 2 2 19.2 2 3 1 1 1 1 1 2 2 2 
281 037513G 31 2 2 2 1 2 2 2 27.9 2 3 2 1 1 1 1 2 2 2 
282 036095G 65 1 2 6 2 2 2 2 14.5 2 3 2 1 1 1 1 2 1 2 
283 087913g 28 1 2 4 2 2 2 2  1 4 2 2 2 2 2 1 2 2 
284 030258g 63 1 2 9 1 2 2 2 21.6 2 6 2 1 1 2 1 2 2 2 
285 036035g 28 1 1 5 1 2 2 2 26.8 2 3 2 1 1 1 1 2 2 2 
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286 034418g 29 2 2 13 1 2 2 2 20.6 2 3 2 2 1 1 2 2 2 2 
287 029362g 58 1 3 2 2 1 1 2  2 3 2 1 1 1 2 2 2 2 
288 416346f 56 1 2 3 1 2 1 2 23.2 2 5 2 2 1 2 2 1 2 2 
289 870211f 40 1 3 3 2 2 2 2 12.8 2 2 2 1 1 1 1 1 1 2 
290 877140f 51 1 3 1 2 2 2 2 18.7 2 3 2 1 1 1 1 2 1 2 
291 880410f 65 1 3 1 2 2 2 2  2 2 2 2 2 1 1 2 2 2 
292 871601f 72 2 2 2 1 2 2 2 27.1 2 2 2 1 1 1 1 2 1 2 
293 879047f 33 2 2 3 1 2 2 2 32 2 3 2 1 1 1 1 2 1 2 
294 883190f 45 1 2 3 1 2 2 2 18.4 2 6 2 1 1 1 1 2 1 2 
295 884610f 43 2 3 3 2 2 2 2 16 2 6 2 1 1 1 1 2 2 2 
296 879478f 18 2 1 5 1 2 2 2  2 5 2 2 1 1 1 2 2 2 
297 095137g 85 2 2 2 1 2 2 2 22.2 2 6 2 2 1 1 2 1 2 2 
 
P-Part involved (1-proximal(cardia) 2- distal (fundus, body, and antrum), b-biopsy(1-Well 
differentiated adenocarcinoma,2-Moderately differentiated adenocarcinoma,3-Poorly 
differentiated adenocarcinoma,4-GIST , 5-NET 6- Lymphoma),A-dysphagia, B-weight loss ,C-
abdomen pain, D-vomiting, E-anorexia, F-hematemesis, G-early satiety, H-abdomen distension. 
Colonic tumor: 
sno hsp a s sc st hat al sm f BMI p b A B C D E F G CEA 
1 477739f 48 2 2 6 1 2 2 2 23.1 2 3 1 1 2 2 2 2 2 1 
2 685192f 52 1 2 1 1 2 1 2 20.3 6 1 2 1 2 2 2 2 1 1 
3 470717f 55 1 3 9 1 2 2 2 25.7 2 2 1 1 1 2 1 1 2 2 
4 683607f 66 1 2 3 2 2 2 2 18.9 6 1 1 1 2 2 1 2 2 2 
5 679172f 54 2 2 2 2 2 2 2 21.3 6 2 1 1 2 1 1 2 2 4 
6 644643f 65 1 3 1 1 2 2 2 25.8 1 2 1 1 2 1 1 2 2  
7 653108f 70 2 2 2 1 2 1 2 20.2 3 2 1 2 1 1 1 2 2 23 
8 485634f 81 1 2 2 1 2 2 2 19.6 3 1 2 2 1 2 2 2 2 2 
9 655876f 52 2 2 2 1 2 2 2 22.9 6 2 2 1 2 2 2 2 1 2 
10 478651f 46 1 2 1 1 2 1 2 17.6 1 3 1 2 1 1 2 2 2 1 
11 667760f 72 2 2 1 1 2 2 2  1 2 1 2 2 1 1 2 2 16 
12 668908f 60 1 2 4 1 2 1 2 20.2 3 2 1 1 1 1 2 2 2 179 
13 665399f 42 2 2 1 2 2 2 2 21.2 6 2 1 1 2 2 2 2 2 1 
14 670287f 56 2 2 5 1 2 2 2 23.5 2 2 1 1 2 2 2 2 2 11 
15 663239f 58 1 2 1 2 2 2 2 24.5 5 2 2 1 2 1 2 2 2 3 
16 658499f 66 1 2 1 2 2 2 2 20.1 6 2 1 1 2 2 1 2 2 2 
17 470874f 29 1 2 1 2 2 2 2 18.2 2 2 1 2 1 1 1 2 2 1 
18 655951f 49 2 2 1 1 2 2 2 20.1 6 2 2 1 2 2 2 1 2  
19 653361f 62 1 1 5 1 2 1 2 19.7 2 1 1 2 1 1 2 2 2 12 
20 659037f 26 1 2 1 1 2 2 2 20.9 6 3 1 1 2 1 1 2 2 5 
21 470874f 29 1 3 1 2 2 2 2 18.2 2 2 1 2 1 1 1 1 1 1 
22 647479f 35 1 3 1 1 2 2 2 22.5 6 1 2 1 1 2 2 1 1  
23 635556f 43 2 2 1 1 2 2 2  2 2 1 1 1 1 1 2 2 10 
24 635443f 56 1 2 1 1 2 1 2 21.5 1 2 1 2 2 1 1 2 1 76 
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25 622419f 39 1 3 1 2 2 2 2 18.3 5 7 1 1 2 1 1 2 2 2 
26 200873d 52 1 2 1 2 2 2 2 18.9 6 1 2 1 2 1 1 1 2 4 
27 641563f 57 1 3 2 1 2 2 1 20.3 6 2 1 1 2 2 2 2 2 12 
28 652461f 36 1 3 1 2 2 2 2  6 1 2 1 2 2 2 2 2 19 
29 649464f 48 1 2 4 2 2 2 2  2 2 2 1 1 1 2 2 2 18 
30 979879d 50 1 2 3 1 2 2 2 22.6 6 2 1 1 2 1 1 1 1 3 
31 106303l 47 2 3 2 2 2 2 2  2 2 1 2 2 1 1 2 2  
32 641797f 45 2 3 2 2 2 2 2 22.1 6 2 1 2 1 1 1 2 2 1 
33 636541f 35 2 2 3 1 2 2 2 18.6 6 2 2 1 2 1 1 2 2 5 
34 642644f 48 2 3 1 1 2 2 2 23.7 2 1 1 1 1 1 1 2 2 49 
35 636134f 72 1 2 2 1 1 1 2 24.7 6 1 1 1 2 1 1 2 2 54 
36 076369c 82 1 2 2 1 2 2 2 23 5 2 1 2 1 2 1 1 2 1 
37 644420f 34 2 3 12 2 2 2 2 17.8 6 2 1 1 2 2 2 2 2 2 
38 732999b 67 1 3 6 2 2 1 2 20.5 6 2 2 1 2 2 2 2 2 2 
39 674283f 53 2 2 13 1 2 2 2 28.9 1 2 1 1 2 1 2 2 1 103 
40 691388f 67 1 3 12 2 2 2 2 23.2 6 2 1 1 2 2 2 1 1 3 
41 689510f 38 2 2 2 2 2 2 2 17.1 2 2 1 2 1 1 1 2 2 56 
42 698098f 26 2 3 13 2 2 2 2 15.8 6 2 2 1 2 2 2 2 1 32 
43 288045d 65 1 3 2 2 2 1 2 22.2 6 3 1 2 2 1 1 2 2 14 
44 691810f 56 1 3 6 2 2 2 2 18.9 6 1 1 1 2 1 1 2 2 2 
45 683951f 38 1 1 19 1 2 2 2 21.4 6 2 1 1 1 1 1 1 2 5 
46 605974f 65 1 2 1 1 2 2 2 17.3 6 2 1 1 2 1 1 2 2 3 
47 812632f 18 1 3 1 2 2 2 2 17 3 3 1 2 1 1 1 1 2  
48 856491f 55 1 3 1 2 2 2 2 17.8 1 1 1 1 1 1 1 2 1  
49 847743f 44 1 2 1 1 2 2 2 22.9 2 2 1 1 2 2 1 2 2 2 
50 855745f 41 1 2 1 1 2 1 2 21.9 6 2 1 1 2 1 2 2 2 19 
51 847735f 73 1 3 6 1 2 1 2 22.1 6 2 1 2 2 1 1 1 2  
52 851149f 33 1 3 1 2 2 2 2 20 6 1 2 1 1 1 2 1 2 40 
53 842483f 39 2 2 1 1 2 2 2 28.4 1 3 1 2 2 1 1 1 2  
54 852395f 61 1 3 3 2 2 2 2 20 2 2 1 2 1 1 2 2 2 5 
55 682202f 23 2 3 3 2 2 2 2 19.8 6 2 2 1 2 1 1 1 2 7 
56 693348f 56 1 3 1 2 2 1 2 22.5 2 1 1 2 1 1 1 1 2  
57 850604v 64 1 2 2 1 2 1 2 20.2 6 2 1 1 2 1 1 2 2 2 
58 700004f 73 1 3 2 1 2 1 2 19.6 6 3 1 2 2 1 2 2 1 1 
59 790636f 58 1 3 1 1 2 2 2 18.7 6 1 1 1 2 1 2 1 2 7 
60 793698f 46 1 2 6 1 2 2 2 19.7 6 1 1 1 2 2 1 2 2 3 
61 994667d 69 2 2 5 1 2 2 2 20.3 6 1 1 1 2 2 1 1 2 4 
62 790105f 72 2 2 6 1 2 2 2 33.3 6 2 2 1 2 1 2 2 2 5 
63 785343f 75 1 2 2 1 2 1 2 22 6 3 1 2 2 2 1 1 1 4 
64 791347f 59 1 1 1 1 2 1 1 8.9 6 2 2 1 2 1 2 2 2 18 
65 788502f 42 1 3 3 2 2 2 2 22.2 2 2 2 2 1 2 2 2 2 3 
66 788297f 69 1 3 4 2 2 1 2 21.8 6 1 2 1 2 2 2 2 2 4 
67 787051f 58 1 3 3 2 2 2 2 19.6 2 2 1 1 1 1 2 2 2 27 
68 784630f 52 1 3 3 2 2 1 2 18.6 6 6 1 1 1 1 1 2 2  
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69 782770F 42 1 3 1 2 2 2 2 17.4 3 2 1 2 1 1 1 1 2 21 
70 784401F 47 1 3 3 2 2 2 2 18.9 3 3 1 1 1 1 1 2 2 2 
71 161544F 33 1 3 7 2 1 1 2 19.9 6 2 1 1 1 1 2 2 2  
72 676018f 32 2 3 3 2 2 2 2 27.1 6 3 1 2 2 2 2 1 2 109 
73 828437f 65 1 3 9 2 2 1 2 22.9 2 1 1 1 1 2 1 1 2 4 
74 834971f 52 1 2 3 1 2 2 2 17.8 1 6 1 1 1 1 1 2 1  
75 832260f 54 2 3 1 2 2 2 2  2 1 1 1 2 2 1 1 2  
76 723696f 35 1 3 1 2 2 2 2 19.8 4 2 1 2 1 1 1 1 2 5 
77 715459f 65 1 2 6 1 2 1 2 20 6 2 1 1 2 1 1 2 2  
78 788342f 40 1 3 2 2 2 1 2 18.3 6 2 2 1 2 2 2 2 2  
79 817698f 50 1 3 12 2 2 2 2 18.3 6 2 1 1 1 2 2 2 1 37 
80 346812c 67 1 3 1 2 2 1 2 21.1 2 2 1 1 2 2 2 2 2 13 
81 807551f 54 2 3 2 1 2 2 2 16.4 6 2 1 1 2 2 2 2 2 158 
82 814819f 75 2 2 1 1 2 2 2 21.3 6 3 1 1 2 1 2 2 2 2 
83 756668f 89 1 2 2 1 2 1 2  6 1 2 1 1 2 2 2 2  
84 808742f 48 2 2 3 1 2 2 2 26 3 1 1 1 2 1 1 1 2 2 
85 764223f 64 1 2 6 1 2 1 2 20.1 6 2 1 1 1 2 1 2 1 2 
86 746976f 61 1 2 1 1 2 1 2 18.7 6 2 1 1 2 1 2 2 2 10 
87 764223f 64 1 2 6 1 2 1 2 22 6 2 1 1 2 1 2 2 1 18 
88 778511f 37 1 2 3 1 2 2 2 20.8 2 2 1 2 1 1 1 1 2 1 
89 775589f 51 1 3 1 2 2 1 2 18.4 5 2 1 1 2 1 1 2 2 4 
90 781639f 43 2 3 1 2 2 2 1 19.8 1 1 1 1 1 1 1 2 2 1 
91 777784d 49 1 2 2 1 2 2 2 24.4 4 2 1 1 1 1 1 1 2 2 
92 769275f 61 2 1 2 1 2 2 1 25.1 2 1 1 1 2 1 1 2 2 12 
93 751192f 52 2 1 16 1 2 2 2 20.2 6 1 1 1 1 1 1 2 2  
94 684708f 54 2 2 5 1 2 2 2 21.5 2 1 1 2 1 1 1 2 2 7 
95 494052f 39 1 3 9 2 2 2 2 16.4 6 6 1 1 2 1 1 1 1  
96 700004f 73 1 2 2 1 2 2 2 22 6 3 1 2 1 1 1 2 1 1 
97 710858f 43 1 2 2 2 2 1 2 18.9 2 2 1 2 1 1 1 2 2 1 
98 682750c 63 2 2 2 1 2 2 2 21.5 6 2 1 1 2 2 2 1 2  
99 728434f 58 2 3 3 2 2 2 2 19.6 6 1 1 1 2 2 2 2 2 7 
100 729680f 44 1 3 13 2 2 1 2 15 6 1 1 1 2 1 2 2 2 2 
101 723696f 35 1 2 2 2 2 1 2 23.6 4 2 1 2 1 1 1 2 2 5 
102 704549f 34 2 2 2 1 2 2 2 19.6 6 1 1 1 1 1 1 2 2 2 
103 689546f 46 2 3 1 2 2 2 2 18.6 6 6 1 2 1 1 1 2 2  
104 708792f 58 1 3 1 2 2 1 2 21.5 5 2 1 1 2 1 1 1 1 2 
105 756352d 54 2 3 3 2 2 2 2 19.9 6 1 2 2 1 2 1 1 2 1 
106 779763f 55 1 2 1 1 2 1 2 21.2 3 1 1 2 1 1 1 2 2 68 
107 782770f 42 1 2 1 1 2 1 2 19.2 2 2 1 2 1 1 1 2 2 21 
108 784401f 47 1 3 3 2 2 1 2 20.6 1 2 1 1 1 1 1 2 2 2 
109 161544f 33 2 1 7 1 2 2 2 18.5 6 3 2 1 1 1 1 2 2 1 
110 806704f 58 2 2 1 1 2 2 2 17.3 6 2 1 2 2 1 2 2 2 5270 
111 814270f 36 2 2 1 2 2 2 2 17.4 4 2 1 1 1 1 1 2 1 1 
112 583041d 60 1 2 3 1 2 1 2 19.2 3 2 1 1 2 1 1 2 2 2 
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113 806268f 68 2 2 6 1 2 2 2 30.6 2 3 2 2 1 1 1 2 2 22 
114 610822c 52 1 2 1 1 2 1 2 21.3 6 1 1 1 2 2 2 1 2 3 
115 438717f 44 1 2 6 1 2 1 2 18.5 1 1 1 2 1 1 1 1 2 3 
116 004441f 46 1 2 1 1 2 1 2 20.3 2 2 1 1 1 1 1 1 1 4 
117 803540f 60 1 2 5 1 2 1 2 23.8 2 1 2 2 1 1 1 2 2 1410 
118 118818f 29 2 3 4 2 2 2 2 17.3 2 2 1 2 1 1 1 2 2 5 
119 881061d 48 1 2 1 1 2 1 2 24.6 5 1 2 1 1 1 2 2 2 10 
120 802543f 39 1 3 2 2 2 2 2 26.7 6 1 1 1 2 1 1 1 2 2 
121 788342f 40 1 3 2 2 2 1 2 18.3 6 2 2 1 2 2 2 2 2 3 
122 796426f 40 2 3 2 2 2 2 2 21.3 6 1 2 1 1 2 2 2 2 16 
123 794623f 45 1 2 1 1 2 1 2 19.8 3 2 2 2 1 1 1 1 2 16 
124 683167d 52 2 2 2 2 2 2 2 18.5 6 2 1 1 1 1 1 2 2 10 
125 662554d 53 1 3 1 2 2 1 2 19.3 3 2 2 1 1 1 1 1 2 9 
126 715154f 55 2 3 2 2 2 2 2  3 2 1 2 2 2 1 2 2  
127 715053f 52 1 2 5 1 2 2 1 23.1 6 2 2 1 2 1 1 2 2 4 
128 711570f 65 1 2 19 1 1 1 2 21.9 6 2 1 1 2 1 1 1 2 49 
129 705415f 69 1 3 1 2 2 2 2 23.8 6 2 1 1 2 1 1 2 2 1 
130 806366f 73 1 2 3 2 2 2 2 18.4 3 1 2 2 1 1 2 2 2 12 
131 858150f 30 2 2 1 2 2 2 2 16.2 5 2 2 2 1 1 2 2 2 20 
132 119193f 37 1 3 6 2 1 1 1 9.2 6 2 1 2 1 2 1 2 1 5 
133 306606b 54 1 2 1 2 2 2 2 24.7 1 1 1 2 1 2 1 2 1 5 
134 862427f 53 1 2 3 2 1 1 2 18 5 3 1 2 1 1 2 2 1 35 
135 857935f 42 1 2 1 1 2 1 2 17.9 2 2 1 1 1 1 1 1 1 2 
136 858010f 51 2 2 5 1 2 2 2 26.2 5 2 1 2 1 1 2 1 1 550 
137 851372f 61 1 2 3 1 2 2 2 23.4 6 2 1 2 1 1 1 2 2 196 
138 853138f 50 1 2 1 1 2 2 2  2 1 1 1 1 1 1 2 2 9 
139 770163F 61 1 2 3 2 2 1 2 19 2 2 1 2 2 1 1 2 2 381 
140 765967F 34 2 2 1 2 2 2 2 17.8 4 6 1 1 1 1 1 1 2 3 
141 805945F 54 1 2 1 1 1 1 2 14.5 5 2 1 2 1 1 1 2 2 544 
142 822711F 44 1 3 1 2 2 1 2 18.7 2 2 1 1 1 2 1 2 2 6 
143 831670F 62 1 2 5 1 2 1 2 23.1 6 2 1 2 2 2 1 1 2 10 
144 820761F 50 1 2 1 1 2 1 2 20.3 4 2 1 1 1 1 1 2 1 12 
145 825827F 47 1 2 1 2 1 2 2 18.9 6 2 1 1 2 2 1 2 2 12 
146 511468d 41 1 2 2 2 2 1 2 18.4 1 6 1 2 1 1 1 1 2  
147 740329f 60 2 2 2 2 2 2 2  2 2 1 1 2 1 1 2 2 6 
148 718630f 65 1 2 5 1 2 1 2 21.1 6 2 2 1 1 1 1 2 2 3 
149 764223f 64 1 2 6 1 2 1 2  6 2 1 1 2 1 1 2 2 18 
150 746876f 66 1 3 2 2 2 1 2 18.9 6 2 1 1 1 1 2 2 2 2 
151 661629f 71 2 2 2 1 2 2 2 26.5 1 2 1 2 2 2 1 2 2 4 
152 681047f 64 1 2 2 1 2 1 2 29.3 5 3 1 2 2 1 1 1 2 53 
153 678082f 62 1 2 3 2 2 1 2 19.8 5 2 1 2 1 1 2 2 2 10 
154 659010f 57 1 2 12 1 2 1 2 17.5 6 2 1 1 1 1 1 2 2 32 
155 902319f 58 1 2 1 2 2 1 2 18.4 2 3 1 1 1 2 1 2 2 8 
156 838237f 79 1 2 3 1 1 1 2 29.4 6 2 1 1 1 1 1 2 2 7 
135 
 
157 836910f 38 1 2 4 1 2 1 2 16.5 2 2 1 1 2 1 1 2 2  
158 272148f 60 1 3 4 2 1 2 2 22.6 1 2 1 2 1 1 1 1 2  
159 687385f 30 2 2 1 2 2 2 2 21.3 6 1 1 1 2 1 1 2 2 6 
160 675355f 75 2 2 2 2 2 2 2 21.4 2 6 1 2 2 1 1 1 2 3 
161 688102f 48 1 2 1 1 2 1 2 20.6 6 5 2 2 2 2 2 1 2  
162 821806f 69 1 2 12 2 2 2 2 18.9 6 2 1 1 2 1 1 2 2 27 
163 986441c 38 2 2 2 2 2 2 2 21 1 2 1 2 1 1 2 2 2 6 
164 799439f 42 1 2 1 2 2 1 2 27.7 1 2 1 2 2 2 2 2 1  
165 839744f 54 2 2 13 1 2 2 2 19.8 2 2 1 1 1 1 1 2 2 87 
166 844389f 68 1 2 2 2 2 2 2 33.4 1 1 1 1 1 1 1 2 2 12 
167 842405f 54 2 2 2 2 2 2 2 23 1 2 1 1 1 1 1 2 2 435 
168 865935f 54 1 2 1 2 2 2 2 17.3 6 6 1 2 2 1 1 1 2  
169 859978f 48 1 2 3 1 2 2 2 18.3 5 6 1 2 1 1 2 2 2  
170 865826f 35 2 2 7 2 2 2 2 30.2 6 2 1 1 1 1 1 1 2 9 
171 868441f 69 1 2 1 2 2 2 2 21.3 1 3 1 2 1 1 1 2 2 7 
172 686194f 59 2 2 1 2 2 2 2 18.9 6 1 1 1 2 1 1 2 2 9 
173 058095f 61 1 2 1 1 2 2 2  6 2 2 2 2 1 1 2 1 10 
174 860635f 73 1 2 1 2 2 2 2 22.4 5 2 1 1 1 2 1 2 1  
175 044059g 26 1 2 3 1 2 2 2 20.1 3 1 1 2 1 1 1 2 2  
176 896997f 39 1 2 1 2 2 1 2 26.6 4 2 1 2 2 2 2 1 2 8 
177 004889g 40 1 2 2 1 2 1 2  5 2 1 2 1 1 1 1 2 283 
178 003912g 66 1 2 1 2 2 2 2 19.6 6 5 1 2 1 1 1 2 2  
179 877598f 56 2 2 1 2 2 1 2 18.6 6 1 1 2 1 2 1 1 2 2 
180 898922f 55 2 2 2 2 2 1 2 22.2 2 2 1 2 2 1 1 2 2 58 
181 891441f 51 1 2 3 2 1 2 2  6 2 1 1 2 1 1 2 2 17 
182 076742g 49 2 2 1 1 2 2 2  6 2 1 1 2 2 2 2 2 4 
183 083142g 67 2 2 17 1 2 2 2 25.8 5 2 1 2 1 1 1 2 1 9 
184 267068f 40 2 3 1 2 2 2 2 16 6 2 1 1 2 1 1 2 1 2 
185 077311g 26 1 3 1 2 2 1 2 17 2 2 1 2 1 1 2 2 2 51 
186 075761G 48 2 2 1 2 2 2 2 16 2 6 2 2 1 2 1 1 2  
187 087641G 35 1 2 1 2 2 2 2 23 5 1 1 2 1 2 1 1 2 13 
188 095194G 43 1 2 3 2 1 2 2  6 1 1 1 2 1 1 2 1 7 
189 091282G 51 2 3 1 2 2 2 2 24.8 2 2 1 2 1 1 1 2 2 85 
190 088980G 30 2 3 1 2 2 2 2  6 2 1 1 2 1 1 1 1 21 
191 929075F 67 1 2 9 2 2 2 2  6 2 1 1 2 1 1 1 2 2 
192 888192F 56 1 3 4 2 2 2 2 20.5 6 2 1 1 2 1 1 1 1 2 
193 889081F 55 2 2 1 2 2 2 2  6 1 1 2 1 2 1 2 2 131 
194 882620F 49 1 2 3 1 1 2 2  6 2 1 1 2 1 1 1 2 2 
195 070882G 38 1 2 16 1 1 2 2 25.5 6 2 2 1 2 2 2 2 2 2 
195 056240G 69 1 1 5 1 2 2 2 20.7 6 2 1 1 2 1 2 2 2  
196 068021G 46 1 2 1 2 1 2 1  6 2 1 1 2 2 2 2 2 10 
198 717945B 72 1 3 2 2 2 2 2 20.4 6 1 1 1 2 2 2 1 1 2 
199 066850G 53 1 2 1 1 2 2 2  5 2 1 1 1 1 1 1 2 22 
200 061121G 25 2 2 3 1 2 2 2  6 3 1 1 1 1 1 2 2 1 
136 
 
201 060382g 62 1 1 3 1 2 2 2 16.3 6 2 1 1 2 1 1 2 2 3 
202 062799g 51 1 1 5 1 2 2 2 23.1 5 3 1 1 2 1 1 2 2 2 
203 062960g 58 1 2 1 2 2 2 2 22.7 2 1 1 2 1 1 1 2 2 17 
204 051275g 66 1 2 18 1 2 2 2  6 1 1 1 2 2 2 2 2 8 
205 057264g 54 1 2 1 2 2 2 2  6 3 1 1 2 2 1 2 2 8 
206 034798G 51 1 2 1 2 2 1 2 21.3 6 2 1 1 2 2 1 2 2 2 
207 030025G 36 1 2 1 2 2 2 2  6 3 1 1 1 1 1 1 2 4 
208 006928G 67 1 2 1 1 2 1 2  6 2 2 1 2 1 1 2 2 2 
209 043434G 35 2 3 1 2 2 2 2 18.9 5 6 1 1 1 1 1 1 2  
210 026094G 30 2 3 9 2 2 2 2 19 3 2 1 1 2 1 1 1 2 5 
211 086270F 59 2 3 6 1 2 2 2 23.8 6 2 1 1 1 1 1 2 2 3 
212 615997C 83 2 1 2 1 2 2 2  2 2 1 1 2 1 1 2 2 4 
213 028826G 49 1 1 2 1 2 1 2 26.7 6 2 1 1 1 2 2 1 2 2 
214 992034C 66 2 2 2 1 2 2 2  6 1 1 1 2 1 1 2 2 2 
215 036362G 61 1 2 2 1 2 2 2 25.6 5 2 1 1 1 2 2 2 2 1 
216 014821G 72 1 2 2 1 2 2 2  2 2 1 1 2 2 2 2 2 2 
217 030447G 51 2 3 1 2 2 2 2  6 1 2 1 2 2 2 2 2 12 
218 917006F 45 1 2 6 2 2 2 2  6 6 1 1 1 1 1 2 2  
219 028337G 62 1 3 1 2 2 2 2 24.5 2 2 1 2 1 2 2 2 2 4 
220 838364f 30 1 1 5 1 2 2 1 27.8 6 2 1 1 2 2 2 2 2 5 
221 908093f 55 1 1 5 1 2 2 1  4 2 1 2 2 2 2 1 1 167 
222 880808f 59 1 2 5 1 1 1 2 25 6 3 1 2 2 1 1 2 2 154 
223 881697f 38 1 2 1 1 2 2 2  6 3 2 1 2 2 1 2 2 175 
224 829658f 60 1 2 3 1 2 1 2 17.2 2 2 1 2 1 2 2 2 2 3 
225 909063f 48 1 3 4 2 2 2 2  6 2 2 1 2 2 1 1 1 550 
226 875881f 32 2 3 1 2 2 2 2  6 2 2 1 2 2 2 2 2 21 
227 122456f 53 2 3 2 2 2 2 2 23.5 6 2 2 1 1 2 2 1 2  
228 100136g 71 1 1 5 1 2 2 2 29 4 3 2 2 2 2 2 2 2 3 
229 095473g 46 2 2 9 1 2 2 2  2 2 2 1 1 1 1 1 2 43 
 
P-Part involved (1-cecum, 2-ascending, 3- transverse, 4- descending, 5-sigmoid ,6- rectum), b-
biopsy(1-Well differentiated adenocarcinoma,2-Moderately differentiated adenocarcinoma,3-
Poorly differentiated adenocarcinoma,4-GIST , 5-NET 6- Lymphoma),A-fatigue, B-bleeding, 
C-abdomen  pain, D-weight loss, E-loss of appetite, F-diarrhea, G-constipation. 
Small intestine: 
sno hsp a s sc st ha al sm f BMI p b A B C D E F G 
1 122416f 41 2 2 6 2 2 2 2 19.6 1 6 2 1 1 2 2 2 2 
2 642521f 52 1 2 3 1 2 2 2  1 1 1 1 1 2 1 2 2 
3 648305f 27 2 3 1 2 2 2 2  1 4 1 1 1 1 1 1 2 
4 651846f 58 1 3 1 2 2 1 2 23.1 1 1 1 1 1 1 2 2 2 
5 640335f 50 1 3 4 2 2 2 2 18.4 1 2 1 1 2 1 2 1 2 
6 853831f 30 1 2 3 1 2 2 2 18.7 1 1 1 1 1 1 2 1 2 
7 795041f 46 2 3 12 2 2 2 2 18 1 1 1 2 1 1 2 2 2 
137 
 
8 786856f 59 1 2 2 1 2 1 2  1 3 1 1 1 1 2 1 2 
9 812620f 53 2 2 6 1 2 2 2  1 2 1 1 1 2 2 2 2 
10 779335f 33 2 3 9 2 2 2 2 21.4 1 3 1 1 1 1 2 1 2 
11 729141f 30 2 3 1 2 2 2 2  1 2 1 1 1 1 2 1 2 
12 715707f 59 1 2 1 1 2 1 2 15.6 1 1 1 1 1 1 1 1 2 
13 807379f 49 1 2 1 2 2 2 2 22.3 1 4 2 1 1 1 2 1 2 
14 831629f 44 1 2 1 2 2 2 2 19.6 1 5 2 2 1 2 2 2 2 
15 795041f 46 2 3 12 2 2 2 2 18.9 1 1 1 1 1 1 2 1 2 
16 755648F 63 1 1 16 1 1 2 2 24.5 3 5 2 2 2 2 2 1 2 
17 850228f 66 1 2 1 2 2 1 2 19.8 1 5 1 1 1 1 2 1 2 
18 848596f 59 1 2 1 1 2 1 2 22.9 3 3 1 1 1 1 2 1 2 
19 004710f 38 1 3 3 2 1 2 2 19.6 1 6 1 1 2 1 2 2 2 
20 690596f 40 1 3 2 2 2 2 2 19.1 1 6 1 1 1 1 1 2 2 
21 845751f 55 1 2 12 2 2 2 2 15.6 1 2 1 2 1 1 2 1 2 
22 452277a 69 1 3 2 2 2 1 2 18.8 1 3 1 1 1 1 1 2 2 
23 868905f 52 1 2 3 2 2 2 2  1 5 1 1 1 1 2 2 2 
24 747106f 65 1 3 2 2 2 2 2 18.3 1 2 1 1 1 1 2 1 2 
25 690596f 40 1 2 2 1 1 2 2 21.4 1 6 1 1 1 1 2 2 2 
26 004710f 38 1 2 3 2 1 2 2 18.6 1 6 1 2 1 2 2 2 2 
27 892091f 45 2 2 3 2 2 2 2 16.9 3 5 1 1 1 1 2 2 2 
28 002055g 39 1 3 2 2 2 1 2 25.3 1 2 1 1 1 1 2 1 2 
29 058601g 50 1 2 1 1 2 2 2 21.1 1 2 1 1 1 1 2 1 2 
 
P-Part involved (1- duodenum, 2- jejunum, 3- ileum), b-biopsy(1-Well differentiated 
adenocarcinoma,2-Moderately differentiated adenocarcinoma,3-Poorly differentiated 
adenocarcinoma,4-GIST , 5-NET 6- Lymphoma),A-weight loss, B-abdomen pain, C-vomiting, 
D-anorexia, E-hematemesis, F-early satiety, G-abdomen distension.  
HCC: 
sno hsp age sex sces state habitat alcohol smoke BMI HBV-DNA A AFP 
1 098408f 70 1 2 2 1 2 2 27.8  2 490 
2 637333f 32 1 2 9 2 2 2   2 23400 
3 857190f 51 1 1 1 1 2 2 20  2 25 
4 864326f 71 1 2 6 1 2 2 23.6  2 2780 
5 852765f 41 1 2 1 2 2 2 19.7 139 2 3 
6 849764f 45 1 3 1 2 2 2 16.5 1000000 2 10800 
7 723796f 58 1 3 2 2 1 1 31.1  2 23 
8 868786D 66 1 1 10 1 2 2 23  2 4070 
9 778864F 51 1 2 16 1 2 2 25.9  2 4 
10 794009F 60 1 2 2 1 1 2   2 75 
11 855799F 57 1 2 5 1 1 1   2 1810 
12 987045C 47 1 2 2 1 2 2 28.8 5770 2 3 
13 872137F 60 1 3 2 2 1 1 20  2 77 
14 909432F 70 1 2 6 1 1 1   2 11300 
138 
 
15 833528f 54 1 2 2 1 2 2   1 74 
16 819487f 26 1 2 7 2 2 2  135 2 2050 
17 865734f 45 1 2 2 1 2 2 25.6  2 177 
18 749307f 49 2 2 11 1 2 2 16.9  2 16 
19 784812f 62 1 1 5 1 2 1 25.1  2 4 
20 865151f 26 2 2 1 1 2 2 32.8  2 94 
21 648058f 46 1 3 2 2 2 1 21.3  2  
22 874583f 62 1 3 6 2 1 1 20.6  2 67000 
23 578241b 54 1 2 2 1 2 1 21.3  2 5 
24 773997F 54 1 3 2 2 2 2 22.9 400000 2 38300 
25 136960c 61 1 2 2 1 2 2 34  2 95400 
26 831345f 50 1 3 2 2 2 1 18.4  2 30000 
27 901422f 29 1 2 2 1 2 2   2 8980 
28 687361f 34 1 3 1 2 2 1 24 2000000 2 12700 
29 281535f 46 1 2 2 1 2 2 26 8000000 2 7 
30 109941d 48 2 2 1 1 2 2 18.9 15 2 5040 
31 608850f 53 1 2 13 2 1 2 21.5  2 5 
32 665010f 33 2 2 3 2 2 2 20.1  2 983 
33 689020f 59 1 2 2 1 1 1 26.1 900000 2 25600 
34 691465f 78 2 2 3 1 2 2   2 9 
35 612267f 54 1 2 5 2 1 1 25.2  2 336 
36 693261f 39 2 2 9 2 2 2 22.8   42 
37 149873f 52 1 2 7 1 2 2 21.5 10  7 
38 670435f 55 1 2 1 2 2 2 23.7 10000000  300 
39 885590d 64 2 2 1 1 2 2 25.6  2 164 
40 658668f 69 1 2 2 1 2 2    4 
41 654821f 37 2 2 2 1 2 2 25.9   2 
42 264309f 34 1 2 6 1 2 2 25.8   56400 
43 643943f 63 1 2 2 1 2 2 24.7   11 
44 636154f 49 1 2 1 2 2 2 24 7000000  15600 
45 388231d 46 1 2 2 2 2 2  10  22 
46 917578d 53 2 2 10 1 2 2 20.8 44  10 
47 783864f 56 1 2 3 1 2 1 24.1   3 
48 692365f 74 1 3 1 2 2 2 20.7   59 
49 705978f 58 1 2 6 2 2 2 34.6   41 
50 706152f 55 1 2 3 2 2 1 21.3   1400 
51 698774f 57 1 2 3 1 2 2 21.8 70000  10600 
52 704070f 56 1 3 2 2 1 2 20.4 1000000  698 
53 719431f 72 1 2 3 1 1 2   1 266 
54 724611f 55 1 2 6 1 1 2 23.2   3980 
55 713728f 68 1 2 1 1 2 2 23.9   103000 
56 713957f 61 1 2 12 1 2 2 26.7   21700 
57 727223f 67 1 2 1 1 2 2 19.5   757 
58 728375f 56 1 2 1 2 2 1 16.5   1 
139 
 
59 759899f 45 1 3 2 2 2 1 20.5  2 5870 
60 806890f 53 1 2 3 2 2 2 25.7   1670 
61 849126f 63 1 2 1 2 2 2 26.3   6 
62 848157f 73 1 2 3 2 2 2    6170 
63 405136c 43 1 2 2 1 2 1 32.2   5 
64 818821f 47 1 2 9 2 2 2 25.2   300000 
65 816681f 55 1 1 5 1 2 2 28.1   3 
66 819487f 26 1 2 7 1 2 2 18.6 135  2050 
67 020715g 62 1 1 5 1 2 1 28.9  2 36700 
68 022608g 52 1 2 1 2 2 2 24.3   807 
69 830317f 56 1 2 1 2 1 1 25.5   10200 
70 460640c 40 1 1 7 1 2 2 18.7  2 215 
71 028278G 63 1 1 5 1 2 2 26.8   578 
72 802164f 38 2 2 6 2 2 1 21.8 9000  8990 
73 631013f 53 1 3 1 2 2 2 18.7  2 54 
74 429585f 70 1 2 2 1 2 2 28.5   24051 
75 627122f 80 1 2 10 2 2 2 20  2 724 
76 613795f 72 1 2 1 1 2 2 22  1 2 
77 440407f 48 2 2 1 1 2 2 28.2  2 5630 
78 315905c 62 2 3 1 2 2 2 23  2 64700 
79 384905f 76 2 2 13 2 2 2 27.6  2 5 
80 722377f 58 2 2 1 2 2 2 24.7  1 57400 
81 689384f 63 1 2 3 2 1 1 25  2 2 
82 385579f 73 1 2 5 1 2 2 25.1  2 253 
83 769890f 57 2 2 1 2 2 2 27  2 3960 
84 766374f 57 1 2 7 1 2 2 23  1 64 
85 727688f 63 1 2 5 1 2 2 29.4  2 10300 
86 885590d 64 2 2 1 2 2 2 27  2 164 
87 767139f 58 1 2 2 1 2 1 25.2  1 300000 
88 125666c 59 1 2 2 1 1 1 20.7   68 
89 295108f 55 1 1 5 1 2 1 30.2  2 3 
90 193445f 55 1 1 5 1 2 2 23.6  1 3 
91 947667c 69 2 1 2 1 2 2 22  2 2150 
92 791510f 76 1 2 2 2 1 1 18.7  1 34200 
93 783049f 58 2 2 3 2 2 1 26  2 56 
94 809196f 61 1 2 5 1 2 2 22  2 235 
95 816749f 31 1 2 1 2 2 2 19.9   123000 
96 247739f 58 1 2 2 1 1 1 20  2 1040 
97 821199f 65 1 2 1 2 2 2 22  2 2170 
98 908019f 66 1 2 5 1 1 2 25.3   68 
99 878997f 44 1 2 1 2 2 2 23.1  2 4250 
100 348065f 64 1 2 3 1 1 1 27.9  2 287 
101 461670d 78 2 2 6 1 2 2 22.1  2 4 
102 896239f 70 1 2 4 2 2 1 15.2  2 3 
140 
 
103 011946g 58 1 2 5 1 1 1 27.5  2 604 
104 774576f 54 1 2 1 1 2 1 24.5 10  1 
105 918201a 61 1 2 2 1 2 2 26.4   398 
106 794779f 44 1 2 2 2 1 1 22.3   37 
107 813877f 75 1 2 5 1 1 1 27.6   6 
108 711400f 71 1 2 5 1 2 2 22.6   2 
109 824771f 69 1 2 5 1 2 2 27.8   1480 
110 825851f 45 1 2 1 2 2 2 24.1   201 
111 833814f 48 1 2 3 1 1 1 19.5   11 
112 707466f 58 1 2 3 1 2 2 27.1 1000000  49 
113 858957f 65 2 2 19 1 2 2 17.6   1840 
114 873440c 54 1 2 5 1 1 2 25.1   47 
115 659209f 47 1 2 10 2 2 2    3730 
116 410060d 54 1 3 6 2 2 1 25.4 58  18600 
117 101794b 72 1 2 2 2 2 1 23.4   36 
118 798213c 27 1 2 2 2 2 2 21.3  2 74700 
119 657664f 52 1 2 2 1 2 1 23.1   275 
120 673248f 68 1 2 3 2 2 2    300 
121 675066f 62 1 2 2 1 2 2 26.7   166000 
122 728730f 36 1 2 1 2 2 1 18.9   2 
123 630583f 55 1 2 2 1 2 1 24.5 2000000  1500 
124 754258f 72 1 2 5 1 2 1 18.9  2 14600 
125 332235f 71 1 2 2 1 2 1    108 
126 390025f 61 2 2 1 1 2 2 21.5   49 
127 816589f 47 1 2 1 1 2 1 21.4 60000000  82900 
128 051720d 44 1 3 2 2 2 1 27    
129 630564c 36 1 2 1 2 2 2    47 
130 917566f 60 1 2 6 2 2 1 24.5   235 
131 858407f 59 1 1 6 1 2 1    1050 
132 005234g 64 1 2 1 2 2 1 19.1 500000  300000 
133 863297c 62 1 2 2 1 2 1   1 104 
134 869161f 44 1 2 2 1 2 1 23.3  2 2 
135 899406f 72 1 2 1 2 2 2 27.3   2 
136 914466f 63 1 2 2 1 2 1     
137 866779d 38 1 2 2 2 2 1 20.6 74  11700 
138 036038g 37 1 2 1 2 2 1 28.9 1000000  2810 
139 066244g 71 1 2 1 2 1 1 19   38000 
140 264309f 34 1 2 6 2 1 1    54600 
141 956819d 49 1 2 6 1 1 2 32  2 5 
142 036038g 37 1 2 1 2 2 2 25.7 1000000  2810 
143 073822g 50 1 2 2 1 1 1  138  12 
144 079884g 63 1 2 5 1 1 1 25.3   378 
145 089748g 57 1 2 6 1 1 2    10 
146 079877g 69 1 2 6 1 1 2    3 
141 
 
147 931365f 42 1 2 1 2 2 1    5390 
148 917402f 85 1 3 2 2 2 2    1700 
149 931055f 64 1 2 1 2 1 1 23.3   30800 
150 931637f 73 1 2 2 2 2 2 23.7   1350 
151 702979f 86 1 2 10 2 2 2    104 
152 878632f 58 1 2 1 1 2 2 19   87 
153 888149f 55 1 2 6 1 2 2 19.6   4610 
154 874499f 35 1 2 9 2 1 1 25   4 
155 890656f 64 1 3 1 2 2 2 21.4   148 
156 000065g 42 1 2 2 2 2 2    300 
157 001263g 66 1 2 5 1 2 1 26.1   9430 
158 899808f 52 1 2 11 1 2 2  300  1870 
159 894239f 58 1 3 1 2 2 2 22.2   75 
160 702901d 65 2 2 2 1 2 2 21   192 
161 016709g 61 1 2 9 2 2 2 19.4 90000  223 
162 035352g 62 1 1 5 1 1 1 26.6  2 1180 
163 920386f 76 1 2 5 1 2 2    1 
164 045451g 38 1 2 9 2 1 1 20.5 39  503 
165 037291g 61 1 2 6 1 2 2 23.2   6 
166 075055g 55 1 2 9 1 2 1 25.9  2 3 
167 089748g 57 1 2 6 1 1 1    10 
168 098257g 70 1 2 5 1 2 2    246 
169 110741g 48 1 2 5 1 1 1    152 
170 066067g 69 1 2 2 1 2 2 24.6   8870 
171 081649G 62 1 3 1 2 2 2    178 
172 103477g 58 1 1 5 1 1 1 22.3   7180 
173 103365g 56 1 3 1 2 2 2  4000000  2730 
174 901160f 57 1 2 7 1 2 2  10  13 
175 111491g 61 1 2 3 1 2 2 19.6   165 
176 922729f 50 1 2 8 2 1 1    300000 
177 856704d 66 1 1 5 1 1 2    4450 
178 836670d 32 1 2 1 1 2 2  57  10 
179 922021f 66 1 2 2 1 2 2    249 
180 936222f 58 1 2 10 1 2 2 27.7  2 2 
181 019601g 60 1 2 11 1 2 1 21  1 16200 
182 094318g 48 1 2 6 1 2 2 23.2   194 
183 126823g 67 1 1 5 1 2 1    38800 
184 118874g 58 1 2 4 2 1 1 20.3   93 
185 010206g 50 1 2 3 2 1 2 17.7   21200 
186 102233g 70 1 2 2 1 2 2 25.7   26400 
187 103365g 56 1 2 1 2 2 2  4000000  1480 
188 111491g 61 1 2 3 1 2 2 19.6   165 
189 620385f 61 1 2 2 1 2 2  1000  35 
190 601550f 75 1 1 2 1 2 2 29   2540 
142 
 
191 640858f 22 1 2 3 2 2 2    126000 
192 633395f 61 1 2 6 1 2 1 18.3 10  226 
193 648938f 48 1 2 1 1 2 2 19.2 20000  53000 
194 471010f 59 1 2 1 1 1 1 19.7   4 
195 661772f 60 2 2 9 1 2 2 22.2   207 
196 669469f 51 1 2 3 1 1 2 18.4   639 
197 676364f 65 1 3 4 2 2 2 20.7   98 
198 796025f 25 1 2 1 2 2 1 17.1   3580 
199 868354f 54 1 2 3 2 2 2 18.5   7 
200 711308f 38 1 2 5 1 2 2    73000 
201 714736f 51 1 2 6 1 2 2 17.5   904 
202 716120f 56 1 3 1 2 2 1 19.6   4 
203 722245f 65 1 1 11 2 2 1 22.9 27  1280 
204 728563f 60 1 2 2 1 1 2    300000 
205 926558f 77 1 2 6 2 2 2 21.5 690  4 
206 820802f 63 1 1 6 1 1 1 25.3   5 
207 806256f 70 1 2 2 1 2 2 23.7   4 
 
sno hsp A B C D E F G P M1 dg HBsAg HBeAg rfy R S M 
1 098408f 2 1 1 2 2 2 2 2 8 2 2 2 4 2 2 2 
2 637333f 1 1 1 2 2 2 2 1 9 2 2 2 1 2 2 2 
3 857190f 2 1 1 1 2 1 2 2 11 2 2 2 3 2 2 2 
4 864326f 2 2 1 1 2 1 2 2 25 2 2 2 3 2 2 2 
5 852765f 2 2 1 1 1 1 2 3 21 2 1 1 2 2 2 2 
6 849764f 2 1 1 1 2 1 2 2 15 2 1 2 2 2 2 2 
7 723796f 1 1 1 2 2 2 2 1 10 2 2 2 4 2 2 2 
8 868786D 2 1 1 2 2 2 2 1 9 2 2 2 4 2 2 2 
9 778864F 1 1 1 2 2 2 2 3 29 1 2  5 2 2 2 
10 794009F 1 1 1 2 2 2 2 2 8 1 1 2 2 2 2 2 
11 855799F 2 2 2 2 1 2 2 1 12 2 2 2 1 2 2 2 
12 987045C 2 2 2 1 2 2 2 2 12 2 1 2 2 2 2 2 
13 872137F 1 2 1 1 2 1 2 2 10 2 2 2 1 2 2 2 
14 909432F 2 2 1 2 2 1 2 3 18 2 2 2 1 2 2 2 
15 833528f 1 1 1 2 2 2 2   2 2 2 1 2 2 2 
16 819487f 2 2 1 2 2 2 2 1 7 1 1 2 2 2 1 1 
17 865734f 1 1 1 2 2 2 2 1 9 2 2 2 5 2 2 1 
18 749307f 1 1 1 1 2 2 2 3 12 2 2 2 5 2 2 2 
19 784812f 1 2 2 2 2 2 2   1 2 2 2 2 2 2 
20 865151f 1 1 1 2 2 2 2 1 7 2 2 2 5 2 2 2 
21 648058f 1 1 1 1 2 2 2   1 2 2 2 2 2 2 
22 874583f 1 1 1 2 2 2 2 1 8 2 1 2 2 2 2 2 
23 578241b 1 1 1 2 2 2 2 1 8 1 2 2 2 2 1 2 
24 773997F 1 2 1 2 2 2 2 1 13 2 1 1 2 2 2 2 
25 136960c 2 1 1 1 1 2 2 3 16 2 2 2 4 2 2 2 
143 
 
26 831345f 1 2 2 2 2 2 2 1 16 2 2 2 3 2 2 2 
27 901422f 1 2 1 1 1 1 1 3 16 2 2 2 5 2 2 2 
28 687361f 1 2 1 2 2 2 2 2 10 2 1 1 2 2 2 2 
29 281535f 2 2 1 1 2 1 2 1 13 2 2 2 2 2 2 2 
30 109941d 1 1 1 2 2 1 2 1 7 2 1 2 2 2 2 2 
31 608850f 2 2 1 2 2 1 2 2 19 1 2 2 1 2 2 1 
32 665010f 1 2 2 1 2 2 2 2 9 2 2 2 5 2 2 2 
33 689020f 1 1 1 1 2 1 2 2 13 2 1 1 2 2 2 2 
34 691465f 2 1 1 2 2 2 2 1 21 2 2 2 5 2 2 2 
35 612267f 2 2 1 1 1 1 2 2 16 1 2 2 1 2 2 1 
36 693261f 2 1 1 1 2 2 2 2 10 2 2  5 2 2 2 
37 149873f 2 2 1 2 2 1 2 1 8 2 1 1 2 2 2 2 
38 670435f 1 2 1 1 2 2 2 2 13 2 1 2 2 2 2 2 
39 885590d 2 2 1 1 2 1 2 1 12 2 2  4 2 2 1 
40 658668f 2 2 1 1 1 1 2 3 18 2 2  5 2 2 2 
41 654821f 2 2 1 1 2 2 2 3 11 2 2  5 2 2 2 
42 264309f 1 2 1 1 1 1 2 3 16 2 2  5 2 2 2 
43 643943f 2 1 1 1 2 2 2 2 16 2 1  2 2 2 2 
44 636154f 2 2 2 1 2 2 2 1 9 2 1 1 2 2 2 2 
45 388231d 2 1 1 2 1 1 2 1 12 2 1 2 2 1 1 1 
46 917578d 2 2 2 2 2 1 2 1 7 2 1 1 2 1 1 1 
47 783864f 1 2 2 2 2 2 2 2 6 1 1  4 2 2 2 
48 692365f 2 1 1 2 2 2 2 1 15 2 2  5 2 2 2 
49 705978f 1 2 2 2 2 2 2 1 7 2 2  4 2 2 1 
50 706152f 2 1 1 1 2 1 1 3 26 2 2  5 2 2 2 
51 698774f 2 2 2 1 2 2 2 3 21 2 1 1 2 2 2 2 
52 704070f 2 2 2 1 1 1 2 2 10 2 1 2 2 2 2 2 
53 719431f 2 2 1 1 2 1 1 3 20 2 2  1 2 2 2 
54 724611f 2 2 1 1 2 1 2 2 14 2 2  5 2 2 2 
55 713728f 1 1 1 2 2 1 2 2 17 2 2  3 2 2 2 
56 713957f 1 2 1 2 2 1 2 3 29 2 1 2 2 2 2 2 
57 727223f 2 2 1 1 2 2 2 1 10 2 2  3 2 2 2 
58 728375f 1 1 1 2 2 2 2   2   2 2 2 2 
59 759899f 1 1 1 2 2 2 2 1 10 2 2  5 2 2 2 
60 806890f 1 1 1 2 2 2 2 2 12 2 2  5 2 2 2 
61 849126f 1 2 1 1 2 1 2 2 12 2 2  5 2 2 2 
62 848157f 1 1 1 1 2 1 2 2 8 2 2 2 3 2 2 1 
63 405136c 1 2 2 2 2 2 2 1 10 1 2  4 2 1 2 
64 818821f 2 2 1 1 1 1 2 3 21 2 2  3 2 2 1 
65 816681f 2 1 1 2 2 1 2 2 17 2 2  4 2 2 1 
66 819487f 2 2 1 2 2 2 2 1 7 1 1 2 2 2 2 1 
67 020715g 2 1 1 2 2 2 2 1 8 2 2  4 2 2 2 
68 022608g 1 1 1 1 2 1 1 3 12 1 1 1 2 2 2 2 
69 830317f 1 2 1 1 2 2 2 3 10 2 2  5 2 2 2 
144 
 
70 460640c 2 2 1 2 1 2 2 2 16 1 2  5 2 2 1 
71 028278G 1 2 1 1 1 1 1 2 13 2 2  4 2 2 2 
72 802164f 1 1 1 2 2 2 2 1 8 1 1 1 2 2 2 2 
73 631013f 1 2 2 2 2 2 2 1 6 1 2  5 2 1 2 
74 429585f 1 2 2 2 2 2 2 1 13 2 2  5 2 2 2 
75 627122f 2 2 2 2 2 2 2 1 7 2 2  5 2 1 2 
76 613795f 1 1 1 2 2 2 2 1 10 2 2  2 2 2 2 
77 440407f 1 2 1 1 1 1 2 3 17 2 2 2 4 2 2 2 
78 315905c 1 1 1 2 2 2 2 2 13 2 2  5 2 2 2 
79 384905f 1 2 1 2 2 2 2 1 6 1 2  5 2 1 1 
80 722377f 1 1 1 2 2 2 2 1 9 2 2  1 2 2 2 
81 689384f 1 1 1 1 2 2 2 1 10 2 2  1 2 2 1 
82 385579f 2 2 1 1 2 2 2 1 16 2 2  4 2 2 2 
83 769890f 2 1 1 2 2 2 2 1 6 2 2  5 2 2 2 
84 766374f 2 1 1 2 2 2 2 2 13 2 2  5 2 2 2 
85 727688f 2 2 1 1 2 1 1 1 17 2 2  5 2 2 2 
86 885590d 2 2 1 1 2 1 1 2 12 2 2  4 2 2 2 
87 767139f 2 1 1 2 2 1 2 2 18 2 2  2 2 2 2 
88 125666c 2 1 1 1 1 1 2 3 23 2 2  1 2 2 2 
89 295108f 2 2 1 1 2 1 2 1 12 1 2  4 2 2 1 
90 193445f 1 2 1 1 2 1 1 2 12 1 2  4 2 2 1 
91 947667c 2 2 1 2 2 1 2 1 9 2 2  5 2 2 1 
92 791510f 2 2 1 1 2 2 2 2 12 2 1  2 2 2 2 
93 783049f 1 1 1 2 2 2 2 1 7 2 2  5 2 2 2 
94 809196f 2 1 1 1 2 2 1 3 18 2 2  4 2 2 2 
95 816749f 1 1 1 1 2 1 2 2 12 2 2  5 2 2 2 
96 247739f 2 1 1 2 2 2 2 1 9 2 2  5 2 2 2 
97 821199f 1 1 1 2 2 1 2 1 9 1 2  5 2 2 2 
98 908019f 2 2 1 1 1 2 2 1 13 2 2  1 2 2 2 
99 878997f 2 2 2 1 1 2 2 1 6 2 2  5 2 2 1 
100 348065f 2 1 1 1 1 1 2 1 7 2 2  1 1 2 1 
101 461670d 2 1 1 1 1 1 2 1 7 2 2  4 2 2 1 
102 896239f 1 1 1 2 2 2 2 1 8 2 2  5 2 2 2 
103 011946g 2 1 2 2 1 2 2 1 12 2 2  1 1 2 1 
104 774576f 2 1 1 2 2 2 2 2 14 2 1 2 2 2 2 1 
105 918201a 2 1 1 2 2 2 2 1 10 2 2  3 2 2 2 
106 794779f 1 1 1 2 1 2 2 1 10 2 1 2 2 2 2 2 
107 813877f 1 1 1 2 2 1 2 1 10 1 2  1 2 2 2 
108 711400f 2 2 2 2 2 2 2 1 8 2 2  5 2 2 2 
109 824771f 1 1 1 2 2 2 2 1 14 2 2  4 2 2 2 
110 825851f 1 1 1 2 2 2 2 1 10 1 1 1 2 2 2 2 
111 833814f 2 2 1 1 2 2 2 2 13 2 2  3 2 2 1 
112 707466f 2 1 1 2 2 2 2 1 10 2 1 1 2 2 2 2 
113 858957f 1 1 1 2 2 2 2 1  1 1  2 2 2 2 
145 
 
114 873440c 2 1 1 2 2 1 2 1 7 1 1 2 2 2 2 1 
115 659209f 2 2 1 1 1 1 2 3 15 2 2  5 2 2 1 
116 410060d 2 2 1 1 2 2 2 3 9 2 1  2 2 2 2 
117 101794b 2 1 1 2 2 2 2 1 10 1 2  3 2 2 2 
118 798213c 2 2 1 2 2 2 2 1 12 2 2  5 2 2 2 
119 657664f 2 2 1 2 1 2 2 1 9 2 1 2 2 2 2 2 
120 673248f 1 1 1 1 2 2 2 3 16 2 1  2 2 2 2 
121 675066f 2 1 1 1 1 1 2 3 31 2 2  4 2 2 1 
122 728730f 1 1 1 2 2 1 2 2 13 2 1 2 2 2 2 2 
123 630583f 1 2 1 1 2 2 2 3 25 2 1 2 2 2 2 2 
124 754258f 2 1 1 2 2 2 2 1 12 2 2  5 2 2 2 
125 332235f 2 1 1 1 2 2 2 2 9 2 1 1 2 2 2 2 
126 390025f 2 1 1 1 2 1 2 1 9 2 2  4 1 2 1 
127 816589f 1 1 1 1 2 1 2 3 18 2 1 2 2 2 2 2 
128 051720d 1 1 1 1 2 1 2 2 13 2 1  2 2 2 2 
129 630564c 2 1 1 2 1 1 2 3 22 2 2  5 2 2 2 
130 917566f 1 1 1 1 2 1 2 3 10 2 1  2 2 2 2 
131 858407f 1 1 1 1 2 1 1 3 24 2 1  2 2 2 2 
132 005234g 1 2 1 1 2 2 2 3 15 2 1 1 2 2 2 2 
133 863297c 2 2 1 1 1 1 2 3 32 2 2  1 2 2 2 
134 869161f 1 2 1 1 1 2 2 1 6 2 2  5 2 2 2 
135 899406f 2 2 1 2 2 2 2 1 8 2 2  5 2 2 2 
136 914466f 2 2 2 2 2 2 1 3 36 2 2  3 2 2 2 
137 866779d 2 2 1 2 2 2 2 2 10 2 1 2 2 2 2 2 
138 036038g 2 2 1 2 1 1 2 1 8 2 1 1 2 1 2 1 
139 066244g 1 1 1 2 2 2 2 2 12 2 2  4 2 2 2 
140 264309f 2 2 1 1 2 1 2 3 15 2 2  1 2 2 2 
141 956819d 2 2 1 1 1 1 2 2 12 2 2  1 1 2 1 
142 036038g 2 2 1 2 1 1 2 1 10 2 1 1 2 1 2 1 
143 073822g 1 1 1 2 2 2 2 1 8 2 1 2 2 2 2 2 
144 079884g 2 1 1 2 2 2 2 1 7 2 2  1 2 2 2 
145 089748g 1 1 1 1 2 1 2 3 14 2 1 2 2 2 2 1 
146 079877g 2 2 1 1 2 1 2 1 10 2 2  1 2 2 1 
147 931365f 2 1 1 1 2 1 2 2 31 2 1  2 2 2 2 
148 917402f 2 2 1 1 2 2 2 2 10 2 1  2 2 2 2 
149 931055f 2 2 1 1 2 1 1 3 22 2 2  1 2 2 2 
150 931637f 1 1 1 2 2 2 2 1 10 2 2  3 2 2 2 
151 702979f 1 1 1 2 2 2 2 1  2 2  5 2 2 2 
152 878632f 2 1 1 2 2 2 2 1 10 2 1  2 2 2 2 
153 888149f 1 1 1 2 2 2 2 1 10 1 2  5 2 2 2 
154 874499f 1 1 1 2 2 2 2 2 16 2 2  2 1 2 1 
155 890656f 2 1 1 2 1 1 2 2 12 2 2  3 2 2 2 
156 000065g 1 1 1 2 2 2 2 1 10 2 1  2 2 2 2 
157 001263g 2 2 1 2 2 2 2 1 10 2 1  2 2 2 2 
146 
 
158 899808f 2 1 1 1 2 1 2 3 32 2 1 2 2 2 2 2 
159 894239f 1 1 1 1 2 2 2 2 11 2 2  5 2 2 2 
160 702901d 2 1 1 2 2 2 2 2 12 2 2  3 2 2 1 
161 016709g 1 1 1 1 2 1 2 2 12 2 1 2 2 2 2 2 
162 035352g 2 2 2 2 2 2 2 1 11 2 2  1 2 2 1 
163 920386f 2 1 1 1 2 1 2 3 17 2 2  4 2 2 2 
164 045451g 2 2 1 2 2 2 2 1 10 2 1 2 2 2 2 2 
165 037291g 2 2 1 2 2 2 2 1 9 2   3 1 2 1 
166 075055g 2 1 1 2 2 2 2 2 15 2 2  5 1 2 1 
167 089748g 1 1 1 1 2 2 2 1 10 2 1  2 2 2 1 
168 098257g 2 1 1 2 2 2 2 1 9 2 1  2 2 2 2 
169 110741g 2 1 1 2 2 2 2 1 9 2 2  1 2 2 2 
170 066067g 1 1 1 2 2 2 2 1 9 1 2  5 2 2 1 
171 081649G 2 1 1 2 2 2 2 1 10 1 2  4 2 2 2 
172 103477g 1 2 2 2 2 2 2 1 8 2 2  1 2 2 2 
173 103365g 1 2 2 2 2 2 2 2  2 1 1 2 2 2 2 
174 901160f 1 1 1 2 2 2 2 2 12 2 1 1 2 2 2 2 
175 111491g 1 1 1 2 2 2 2 1 10 2 2  4 2 2 2 
176 922729f 1 2 1 1 2 2 2 2 14 2 2  3 2 2 2 
177 856704d 1 2 1 1 1 1 2 3 14 2 2 2 1 2 2 2 
178 836670d 2 1 1 1 2 1 2 3 16 2 1 2 2 2 2 2 
179 922021f 1 2 1 1 1 2 2 3 17 2 2  5 2 2 2 
180 936222f 1 1 1 1 2 1 2 3 24 2 2  5 2 2 2 
181 019601g 1 1 1 2 2 2 2 1 8 2 2  2 2 2 2 
182 094318g 2 2 2 2 2 2 2 1 7 2 2  3 2 2 1 
183 126823g 2 2 1 2 2 1 2 1 8 2 1  2 2 2 2 
184 118874g 2 1 1 2 2 2 2 1 8 2 2  1 2 2 2 
185 010206g 1 1 1 2 2 2 2 1 8 2 2  1 2 2 2 
186 102233g 1 1 1 2 2 2 2 1 8 2 2  4 2 2 2 
187 103365g 1 2 1 2 2 2 2 1 7 2 1 1 2 2 2 2 
188 111491g 2 2 2 2 1 2 2 1 8 2 2  1 2 2 2 
189 620385f 1 1 1 2 2 2 2 2 14 2 1 1 2 2 2 2 
190 601550f 1 1 1 2 2 1 2   2 2  4 2 2 1 
191 640858f 1 1 1 2 2 2 2 1 8 2 1 1 2 2 2 2 
192 633395f 2 2 2 2 2 1 2 1 8 2 1 2 2 1 2 1 
193 648938f 1 2 1 1 1 1 2 2 16 2 1 2 2 2 2 2 
194 471010f 1 1 1 2 2 2 2 1  2 2  5 2 2 2 
195 661772f 2 1 1 2 2 2 2 2 17 2 2  3 2 2 2 
196 669469f 2 1 1 1 2 1 2 3 9 2 2  3 2 2 2 
197 676364f 2 2 1 1 2 2 2 2 8 2 2  5 2 2 2 
198 796025f 1 1 1 1 2 2 2 1 9 2 2  5 2 2 2 
199 868354f 2 2 1 1 1 2 2 1 7 2 2  4 2 2 1 
200 711308f 1 2 2 1 2 1 2 2  2 1  2 2 2 2 
201 714736f 1 2 2 2 2 2 2 1 8 1 2  3 2 2 2 
147 
 
202 716120f 1 1 1 2 2 2 2 1 8 1 2  5 2 2 2 
203 722245f 2 1 1 2 2 2 2 1 6 2 1 1 2 2 2 2 
204 728563f 1 1 1 2 2 2 2   2 1  2 2 2 2 
205 926558f 1 1 1 2 2 2 2 2 8 2 1 2 2 2 2 2 
206 820802f 2 2 1 1 2 2 2   2 1  2 2 2 2 
207 806256f 2 2 2 2 2 2 2 2 13 2 2  5 2 2 1 
 
A-Anti-HBcAb(1-+ve,2-ve),rfy-etiology(1-Alcohol,2-HBV,3-HCV,4-NAFLD,5-Cryptogenic,6-
other),P-CTP-1-classA,2-B,3-C,dg-diagnosis(1-biopsy,2-radiological),HBsAg(1-+ve,2-ve),M1-
MELD score, HBeAg(1-+ve,2-ve), A-abdomen pain, B-weight loss, C-weakness, D-abdomen 
distension, E-hematemesis, F-jaundice, G-altered sensorium, R-RFA,S-surgical candidate, M-
Milan criteria,  
Gall bladder carcinoma: 
sno hsp a s sc st ha al sm f BMI dg rfy CA19-9 
1 683365f 65 2 2 16 1 2 2 2  2  4440 
2 475013f 48 1 3 3 2 2 1 2 19.1 2  250 
3 654537f 43 2 3 1 2 2 2 2  2   
4 662543f 53 2 2 1 1 2 2 2  1  19 
5 685533f 47 2 3 1 2 2 2 2 18.9 2  454 
6 625542f 58 1 2 3 1 1 2 2 20.8 1   3 
7 824302f 56 2 3 1 2 2 2 2 15.1 2 1 2700 
8 856045f 80 2 2 13 2 2 2 2 19.9 1  176 
9 785243F 53 2 2 8 1 2 2 2 18.9 1   
10 723370f 55 1 3 1 2 2 2 2 20.2 1 1 12300 
11 837997f 56 2 2 18 1 2 2 2 31.2 1 1  
12 818472f 84 1 2 6 1 2 2 2  1  2700 
13 901866f 49 2 3 3 2 2 2 2  1 1  
14 772057f 43 2 2 3 1 2 2 2 18.4 1   
15 974915c 64 2 2 2 2 2 2 2 23.3 1  9 
16 710676f 56 1 3 1 1 2 2 2 19.9 2   
17 781929f 59 1 3 5 2 2 1 2  1   
18 781419f 54 2 3 3 2 2 2 2 17.8 2 1 421 
19 835786f 39 2 2 2 1 2 2 2 26.6 2  111 
20 709122f 61 2 2 1 2 2 2 2 17.2 1 1 273 
21 814633f 65 1 2 3 1 2 1 2 21 1   
22 835093f 62 2 2 1 2 2 2 2 17.1 1 1  
23 839229f 45 1 3 3 2 2 2 2  2 1  
24 690848f 56 1 3 1 2 2 1 2 17.7 1  135 
25 686412f 50 2 2 1 2 2 2 2 21.1 2 1 315 
26 988635c 71 1 2 1 2 2 2 2 19.2 2  2 
27 701312f 48 1 2 1 2 2 1 2 25.8 2   
28 722726f 30 1 3 9 2 2 1 2 17.6 2   
148 
 
29 719819f 42 2 3 3 2 2 2 2 20 1 1 2 
30 718860f 45 2 2 1 2 2 2 2 15.2 2  923 
31 852161f 39 2 3 3 2 2 2 2 13.1 1 1 19 
32 846077f 84 1 2 3 2 2 1 2  2  68 
33 835857f 54 2 2 11 2 2 2 2 16.8 1  1066 
34 839229f 45 1 2 3 2 2 2 2 23.4 2 1  
35 835093f 62 2 2 1 2 2 2 2 17.1 1 1  
36 806180f 54 1 1 5 1 2 2 2 22.9 2 1 63 
37 849591f 54 2 2 1 2 2 2 2 24.2 2 1 20000 
38 818849f 65 2 2 9 2 2 2 2 21.3 2 1 9 
39 774811f 46 2 2 1 2 2 2 2 26.6 2  3 
40 655856f 53 2 2 1 1 2 2 2 20.7 2   
41 729038c 52 1 2 1 2 2 2 2 23.5 1  30 
42 881549f 52 1 2 3 2 2 2 2  2   
43 888054F 46 2 2 3 1 2 2 2 21.1 1 1 1000 
44 909942f 57 1 2 1 1 1 1 2  1  20000 
45 029995g 38 2 2 9 1 2 2 2 16.6 1  2480 
 
sno hsp A B C D E F G H O M 
1 683365f 1 1 1 1 1 2 1 2 2 1 
2 475013f 1 1 1 1 1 2 1 2 1 2 
3 654537f 1 1 1 1 1 1 2 2 2 2 
4 662543f 1 1 1 1 2 2 2 2 2 1 
5 685533f 1 1 2 1 2 2 2 2 2 2 
6 625542f 1 1 2 1 2 2 1 2 2 1 
7 824302f 1 2 1 2 1 2 1 2 2 1 
8 856045f 1 1 1 2 2 2 1 2 2 1 
9 785243F 1 1 1 2 1 2 2 2 2 2 
10 723370f 1 1 1 2 1 2 2 2 2 2 
11 837997f 1 1 1 2 2 2 2 2 2 2 
12 818472f 1 2 1 2 1 2 2 2 2 2 
13 901866f 1 1 1 1 1 2 2 2 2 1 
14 772057f 1 1 1 1 1 1 1 1 2 2 
15 974915c 1 1 1 2 2 2 1 2 2 2 
16 710676f 1 2 1 1 1 2 1 2 2 2 
17 781929f 1 1 1 1 1 1 1 2 2 1 
18 781419f 1 1 1 2 1 1 1 2 2 2 
19 835786f 2 2 2 2 2 2 2 2 2 2 
20 709122f 1 2 1 1 1 1 2 2 2 1 
21 814633f 1 1 1 1 1 1 1 1 2 2 
22 835093f 1 1 1 2 1 2 2 2 2 1 
23 839229f 1 1 1 1 1 2 1 2 2 2 
24 690848f 1 1 1 1 1 2 1 2 2 1 
25 686412f 1 1 2 1 1 2 1 2 2 2 
149 
 
26 988635c 1 1 1 2 1 2 1 2 2 2 
27 701312f 1 1 1 1 1 2 2 2 2 2 
28 722726f 1 2 1 1 1 2 2 2 2 2 
29 719819f 1 1 1 1 1 1 1 2 2 2 
30 718860f 1 1 1 1 1 2 1 2 2 1 
31 852161f 1 1 1 1 2 2 1 2 2 1 
32 846077f 1 1 1 1 1 2 1 2 2 1 
33 835857f 1 1 1 1 1 2 1 2 2 1 
34 839229f 1 1 1 1 1 1 2 2 2 2 
35 835093f 1 1 1 1 2 2 2 2 2 1 
36 806180f 1 1 1 1 1 2 1 2 2 2 
37 849591f 1 1 1 1 1 2 1 2 2 1 
38 818849f 1 1 1 1 2 2 1 2 2 1 
39 774811f 1 1 1 1 1 2 2 2 2 1 
40 655856f 1 1 1 2 1 2 2 2 2 1 
41 729038c 1 1 1 1 2 2 2 2 2 1 
42 881549f 1 1 1 1 1 2 1 2 2 2 
43 888054F 1 1 1 1 1 2 1 2 2 1 
44 909942f 1 1 1 1 1 1 1 2 2 1 
45 029995g 1 1 1 1 1 1 1 2 2 1 
 
dg-diagnosis (1-biopsy,2-radiological), rfk-risk factor(1-gall stone),A-weight loss, B-abdomen 
pain, C-vomiting ,D-anorexia, E-jaundice, F-cholangitis, G-early satiety, H-abdomen 
distension. O-operable, M-liver metastasis. 
Cholangiocarcinoma: 
sno hsp a s sc st ha al sm f BMI ca19-9 dg 
1 662048f 46 1 2 5 1 2 2 2 22.7 345 2 
2 655133f 52 1 2 1 1 2 2 2 20.1 3758 2 
3 625724f 31 1 2 1 1 2 2 2 18.1  2 
4 914227d 45 2 2 3 2 2 2 2 20.8 382 2 
5 823981f 34 1 3 1 2 2 1 2 23.1 1320 1 
6 747380f 44 1 2 1 2 1 1 2 24.2 100 2 
7 747493f 53 1 3 1 2 2 2 2   1 
8 709922f 55 1 2 1 1 2 1 2 21.3 44 2 
9 555931b 63 1 2 11 2 2 2 2 25.5 1150 2 
10 907095f 50 2 3 2 2 2 2 2  7 2 
11 773605F 55 1 2 16 2 2 1 2 23.4 69 2 
12 237863d 58 2 2 3 1 2 2 2 24.7 10000 1 
13 712974f 25 1 2 1 2 2 2 2 20.2 49 1 
14 902652f 60 1 3 2 2 2 1 2 21.5 308 2 
15 823981f 34 1 2 1 2 2 1 2 23.1 1320 2 
16 844096f 50 2 2 1 1 2 2 2 28.4 2890 2 
17 868214f 55 1 3 3 2 2 2 2  20100 2 
150 
 
18 773605f 55 1 2 16 1 2 1 2 23.4 69 2 
19 322427 69 1 2 2 1 2 2 2 22.8 661 1 
20 092622f 48 1 2 6 1 2 2 2 16 20 1 
21 038880g 53 1 1 20 1 2 2 2 24.5  1 
22 077967g 59 2 2 1 1 2 2 2  2 1 
23 928295F 75 1 2 6 1 1 1 2 18.1  1 
 
sno hsp A B C D E F G H O M 
1 662048f 1 1 2 2 1 2 2 1 2 1 
2 655133f 1 1 2 1 2 2 1 2 2 2 
3 625724f 1 1 2 2 1 2 1 2 2 2 
4 914227d 1 1 2 2 1 1 1 2 2 2 
5 823981f 1 2 1 1 1 2 1 2 2 2 
6 747380f 1 1 1 2 1 1 1 2 2 2 
7 747493f 1 1 1 2 1 1 1 2 2 1 
8 709922f 1 1 2 2 1 2 2 2 2 1 
9 555931b 1 1 1 1 1 2 1 2 1 2 
10 907095f 1 1 1 1 1 2 1 2 2 1 
11 773605F 1 1 1 1 1 2 1 2 2 1 
12 237863d 1 1 1 1 2 2 1 2 2 1 
13 712974f 1 1 1 2 1 2 1 2 2 2 
14 902652f 1 1 1 1 1 2 1 1 2 2 
15 823981f 1 2 1 1 1 2 2 2 2 2 
16 844096f 1 1 1 1 1 2 1 2 2 2 
17 868214f 1 1 1 1 1 1 1 2 2 2 
18 773605f 1 1 1 1 1 2 1 2 2 2 
19 322427 1 1 1 1 2 2 1 2 2 2 
20 092622f 1 1 1 1 1 1 1 1 2 2 
21 038880g 1 1 1 1 1 1 1 2 2 1 
22 077967g 2 1 1 2 2 2 2 2 1 2 
23 928295F 1 1 1 1 1 2 2 2 1 2 
 
dg-diagnosis (1-biopsy,2-radiological), rfk-risk factor(1-gall stone), A-weight loss, B-abdomen 
pain, C-vomiting ,D-anorexia, E-jaundice, F-cholangitis, G-early satiety, H-abdomen 
distension, M-liver metastasis, O-operable. 
Pancreatic malignancy: 
sno hsp a s sc st ha al sm f BMI ca19-9 dg 
1 649843f 54 1 2 2 1 2 1 2 35.2 2 1 
2 667136f 40 1 2 7 1 1 1 1 20.9 2 1 
3 668751f 74 1 2 3 1 2 2 2 19.6 390 2 
4 645836f 35 1 2 3 1 2 2 2 23.9 1 2 
5 659830f 37 2 2 2 1 2 2 2 27.6  1 
151 
 
6 653592f 42 2 2 9 1 2 2 2 23.8 369 1 
7 643027f 51 1 2 20 1 1 1 2 20.1 8 1 
8 113447c 35 2 2 2 1 2 2 2 23.4 16 2 
9 622912f 421 1 2 1 2 2 2 2 17.4 1820 1 
10 628655f 37 1 2 13 2 1 1 2 20.7 370 1 
11 494539f 71 1 2 2 2 2 2 2 20.6 144 1 
12 760955c 53 2 2 1 1 2 2 2 18.1 3275 1 
13 847095f 42 1 3 3 1 2 2 2 15.7 546 1 
14 854875f 35 2 3 1 2 2 2 2 15.4 395 1 
15 839206f 53 2 2 5 1 2 2 2 18.9 14 1 
16 775704f 50 1 3 10 2 1 2 2 19.5 411 1 
17 777014F 46 1 3 3 2 1 2 2 16.2 168 1 
18 772855F 40 1 2 3 1 1 1 2 19 59 2 
19 386933F 38 2 2 2 1 2 2 2 26.8 3 2 
20 124194F 46 2 3 18 2 2 2 2 18.9  1 
21 759768f 44 2 3 10 2 2 2 2 26.7 20000 1 
22 827662f 59 2 3 1 2 2 2 2 21.1 144 1 
23 719903f 46 2 2 2 1 2 2 2 31.1  2 
24 763976f 56 2 2 1 2 2 2 2 17.9 379 2 
25 727163f 48 1 2 1 2 2 1 2 20.6 2 1 
26 745302f 62 2 2 5 1 2 2 2 18.6  1 
27 728430f 60 1 3 1 2 2 1 2  2 2 
28 729941f 57 1 3 17 2 2 1 2 23.4 956 1 
29 710855f 61 1 3 1 2 2 1 2 21.3 3210 1 
30 777014f 46 1 3 3 2 1 1 2 17.6 169 1 
31 784232f 57 1 2 3 1 2 2 2 21 19 2 
32 781292f 52 1 2 1 1 2 1 2 23.1 32 1 
33 800517f 32 1 2 10 1 2 1 2 18.4 29 1 
34 621173f 45 2 3 13 2 2 2 2 18.6 14 1 
35 401708f 71 1 2 13 1 1 1 2 18.8 167 1 
36 795856f 56 1 2 3 1 2 1 2 18.4 126 1 
37 224567f 60 1 2 2 2 2 1 2 29.6 203 1 
38 842945f 69 2 3 4 2 2 2 2 16.9 2360 1 
39 847095f 42 1 2 3 2 1 2 2 15.6 546 2 
40 839206f 53 2 2 5 1 2 2 2 19.9  1 
41 812320F 55 2 2 1 1 2 2 2 21.8  1 
42 814699F 50 1 2 1 1 2 1 2 24.2 8 1 
43 817018F 58 1 2 2 1 2 1 2 23.3 934 1 
44 810354F 39 1 2 1 2 2 1 2 23.2 4 1 
45 832609f 53 1 2 12 2 1 1 2 19.8 34 2 
46 844311f 64 2 2 3 1 2 2 2 24.6  2 
47 883365f 54 1 3 3 2 2 1 2 16.6 2 2 
48 843681f 58 2 2 1 1 2 2 2 21.2 20900 1 
49 845175f 39 2 2 1 2 2 2 2 20.6 33900 1 
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50 312782f 56 1 2 1 2 2 2 2 18.3 318 2 
51 706632f 44 2 2 1 1 2 2 2 18.5 153 2 
52 719657f 72 1 2 1 2 1 1 2 16.6 21 2 
53 717147f 46 1 2 1 2 2 2 2  22770 2 
54 810500f 39 1 2 1 2 2 2 2 17.5 6400 1 
55 814193f 55 2 3 2 2 2 2 2 21.5 6050 1 
56 851801f 69 1 2 1 2 2 2 2 14.5 10000 2 
57 876822f 49 1 2 1 2 2 2 2 22.3  2 
58 840483f 69 1 1 5 1 2 2 2 24.9  1 
59 859323f 74 1 3 6 2 2 1 2 19.1 5680 1 
60 626115d 71 1 2 1 2 2 2 2 23.4 1980 1 
61 245660f 52 2 1 6 1 2 2 2 19.1 354 1 
62 029044g 54 2 2 1 2 2 2 2   1 
63 898095f 62 2 2 5 1 2 2 2 23.1  1 
64 001939g 42 1 2 2 2 2 1 2 30.1  1 
65 893158f 58 1 2 5 1 2 1 2 18.2 575 1 
66 914204f 55 2 2 3 2 2 2 2   1 
67 061999g 40 2 2 1 2 2 2 2 21.4 658 1 
68 073322g 62 2 2 3 1 2 2 2 30.5 10620 1 
69 073472g 29 2 2 2 1 2 2 2 24.4 2 1 
70 080596G 35 1 3 4 2 2 1 2 16.4 1340 1 
71 886693F 53 1 2 1 1 2 2 2 16.9  1 
72 096628g 44 2 2 1 2 2 2 2 16.2 7 1 
73 877153F 36 1 2 2 1 1 2 2 22.3  1 
74 923374F 51 2 2 9 1 2 2 2 17.9  1 
75 061063G 47 1 3 2 2 2 2 2 15.8 71 1 
76 068299G 64 2 2 3 1 2 2 2 24.8 459 1 
77 063348G 58 1 3 1 2 2 1 2  543 1 
78 017708G 60 1 2 2 1 1 1 2 19.5 20000 1 
79 761523f 46 1 2 1 1 2 1 2 17.6 2 1 
80 091178g 41 2 2 1 1 2 2 2 23.5 465 1 
 
sno hsp A B C D E F G H P R O M 
1 649843f 1 1 2 1 2 2 1 2 3 2 2 1 
2 667136f 1 2 2 2 1 2 1 2 1 1 1 2 
3 668751f 2 2 2 2 1 2 1 2 1 2 1 2 
4 645836f 2 1 2 1 2 2 2 2 3 2 1 2 
5 659830f 2 1 1 2 2 2 2 2 2 2 1 2 
6 653592f 2 1 2 1 2 2 2 2 1 2 2 2 
7 643027f 2 1 2 1 2 2 2 2 4 2 1 2 
8 113447c 1 1 1 1 2 2 1 2 1 2 1 2 
9 622912f 1 2 2 2 1 2 1 2 1 2 2 1 
10 628655f 1 1 1 1 2 2 2 2 1 1 1 2 
11 494539f 1 2 2 2 1 2 2 2 1 2 1 2 
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12 760955c 1 1 2 2 2 2 2 2 1 2 2 1 
13 847095f 1 2 1 2 1 2 1 1 1 2 2 2 
14 854875f 1 1 1 1 2 2 1 2 1 1 1 2 
15 839206f 1 1 1 2 1 2 1 2 1 2 2 2 
16 775704f 2 1 1 2 1 2 1 2 1 2 1 2 
17 777014F 1 1 1 1 2 2 2 2 1 1 1 2 
18 772855F 1 1 1 2 2 2 2 2 1 2 1 2 
19 386933F 2 2 2 2 2 2 2 2 1 2 1 2 
20 124194F 2 1 1 2 2 2 2 2 1 2 2 1 
21 759768f 2 1 1 2 2 2 2 2 3 2 2 1 
22 827662f 1 1 2 1 2 2 2 2 3 2 2 1 
23 719903f 2 2 1 2 2 2 2 2 1 2 1 2 
24 763976f 1 1 1 2 1 2 2 2 1 2 2 2 
25 727163f 1 1 2 1 2 2 2 2 3 1 1 2 
26 745302f 1 2 1 2 2 2 2 2 1 2 1 2 
27 728430f 1 1 1 1 1 2 1 2 3 2 1 2 
28 729941f 1 1 1 1 2 2 1 2 1 2 2 2 
29 710855f 1 1 1 1 2 2 2 2 1 1 1 2 
30 777014f 1 1 1 1 2 2 2 2 1 1 2 2 
31 784232f 2 1 1 1 2 2 1 2 1 1 2 2 
32 781292f 1 1 1 1 2 2 2 2 1 2 1 2 
33 800517f 2 1 1 2 2 2 1 2 1 2 2 2 
34 621173f 1 1 1 2 2 2 1 2 1 2 2 2 
35 401708f 1 1 1 1 1 2 1 2 1 2 2 2 
36 795856f 1 1 1 1 2 2 2 2 2 2 2 2 
37 224567f 1 1 2 2 2 2 2 2 1 2 2 2 
38 842945f 1 1 2 1 2 2 1 2 3 2 2 1 
39 847095f 1 1 1 2 1 2 1 1 1 2 2 2 
40 839206f 1 1 1 1 1 2 1 2 1 2 2 2 
41 812320F 1 1 1 1 1 2 1 2 1 2 2 2 
42 814699F 1 1 1 2 2 2 1 2 1 1 1 2 
43 817018F 1 1 1 1 2 2 2 2 3 2 2 2 
44 810354F 2 1 1 2 2 2 2 2 1 2 1 2 
45 832609f 1 1 1 1 2 2 2 2 1 2 1 2 
46 844311f 1 1 2 1 1 1 2 2 1 2 1 2 
47 883365f 1 1 1 1 1 2 1 2 1 2 2 2 
48 843681f 1 1 1 1 1 2 1 2 3 2 2 2 
49 845175f 1 1 1 1 1 2 1 2 1 2 2 2 
50 312782f 1 1 1 1 2 2 1 2 2 2 2 2 
51 706632f 1 1 1 1 1 2 1 2 1 2 1 2 
52 719657f 2 1 1 1 2 2 2 2 3 2 2 1 
53 717147f 1 1 1 1 2 2 1 2 3 1 2 2 
54 810500f 1 1 1 1 2 2 1 1 2 1 2 2 
55 814193f 1 1 1 1 2 2 1 2 3 2 2 1 
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56 851801f 1 1 1 1 1 2 1 2 1 2 2 1 
57 876822f 1 1 1 1 2 2 2 1 3 2 2 2 
58 840483f 1 1 1 1 2 2 2 2 4 2 2 1 
59 859323f 1 1 1 1 1 2 1 2 1 2 2 1 
60 626115d 1 1 1 1 2 2 1 2 2 1 2 2 
61 245660f 1 1 1 1 1 2 1 2 1 2 1 2 
62 029044g 1 1 1 1 1 2 1 2 1 2 2 2 
63 898095f 1 1 1 1 1 2 2 2 2 2 2 1 
64 001939g 2 2 2 2 2 2 2 2 4 2 1 2 
65 893158f 1 1 1 2 2 2 2 2 1 2 2 2 
66 914204f 1 1 1 1 1 1 1 2 1 2 2 1 
67 061999g 1 1 1 1 1 1 1 2 1 2 2 1 
68 073322g 1 1 1 1 2 2 1 2 3 2 2 2 
69 073472g 2 1 1 1 2 2 2 2 1 2 1 2 
70 080596G 1 1 1 1 2 2 2 2 1 2 2 2 
71 886693F 1 1 1 1 1 1 1 2 1 2 2 1 
72 096628g 1 1 1 1 2 2 1 2 5 1 2 1 
73 877153F 2 1 1 1 1 1 1 2 1 2 2 1 
74 923374F 1 1 1 1 1 2 1 2 1 2 1 2 
75 061063G 1 1 1 1 2 2 1 2 1 2 2 2 
76 068299G 1 1 1 1 2 2 1 2 3 2 2 2 
77 063348G 1 1 1 1 1 1 1 2 1 2 2 2 
78 017708G 1 1 1 1 2 2 1 2 3 2 2 2 
79 761523f 1 1 1 1 1 2 1 2 1 2 2 2 
80 091178g 1 1 1 1 2 2 2 2 5 2 1 2 
 
dg-diagnosis (1-biopsy,2-radiological), A-weight loss, B-abdomen pain, C-vomiting ,D-
anorexia, E-jaundice, F-cholangitis, G-early satiety, H-abdomen distension, R-risk factor(1-
ch pancreatitis,2-no),P-part involved(1- head, 2-uncinate process, 3-body 4- tail 5-neck),M-
liver metastasis, O-operable. 
  
Periampullary carcinoma: 
 
sno hsp age s sc st ha al sm f BMI ca19-9 b A B C D E F G H O M 
1 664773f 42 1 2 6 1 2 2 2   1 1 1 1 2 1 2 1 2 1 2 
2 608131f 70 1 2 1 1 2 2 2 21.4 1000 2 1 1 1 1 1 2 2 2 1 2 
3 266891f 54 1 3 1 1 2 2 2 18.7 5622 2 2 1 2 1 1 2 2 2 1 2 
4 680691f 571 1 2 12 2 2 2 2 21.3 45 2 2 2 2 1 1 2 1 2 1 2 
5 722295d 73 1 2 1 2 2 1 2 24.5  2 1 2 2 1 1 2 1 2 1 2 
6 507968f 40 1 3 6 2 2 2 2 18.6  1 1 2 1 1 1 2 1 2 1 2 
7 670553f 44 1 2 1 2 2 2 2 23.9 132 1 2 1 2 2 1 2 2 2 2 1 
8 880394d 53 2 2 2 1 2 2 2 36.1 12 2 1 1 2 2 1 2 2 2 1 2 
9 694914f 51 2 3 1 2 2 2 2 21.5  2 1 1 1 2 1 2 2 2 1 2 
10 697142f 63 1 2 12 1 2 2 2 20.8 8890 2 1 1 1 1 1 2 1 2 1 2 
11 691582f 472 2 3 4 2 2 2 2 19.7 2 1 2 1 2 2 2 2 2 2 1 2 
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12 691534f 38 1 3 3 2 1 1 2 19.9 10000 2 1 1 2 2 1 1 2 2 1 2 
13 691779f 55 1 2 1 2 2 2 2 22.2 41 2 1 1 2 2 1 2 1 2 1 2 
14 708907f 59 2 2 10 1 2 2 2 26.4 99 2 1 1 1 2 1 2 1 2 1 2 
15 706092f 46 2 3 3 2 2 2 2 20  1 1 1 1 2 1 2 1 2 2 1 
16 594764c 63 1 3 2 1 2 2 2 24.5 6280 1 1 1 2 1 2 2 2 2 2 1 
17 723796 58 1 3 2 2 1 1 2 31.1 99 2 1 1 1 1 1 2 1 2 2 1 
18 748950F 45 1 2 2 1 1 2 2 21.2  1 1 1 2 2 1 2 2 2 2 1 
19 901436f 53 1 3 2 2 2 1 2 21.1 17 2 1 1 1 2 1 2 2 2 1 2 
20 815470f 70 2 3 1 2 2 2 2 21.3  1 1 1 2 1 1 2 2 2 1 2 
21 806127f 42 1 3 1 2 2 1 2 21.5  1 1 1 2 1 1 2 2 2 1 2 
22 744308f 68 1 3 3 2 2 1 2 21 4060 1 1 1 1 2 1 2 1 2 2 2 
23 761813f 40 1 2 2 1 1 2 2 21.2  2 1 1 1 2 1 2 2 2 1 2 
24 725091f 55 2 2 1 2 2 2 2 15.8 45 2 1 1 1 2 1 2 2 2 1 2 
25 772426f 54 1 3 2 2 2 2 2 25.6  1 1 2 2 1 1 2 2 2     
26 475808d 46 1 2 1 1 2 1 2 21.3 62 2 1 1 1 1 1 2 2 2 1 2 
27 710068f 66 2 2 5 1 2 2 2 19.9 88 2 1 2 2 2 1 2 1 2 1 2 
28 705008f 50 1 2 3 2 2 1 2 26.8  1 1 1 1 1 2 2 1 2 2 1 
29 691779f 55 1 2 1 2 2 2 2 22.2 25 2 1 1 1 2 1 2 1 2 1 2 
30 708907f 60 2 2 10 1 2 2 2 25.7 99 2 1 1 1 1 1 2 1 2 1 2 
31 706092f 46 2 3 3 2 2 2 2 20  1 1 1 1 1 1 2 2 2 1 2 
32 713224f 53 1 2 1 1 2 1 2 18.6 10 1 1 1 1 1 2 2 1 2 2 1 
33 608131f 70 1 2 1 1 2 2 2 21.4 1000 2 1 1 1 1 1 2 1 2 2 2 
34 803659f 58 1 1 3 1 2 2 2 21.4  2 1 1 1 1 1 2 1 2 1 2 
35 788942f 44 2 3 1 2 2 2 2 21 45 2 1 1 1 1 1 1 2 2 1 2 
36 793446f 37 1 3 1 2 2 1 2 20.5 56 2 1 1 1 1 1 2 1 2 1 2 
37 491585f 46 1 2 4 2 1 1 2 18.4 332 2 1 1 1 2 1 2 2 2 1 2 
38 833289F 41 1 2 1 2 2 2 2 22.7 35 1 1 1 1 2 1 1 1 2 1 2 
39 827838F 71 2 3 3 2 2 2 2 20.5  2 1 1 1 2 1 2 2 2 1 2 
40 830892F 57 1 2 1 2 2 2 2 18.9 60100 1 1 1 1 2 1 1 1 2 1 2 
41 815726F 45 2 3 9 2 2 2 2 17.1  1 1 2 1 2 2 2 1 2 1 2 
42 825908F 52 1 2 1 2 1 1 2 19.8 10000 1 1 1 1 2 1 1 2 2 1 2 
43 827129F 31 1 3 4 2 1 2 2 19.5  3 1 1 2 1 1 2 1 2 2 2 
44 841618f 49 1 2 3 1 2 1 2 17.3 34 1 1 1 1 1 1 1 1 2 1 2 
45 840811f 34 1 3 1 2 2 2 2 17.4 16440 2 1 1 1 1 1 2 1 1 1 2 
46 690259f 45 1 2 5 1 2 1 2 21.3  2 1 2 2 1 1 1 1 2 1 2 
47 669804f 38 2 2 1 2 2 2 2 18.8 12 2 1 1 1 1 1 2 1 2 1 2 
48 485940f 41 1 3 3 2 2 2 2  71400 2 1 1 1 2 1 1 2 2 2 2 
49 864640f 51 1 2 3 2 2 1 1 27.1 311 1 1 1 1 1 1 2 1 2 1 2 
50 669804f 38 2 2 1 2 2 2 2 18.8 12 2 1 2 2 2 1 2 2 2 1 2 
51 920656f 72 1 2 3 1 2 2 2  105 1 1 1 1 1 1 1 2 2 2 2 
52 050777g 38 1 2 3 2 1 2 2 19.1 4 2 1 1 1 1 1 2 1 2 1 2 
53 045227g 55 1 2 1 2 2 1 2 21.1  3 2 2 2 2 1 2 2 2 1 2 
54 914239f 56 2 2 2 2 2 2 2   1 1 1 1 1 1 1 1 2 2 2 
55 759040f 45 1 2 2 1 2 2 2  146 1 1 1 1 1 2 2 1 2 1 2 
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56 928890f 36 2 2 2 1 2 2 2 17.8 95 2 1 1 1 1 1 1 1 2 1 2 
57 080304G 22 1 3 3 2 2 2 2 16 6220 2 1 1 1 1 1 2 2 2 2 2 
58 929747f 55 2 3 1 2 2 2 2 12.7  1 1 1 1 1 1 2 1 2 2 1 
59 090605g 40 1 3 1 2 2 2 2 18.3 28 1 1 2 1 1 1 2 1 2 2 1 
60 889711F 60 1 2 1 2 2 1 2 25.3 332 2 1 1 1 1 1 1 1 2 1 2 
61 881598F 35 1 2 4 2 1 2 2  2 2 1 1 1 1 2 2 2 2 1 2 
62 887198F 59 1 2 3 1 1 1 2 20.3 7 2 1 1 1 1 1 1 1 2 2 1 
63 040489G 59 1 2 3 1 2 2 2 22 2 2 1 2 1 1 1 2 1 2 1 2 
64 057597g 50 1 2 2 2 2 2 2 17.8 10000 2 1 1 1 1 1 1 1 2 1 2 
65 880666f 65 1 1 5 1 2 1 2 16.5 208 2 1 1 1 1 1 2 1 2 1 2 
66 909136f 74 1 3 4 2 2 2 2  1776 1 1 1 1 1 1 2 2 2 2 2 
67 874840f 55 2 2 2 1 2 2 2 19.7  2 1 1 1 1 1 2 1 2 1 2 
68 880206f 44 1 2 1 2 2 1 2 18.4  1 1 1 1 1 1 1 1 2 1 2 
69 857289f 60 1 2 2 1 1 2 2 24.1 140 2 1 1 1 1 1 2 1 2 1 2 
 
A-weight loss, B-abdomen pain, C-vomiting, D-anorexia, E-jaundice, F-cholangitis, G-early 
satiety, H-abdomen distension, b-biopsy report(1-Well differentiated adenocarcinoma,2-
Moderately differentiated adenocarcinoma,3- Poorly differentiated adenocarcinoma),O-
operable, M-liver metastasis. 
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                                                      PROFORMA 
Study number:                                                         Date: 
Name:                                                                           Hospital number: 
Age   :                                                                           Sex:  Male/ Female                        
Socioeconomic status:     
Occupation: 
Address:       
Phone number:     
Email: 
Habitat:         1) urban      2) rural                                                                         
Alcoholic/non-alcoholic: 
Smoker/non-smoker:          
Symptoms: 
Past history: previous surgery, IBD, Cirrhosis, PSC, Chronic pancreatitis, gall stones.. 
Family history of GI/HPB malignancy:  1) yes   2) no 
BMI: 
Site of involvement: 
Esophagus: Type [adenocarcinoma or squamous cell), portion involved (cervical (15-20 cm), 
upper (20-25 cm), middle (25-30cm), lower (30-40cm), or GE junction (I- esophagus, II- 
cardiac, III-subcardiac)] 
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Stomach: Type (adenocarcinoma, lymphoma, GIST), part involved [proximal (cardia) or distal 
(fundus, body, and antrum)] 
Colon / rectum: Part involved (cecum, ascending, transverse, descending, sigmoid and  rectum)  
Small bowel: Part involved (duodenum, jejunum or ileum) 
Liver – primary 
Gall Bladder 
Cholangiocarcinoma: Intra or extra hepatic {Bismuth-Corlette classification [Tumors below 
the confluence of the left and right hepatic ducts (Type I), Tumors reaching the confluence 
(Type II), Tumors occluding the common hepatic duct and either the right or left hepatic duct 
(Types IIIa and IIIb, respectively), Tumors that are multicentric, or that involve the 
confluence and both the right or left hepatic duct (Type IV)}. 
Pancreas: Part involved (head, uncinate process, body or tail), type (adenocarcinoma, cystic or 
NET) 
Periampullary  
Liver – secondary (with primary if known) 
Risk factors for malignancy: 
Esophagus:  
Barrett’s esophagus, chronic strictures – acid or alkali related / radiation related, chronic 
achalasia, Plummer-Vinson syndrome, tylosis palmaris et plantaris  
Stomach: 
H. pylori, previous gastric resection, pernicious anaemia 
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Colorectal: 
Inflammatory bowel disease, Familial polyposis coli 
Liver (Hepatocellular carcinoma): cirrhosis 
Aetiology of liver disease 
Gall Bladder:  
Adenomyomatosis, Anomolous union of the pancreaticobiliary ductal system, 
Cholangiocarcinoma, Cholelithiasis (stone size >1 cm), First-degree relative with gallbladder 
cancer, Inflammatory bowel disease, Porcelain gallbladder, Primary sclerosing cholangitis 
Bile duct: 
Primary sclerosing cholangitis, Choledochal cyst 
Pancreas: Aetiology of chronic pancreatitis 
Labs and other investigations:               
Relevant tumor markers: AFP, CEA, CA 19-9 
HBsAg, HBV-DNA, HBeAg (+ve/-ve): 
HCV- Ab, HCV-RNA:  
Endoscopy report: 
Biopsy report: 
Radiology finding: Abdomen imaging findings (1.USG / 2.CT/ 3.MRI): 
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                                              PATIENT CONSENT FORM  
 I understand that Dr Ramesh Kumar is  doing a study to find out  the spectrum of 
gastrointestinal and hepato-pancreato-biliary tract malignancies at a tertiary centre, south 
India.The study involves being interviewed about the disease and noticing the results of the test 
that are  being done by the  treating doctors for clinical care. The result of the study may not 
directly benefit me. 
Study Title: To study the spectrum of gastrointestinal and hepato-pancreato-biliary tract malignancies 
at a tertiary centre, south India. 
Study Number: 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
Please tick boxes: 
(i) I confirm that I have read and understood the information sheet dated _________ for the 
above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission to 
look at my health records both in respect of the current study and any further research that 
may be conducted in relation to it, even if I withdraw from the trial. I agree to this access. 
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However, I understand that my identity will not be revealed in any information released to 
third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
Signature of the Witness: ___________________________ 
Date: _____/_____/_______ 
Name of the Witness: ______________________________ 
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INFORMATION SHEET  
Department of Gastroenterology  
Christian Medical College  
Vellore  
To study the spectrum of gastrointestinal and hepato-pancreato-biliary tract malignancies 
at a tertiary centre in south India. 
You are being requested to participate in a study of gastrointestinal and hepato- pancreato- 
biliary tract malignancies at a tertiary centre in south India. 
What is gastrointestinal and hepato-pancreato-biliary tract malignancies? 
Gastrointestinal and hepato- pancreato- biliary tract malignancies  refers to malignant conditions 
of the gastrointestinal tract, including the food pipe , stomach, large and small bowel, liver, gall 
bladder and bile duct and  pancreas. The symptoms relate to the organ affected, and can include 
obstruction (leading to difficulty swallowing or defecating), abnormal bleeding, or belly pain 
and jaundice. The diagnosis often requires endoscopy, followed by biopsy of suspicious tissue 
and / or radiology tests like ultrasound or CT scan of the abdomen. The treatment depends on 
the location of the tumor, as well as the type of cancer cell and whether it has invaded other 
tissues or spread elsewhere in the body.  
If you take part what will you have to do?  
If you agree to participate in this study, we will not do any additional procedures or blood tests . 
We will collect information about the cancer. 
Can you withdraw from this study after it starts?  
Your participation in this study is entirely voluntary and you are also free to decide to withdraw 
permission to participate in this study. If you do so, this will not affect your usual treatment at 
this hospital in any way.  
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Are there any chances of developing any study related injury?  
As part of the study, we are not doing any extra tests or procedures or giving you any 
medication other than those required for diagnosis or treatment of your cancer. So, we do not 
expect any study related injury to occur to you.  
Will you have to pay for the study investigations?  
As we are not doing any extra investigations specifically for this study, there will be no extra 
charge as a part of the study.  
Will your personal details be kept confidential?  
The results of this study will be published in a medical journal but you will not be identified by 
name in any publication or presentation of results. However, your medical notes may be 
reviewed by people associated with the study, without your additional permission, should you 
decide to participate in this study.  
If you have any further questions, please ask Dr Ramesh Kumar (tel: 04162148/ 04162496) 
or email:gastro@cmcvellore.ac.in 
